Advanced Search (OLGA)

Gene: RGMA (repulsive guidance molecule BMP co-receptor a) Homo sapiens

Subscribe to Updates

Analyze

Symbol:

RGMA

Name:

repulsive guidance molecule BMP co-receptor a

RGD ID:

1323724

HGNC Page

HGNC:30308

Description:

Enables transferrin receptor binding activity. Involved in positive regulation of transcription by RNA polymerase II. Located in endoplasmic reticulum. Implicated in multiple sclerosis.

Type:

protein-coding

RefSeq Status:

REVIEWED

Previously known as:

repulsive guidance molecule A; repulsive guidance molecule family member a; RGM; RGM domain family, member A

RGD Orthologs

Alliance Orthologs

More Info

more info ...

Allele / Splice:

See ClinVar data

Latest Assembly:

GRCh38 - Human Genome Assembly GRCh38

NCBI Annotation Information:

Note: This gene has been reviewed for its involvement in coronavirus biology, and is locus in the vicinity of disease-associated variant(s).

Position:

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	15	93,035,271 - 93,089,211 (-)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	15	93,035,271 - 93,089,211 (-)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	15	93,578,501 - 93,632,440 (-)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	15	91,387,641 - 91,433,437 (-)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	15	91,387,640 - 91,433,437	NCBI
Celera	15	69,998,187 - 70,044,004 (-)	NCBI		Celera
Cytogenetic Map	15	q26.1	NCBI
HuRef	15	69,723,091 - 69,768,218 (-)	NCBI		HuRef
CHM1_1	15	93,427,333 - 93,473,451 (-)	NCBI		CHM1_1
T2T-CHM13v2.0	15	90,797,572 - 90,851,558 (-)	NCBI		T2T-CHM13v2.0

JBrowse:

View Region in Genome Browser (JBrowse)

Model

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
RGMA	Human	middle cerebral artery infarction	treatment	ISO	RGD:1311983	9850122		RGD
RGMA	Human	middle cerebral artery infarction	treatment	ISO	RGD:1311983	9850121		RGD
RGMA	Human	multiple sclerosis		IAGP		6892695	DNA:SNPs:intron: (rs997941, rs34925346) (human)	RGD
RGMA	Human	Penetrating Eye Injuries		ISO	RGD:1311983	9850142	protein:increased expression:retina	RGD
RGMA	Human	sciatic neuropathy		ISO	RGD:1311983	9850145		RGD
RGMA	Human	Spinal Cord Injuries	treatment	ISO	RGD:1311983	9850138		RGD
RGMA	Human	temporal lobe epilepsy		ISO	RGD:1311983	9850144	protein:decreased expression:CA3 field of hippocampus	RGD

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
RGMA	Human	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1311983	6480464	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of RGMA mRNA	CTD	PMID:27840820
RGMA	Human	1,2-dimethylhydrazine	increases expression	ISO	RGD:1323725	6480464	1,2-Dimethylhydrazine results in increased expression of RGMA mRNA	CTD	PMID:22206623
RGMA	Human	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1311983	6480464	1-Naphthylisothiocyanate results in increased expression of RGMA mRNA	CTD	PMID:30723492
RGMA	Human	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1323725	6480464	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RGMA mRNA	CTD	PMID:17942748
RGMA	Human	17alpha-ethynylestradiol	increases expression	ISO	RGD:1323725	6480464	Ethinyl Estradiol results in increased expression of RGMA mRNA	CTD	PMID:17942748
RGMA	Human	17beta-estradiol	multiple interactions	EXP		6480464	[Estradiol co-treated with TGFB1 protein] results in decreased expression of RGMA mRNA	CTD	PMID:30165855
RGMA	Human	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1323725	6480464	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in decreased expression of more ...	CTD	PMID:38995820
RGMA	Human	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1323725	6480464	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RGMA mRNA	CTD	PMID:17942748
RGMA	Human	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1311983	6480464	Tetrachlorodibenzodioxin results in decreased expression of RGMA mRNA	CTD	PMID:33387578
RGMA	Human	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		6480464	Tetrachlorodibenzodioxin affects the expression of RGMA mRNA	CTD	PMID:22574217
RGMA	Human	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1323725	6480464	Tetrachlorodibenzodioxin affects the expression of RGMA mRNA	CTD	PMID:21570461
RGMA	Human	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1311983	6480464	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of RGMA mRNA	CTD	PMID:32109520
RGMA	Human	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1323725	6480464	tetrabromobisphenol A results in decreased expression of RGMA mRNA	CTD	PMID:25172293
RGMA	Human	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		6480464	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ...	CTD	PMID:28628672
RGMA	Human	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1311983	6480464	Propylthiouracil results in decreased expression of RGMA mRNA	CTD	PMID:30047161\|PMID:36843608
RGMA	Human	acrylamide	decreases expression	ISO	RGD:1311983	6480464	Acrylamide results in decreased expression of RGMA mRNA	CTD	PMID:28959563
RGMA	Human	acrylamide	decreases expression	EXP		6480464	Acrylamide results in decreased expression of RGMA mRNA	CTD	PMID:32763439
RGMA	Human	actinomycin D	increases expression	EXP		6480464	Dactinomycin results in increased expression of RGMA mRNA	CTD	PMID:38460933
RGMA	Human	actinomycin D	multiple interactions	EXP		6480464	[Dactinomycin co-treated with nutlin 3] results in increased expression of RGMA mRNA	CTD	PMID:38460933
RGMA	Human	aflatoxin B1	increases expression	EXP		6480464	Aflatoxin B1 results in increased expression of RGMA mRNA	CTD	PMID:21641981
RGMA	Human	aflatoxin B1	increases methylation	EXP		6480464	Aflatoxin B1 results in increased methylation of RGMA 3' UTR; Aflatoxin B1 results in increased more ...	CTD	PMID:27153756\|PMID:30157460
RGMA	Human	all-trans-retinoic acid	decreases expression	EXP		6480464	Tretinoin results in decreased expression of RGMA mRNA	CTD	PMID:21934132\|PMID:23724009
RGMA	Human	alpha-Zearalanol	multiple interactions	ISO	RGD:1311983	6480464	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of RGMA mRNA	CTD	PMID:35163327
RGMA	Human	amitrole	decreases expression	ISO	RGD:1311983	6480464	Amitrole results in decreased expression of RGMA mRNA	CTD	PMID:30047161
RGMA	Human	aristolochic acid A	increases expression	EXP		6480464	aristolochic acid I results in increased expression of RGMA mRNA	CTD	PMID:33212167
RGMA	Human	arsane	affects methylation	EXP		6480464	Arsenic affects the methylation of RGMA gene	CTD	PMID:25304211
RGMA	Human	arsane	multiple interactions	EXP		6480464	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of RGMA more ...	CTD	PMID:32525701
RGMA	Human	arsenic atom	affects methylation	EXP		6480464	Arsenic affects the methylation of RGMA gene	CTD	PMID:25304211
RGMA	Human	arsenic atom	multiple interactions	EXP		6480464	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of RGMA more ...	CTD	PMID:32525701
RGMA	Human	atrazine	increases expression	EXP		6480464	Atrazine results in increased expression of RGMA mRNA	CTD	PMID:22378314
RGMA	Human	benzo[a]pyrene	multiple interactions	ISO	RGD:1323725	6480464	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of RGMA mRNA]	CTD	PMID:22228805
RGMA	Human	benzo[a]pyrene	increases expression	EXP		6480464	Benzo(a)pyrene results in increased expression of RGMA mRNA	CTD	PMID:32234424
RGMA	Human	benzo[a]pyrene	affects methylation	EXP		6480464	Benzo(a)pyrene affects the methylation of RGMA intron; Benzo(a)pyrene affects the methylation of RGMA promoter	CTD	PMID:27901495\|PMID:30157460
RGMA	Human	benzo[a]pyrene	increases methylation	EXP		6480464	Benzo(a)pyrene results in increased methylation of RGMA 3' UTR; Benzo(a)pyrene results in increased methylation of more ...	CTD	PMID:27901495
RGMA	Human	benzo[a]pyrene	increases expression	ISO	RGD:1323725	6480464	Benzo(a)pyrene results in increased expression of RGMA mRNA	CTD	PMID:22228805
RGMA	Human	beta-lapachone	increases expression	EXP		6480464	beta-lapachone results in increased expression of RGMA mRNA	CTD	PMID:38218311
RGMA	Human	bis(2-ethylhexyl) phthalate	decreases expression	EXP		6480464	Diethylhexyl Phthalate results in decreased expression of RGMA mRNA	CTD	PMID:31163220
RGMA	Human	bisphenol A	affects expression	ISO	RGD:1311983	6480464	bisphenol A affects the expression of RGMA mRNA	CTD	PMID:25181051
RGMA	Human	bisphenol A	increases expression	ISO	RGD:1323725	6480464	bisphenol A results in increased expression of RGMA mRNA	CTD	PMID:32156529\|PMID:34585602
RGMA	Human	bisphenol A	increases expression	ISO	RGD:1311983	6480464	bisphenol A results in increased expression of RGMA mRNA	CTD	PMID:30816183
RGMA	Human	bisphenol A	increases methylation	ISO	RGD:1311983	6480464	bisphenol A results in increased methylation of RGMA gene	CTD	PMID:28505145
RGMA	Human	bisphenol A	multiple interactions	EXP		6480464	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ...	CTD	PMID:28628672
RGMA	Human	bisphenol A	decreases expression	EXP		6480464	bisphenol A results in decreased expression of RGMA mRNA	CTD	PMID:27685785
RGMA	Human	bisphenol F	multiple interactions	EXP		6480464	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ...	CTD	PMID:28628672
RGMA	Human	bromobenzene	increases expression	ISO	RGD:1311983	6480464	bromobenzene results in increased expression of RGMA mRNA	CTD	PMID:32479839
RGMA	Human	butanal	increases expression	EXP		6480464	butyraldehyde results in increased expression of RGMA mRNA	CTD	PMID:26079696
RGMA	Human	cadmium atom	multiple interactions	EXP		6480464	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RGMA more ...	CTD	PMID:35301059
RGMA	Human	cadmium dichloride	increases expression	EXP		6480464	Cadmium Chloride results in increased expression of RGMA mRNA	CTD	PMID:38382870
RGMA	Human	cadmium dichloride	multiple interactions	EXP		6480464	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RGMA more ...	CTD	PMID:35301059
RGMA	Human	camptothecin	increases expression	EXP		6480464	Camptothecin results in increased expression of RGMA mRNA	CTD	PMID:38460933
RGMA	Human	cantharidin	decreases expression	ISO	RGD:1323725	6480464	Cantharidin results in decreased expression of RGMA mRNA	CTD	PMID:36907384
RGMA	Human	carbamazepine	affects expression	EXP		6480464	Carbamazepine affects the expression of RGMA mRNA	CTD	PMID:25979313
RGMA	Human	CGP 52608	multiple interactions	EXP		6480464	CGP 52608 promotes the reaction [RORA protein binds to RGMA gene]	CTD	PMID:28238834
RGMA	Human	chlorpyrifos	increases expression	ISO	RGD:1323725	6480464	Chlorpyrifos results in increased expression of RGMA mRNA	CTD	PMID:37019170
RGMA	Human	cisplatin	increases expression	EXP		6480464	Cisplatin results in increased expression of RGMA mRNA	CTD	PMID:27392435
RGMA	Human	cisplatin	multiple interactions	EXP		6480464	[Cisplatin co-treated with jinfukang] results in increased expression of RGMA mRNA	CTD	PMID:27392435
RGMA	Human	Cuprizon	increases expression	ISO	RGD:1311983	6480464	Cuprizone results in increased expression of RGMA mRNA	CTD	PMID:26577399
RGMA	Human	DDE	decreases expression	EXP		6480464	Dichlorodiphenyl Dichloroethylene results in decreased expression of RGMA mRNA	CTD	PMID:38568856
RGMA	Human	dexamethasone	decreases expression	ISO	RGD:1323725	6480464	Dexamethasone results in decreased expression of RGMA mRNA	CTD	PMID:22733784
RGMA	Human	dexamethasone	multiple interactions	EXP		6480464	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ...	CTD	PMID:28628672
RGMA	Human	dieldrin	affects methylation	ISO	RGD:1323725	6480464	Dieldrin affects the methylation of RGMA gene	CTD	PMID:38995845
RGMA	Human	dorsomorphin	multiple interactions	EXP		6480464	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ...	CTD	PMID:27188386
RGMA	Human	doxorubicin	increases expression	EXP		6480464	Doxorubicin results in increased expression of RGMA mRNA	CTD	PMID:30031762
RGMA	Human	endosulfan	decreases expression	ISO	RGD:1311983	6480464	Endosulfan results in decreased expression of RGMA mRNA	CTD	PMID:29391264
RGMA	Human	epoxiconazole	decreases expression	ISO	RGD:1323725	6480464	epoxiconazole results in decreased expression of RGMA mRNA	CTD	PMID:35436446
RGMA	Human	ethanol	increases expression	ISO	RGD:1323725	6480464	Ethanol results in increased expression of RGMA mRNA	CTD	PMID:30319688
RGMA	Human	folic acid	decreases expression	EXP		6480464	Folic Acid results in decreased expression of RGMA mRNA	CTD	PMID:21867686
RGMA	Human	fulvestrant	increases methylation	EXP		6480464	Fulvestrant results in increased methylation of RGMA gene	CTD	PMID:31601247
RGMA	Human	gentamycin	decreases expression	ISO	RGD:1311983	6480464	Gentamicins results in decreased expression of RGMA mRNA	CTD	PMID:33387578
RGMA	Human	indometacin	multiple interactions	EXP		6480464	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ...	CTD	PMID:28628672
RGMA	Human	Licochalcone B	increases expression	EXP		6480464	licochalcone B results in increased expression of RGMA mRNA	CTD	PMID:33647349
RGMA	Human	mercury dibromide	decreases expression	EXP		6480464	mercuric bromide results in decreased expression of RGMA mRNA	CTD	PMID:26272509
RGMA	Human	mercury dibromide	multiple interactions	EXP		6480464	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ...	CTD	PMID:27188386
RGMA	Human	methimazole	decreases expression	ISO	RGD:1311983	6480464	Methimazole results in decreased expression of RGMA mRNA	CTD	PMID:30047161
RGMA	Human	methoxychlor	affects methylation	ISO	RGD:1311983	6480464	Methoxychlor affects the methylation of RGMA gene	CTD	PMID:35440735
RGMA	Human	methylmercury chloride	decreases expression	EXP		6480464	methylmercuric chloride results in decreased expression of RGMA mRNA	CTD	PMID:28001369
RGMA	Human	methylphenidate	decreases expression	ISO	RGD:1323725	6480464	Methylphenidate results in decreased expression of RGMA mRNA	CTD	PMID:22470460
RGMA	Human	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	decreases expression	ISO	RGD:1323725	6480464	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of RGMA mRNA	CTD	PMID:25566086
RGMA	Human	niclosamide	decreases expression	EXP		6480464	Niclosamide results in decreased expression of RGMA mRNA	CTD	PMID:36318118
RGMA	Human	Nutlin-3	multiple interactions	EXP		6480464	[Dactinomycin co-treated with nutlin 3] results in increased expression of RGMA mRNA	CTD	PMID:38460933
RGMA	Human	Nutlin-3	increases expression	EXP		6480464	nutlin 3 results in increased expression of RGMA mRNA	CTD	PMID:38460933
RGMA	Human	okadaic acid	decreases expression	EXP		6480464	Okadaic Acid results in decreased expression of RGMA mRNA	CTD	PMID:38832940
RGMA	Human	p-chloromercuribenzoic acid	decreases expression	EXP		6480464	p-Chloromercuribenzoic Acid results in decreased expression of RGMA mRNA	CTD	PMID:26272509
RGMA	Human	p-chloromercuribenzoic acid	multiple interactions	EXP		6480464	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ...	CTD	PMID:27188386
RGMA	Human	panobinostat	multiple interactions	EXP		6480464	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ...	CTD	PMID:27188386
RGMA	Human	panobinostat	decreases expression	EXP		6480464	panobinostat results in decreased expression of RGMA mRNA	CTD	PMID:26272509
RGMA	Human	paraquat	decreases expression	ISO	RGD:1311983	6480464	Paraquat results in decreased expression of RGMA mRNA	CTD	PMID:32680482
RGMA	Human	PCB138	decreases expression	ISO	RGD:1311983	6480464	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of RGMA mRNA	CTD	PMID:23829299
RGMA	Human	perfluorooctanoic acid	multiple interactions	ISO	RGD:1311983	6480464	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of RGMA mRNA	CTD	PMID:35163327
RGMA	Human	phenylmercury acetate	decreases expression	EXP		6480464	Phenylmercuric Acetate results in decreased expression of RGMA mRNA	CTD	PMID:26272509
RGMA	Human	phenylmercury acetate	multiple interactions	EXP		6480464	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ...	CTD	PMID:27188386
RGMA	Human	propanal	increases expression	EXP		6480464	propionaldehyde results in increased expression of RGMA mRNA	CTD	PMID:26079696
RGMA	Human	SB 431542	multiple interactions	EXP		6480464	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of RGMA more ...	CTD	PMID:27188386\|PMID:37664457
RGMA	Human	silicon dioxide	decreases expression	EXP		6480464	Silicon Dioxide analog results in decreased expression of RGMA mRNA	CTD	PMID:25895662
RGMA	Human	silver atom	decreases expression	ISO	RGD:1323725	6480464	Silver results in decreased expression of RGMA mRNA	CTD	PMID:27131904
RGMA	Human	silver(0)	decreases expression	ISO	RGD:1323725	6480464	Silver results in decreased expression of RGMA mRNA	CTD	PMID:27131904
RGMA	Human	sodium arsenate	multiple interactions	EXP		6480464	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of RGMA more ...	CTD	PMID:32525701
RGMA	Human	tetrachloromethane	affects expression	ISO	RGD:1323725	6480464	Carbon Tetrachloride affects the expression of RGMA mRNA	CTD	PMID:17484886
RGMA	Human	tetrachloromethane	decreases expression	ISO	RGD:1311983	6480464	Carbon Tetrachloride results in decreased expression of RGMA mRNA	CTD	PMID:31150632
RGMA	Human	thapsigargin	decreases expression	EXP		6480464	Thapsigargin results in decreased expression of RGMA mRNA	CTD	PMID:29453283
RGMA	Human	thiram	increases expression	EXP		6480464	Thiram results in increased expression of RGMA mRNA	CTD	PMID:38568856
RGMA	Human	titanium dioxide	increases methylation	ISO	RGD:1323725	6480464	titanium dioxide results in increased methylation of RGMA gene	CTD	PMID:35295148
RGMA	Human	trichloroethene	increases expression	ISO	RGD:1311983	6480464	Trichloroethylene results in increased expression of RGMA mRNA	CTD	PMID:33387578
RGMA	Human	trichostatin A	decreases expression	EXP		6480464	trichostatin A results in decreased expression of RGMA mRNA	CTD	PMID:22723015\|PMID:24935251\|PMID:26272509
RGMA	Human	trichostatin A	multiple interactions	EXP		6480464	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ...	CTD	PMID:27188386
RGMA	Human	triclosan	increases methylation	EXP		6480464	Triclosan results in increased methylation of RGMA gene	CTD	PMID:34523531
RGMA	Human	trimellitic anhydride	decreases expression	ISO	RGD:1323725	6480464	trimellitic anhydride results in decreased expression of RGMA mRNA	CTD	PMID:19042947
RGMA	Human	urethane	increases expression	EXP		6480464	Urethane results in increased expression of RGMA mRNA	CTD	PMID:28818685
RGMA	Human	valproic acid	decreases methylation	EXP		6480464	Valproic Acid results in decreased methylation of RGMA gene	CTD	PMID:29154799
RGMA	Human	valproic acid	multiple interactions	EXP		6480464	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ...	CTD	PMID:27188386
RGMA	Human	valproic acid	decreases expression	EXP		6480464	Valproic Acid results in decreased expression of RGMA mRNA	CTD	PMID:23179753\|PMID:24383497\|PMID:24935251\|PMID:26272509\|PMID:28001369
RGMA	Human	valproic acid	affects expression	ISO	RGD:1323725	6480464	Valproic Acid affects the expression of RGMA mRNA	CTD	PMID:17963808
RGMA	Human	vorinostat	multiple interactions	EXP		6480464	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ...	CTD	PMID:27188386
RGMA	Human	vorinostat	decreases expression	EXP		6480464	vorinostat results in decreased expression of RGMA mRNA	CTD	PMID:26272509
RGMA	Human	zaragozic acid A	increases expression	ISO	RGD:1323725	6480464	squalestatin 1 results in increased expression of RGMA mRNA	CTD	PMID:27225895
RGMA	Human	zaragozic acid A	decreases expression	ISO	RGD:1311983	6480464	squalestatin 1 results in decreased expression of RGMA mRNA	CTD	PMID:27225895

Biological Process

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
RGMA	Human	BMP signaling pathway	involved_in	IBA	MGI:1916049\|MGI:1916835\|MGI:2679262\|PANTHER:PTN001265550\|UniProtKB:Q6ZVN8	150520179		GO_Central	GO_REF:0000033
RGMA	Human	BMP signaling pathway	acts_upstream_of_or_within	IEA	UniProtKB:Q6PCX7\|ensembl:ENSMUSP00000091870	150520179		Ensembl	GO_REF:0000107
RGMA	Human	membrane protein ectodomain proteolysis	acts_upstream_of	IEA	UniProtKB:Q6PCX7\|ensembl:ENSMUSP00000091870	150520179		Ensembl	GO_REF:0000107
RGMA	Human	negative regulation of axon regeneration		ISO	RGD:1311983	9068941		RGD	PMID:16585268\|REF_RGD_ID:9850138
RGMA	Human	negative regulation of axon regeneration	involved_in	IEA	UniProtKB:A6JBX6\|UniProtKB:D4A188\|ensembl:ENSRNOP00000061067	150520179		Ensembl	GO_REF:0000107
RGMA	Human	negative regulation of collateral sprouting		ISO	RGD:1311983	9068941		RGD	PMID:23744345\|REF_RGD_ID:9850124
RGMA	Human	negative regulation of collateral sprouting	involved_in	IEA	UniProtKB:A6JBX6\|UniProtKB:D4A188\|ensembl:ENSRNOP00000061067	150520179		Ensembl	GO_REF:0000107
RGMA	Human	negative regulation of neuron projection development		ISO	RGD:1311983	9068941		RGD	PMID:16585268\|PMID:21645559\|REF_RGD_ID:13703101\|REF_RGD_ID:9850138
RGMA	Human	negative regulation of neuron projection development	acts_upstream_of_or_within	IEA	UniProtKB:Q6PCX7\|ensembl:ENSMUSP00000091870	150520179		Ensembl	GO_REF:0000107
RGMA	Human	negative regulation of neuron projection development	involved_in	IEA	UniProtKB:A6JBX6\|UniProtKB:D4A188\|ensembl:ENSRNOP00000061067	150520179		Ensembl	GO_REF:0000107
RGMA	Human	neural tube closure	acts_upstream_of_or_within	IEA	UniProtKB:Q6PCX7\|ensembl:ENSMUSP00000091870	150520179		Ensembl	GO_REF:0000107
RGMA	Human	neuron projection development	acts_upstream_of_or_within	IEA	UniProtKB:Q6PCX7\|ensembl:ENSMUSP00000091870	150520179		Ensembl	GO_REF:0000107
RGMA	Human	positive regulation of GTPase activity	acts_upstream_of_or_within	ISO	RGD:1323725	9068941	PMID:26651291	MGI	PMID:26651291
RGMA	Human	positive regulation of membrane protein ectodomain proteolysis	acts_upstream_of_or_within	IEA	UniProtKB:Q6PCX7\|ensembl:ENSMUSP00000091870	150520179		Ensembl	GO_REF:0000107
RGMA	Human	positive regulation of neuron projection development		ISO	RGD:1311983	9068941		RGD	PMID:18452705\|REF_RGD_ID:9850152
RGMA	Human	positive regulation of neuron projection development	involved_in	IEA	UniProtKB:A6JBX6\|UniProtKB:D4A188\|ensembl:ENSRNOP00000061067	150520179		Ensembl	GO_REF:0000107
RGMA	Human	positive regulation of transcription by RNA polymerase II	involved_in	IDA		150520179	PMID:22728873	BHF-UCL	PMID:22728873
RGMA	Human	regulation of BMP signaling pathway	acts_upstream_of_or_within	IEA	UniProtKB:Q6PCX7\|ensembl:ENSMUSP00000091870	150520179		Ensembl	GO_REF:0000107

Cellular Component

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
RGMA	Human	cell surface	located_in	IEA	UniProtKB:Q6PCX7\|ensembl:ENSMUSP00000091870	150520179		Ensembl	GO_REF:0000107
RGMA	Human	endoplasmic reticulum	located_in	IDA		150520179		LIFEdb	GO_REF:0000054
RGMA	Human	membrane	located_in	IEA	UniProtKB-KW:KW-0472	150520179		UniProt	GO_REF:0000043
RGMA	Human	plasma membrane	located_in	IEA	UniProtKB-SubCell:SL-0039	150520179		UniProt	GO_REF:0000044
RGMA	Human	plasma membrane	located_in	IEA	UniProtKB-KW:KW-1003	150520179		UniProt	GO_REF:0000043
RGMA	Human	plasma membrane	is_active_in	IBA	MGI:1916049\|PANTHER:PTN001265550\|RGD:1310195\|UniProtKB:Q6ZVN8\|WB:WBGene00022154	150520179		GO_Central	GO_REF:0000033
RGMA	Human	side of membrane	located_in	IEA	UniProtKB-KW:KW-0336	150520179		UniProt	GO_REF:0000043

Molecular Function

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
RGMA	Human	coreceptor activity	enables	IEA	UniProtKB:Q6PCX7\|ensembl:ENSMUSP00000091870	150520179		Ensembl	GO_REF:0000107
RGMA	Human	coreceptor activity	enables	IBA	MGI:1916835\|MGI:2679262\|PANTHER:PTN001265550\|UniProtKB:Q6ZVN8	150520179		GO_Central	GO_REF:0000033
RGMA	Human	protein binding	enables	IPI	UniProtKB:Q9NYB0	150520179	PMID:21044950	IntAct	PMID:21044950
RGMA	Human	protein binding	enables	IPI	UniProtKB:Q05BL1	150520179	PMID:32296183	IntAct	PMID:32296183
RGMA	Human	protein binding	enables	IPI	UniProtKB:Q30201	150520179	PMID:22728873	BHF-UCL	PMID:22728873
RGMA	Human	protein binding	enables	IPI	UniProtKB:P12643	150520179	PMID:25938661	IntAct	PMID:25938661
RGMA	Human	signaling receptor binding	enables	IEA	UniProtKB:Q6PCX7\|ensembl:ENSMUSP00000091870	150520179		Ensembl	GO_REF:0000107
RGMA	Human	transferrin receptor binding	enables	IPI	UniProtKB:Q9UP52	150520179	PMID:22728873	BHF-UCL	PMID:22728873

Imported Annotations - PID (archival)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
RGMA	Human	Bone morphogenetic proteins signaling pathway		EXP		6484113		PID	PID:200144

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
RGMA	Human	Abnormal nervous system physiology		IAGP		6892695	increased CSF interferon-gamma expression;DNA:SNPs:intron: (rs6497019, rs725458) (human)	RGD

#	Reference Title	Reference Citation
1.	Induction of repulsive guidance molecule in neurons following sciatic nerve injury.	Doya H, etal., J Chem Neuroanat. 2006 Aug;32(1):74-7. Epub 2006 Jul 24.
2.	RGMa inhibition promotes axonal growth and recovery after spinal cord injury.	Hata K, etal., J Cell Biol. 2006 Apr 10;173(1):47-58. Epub 2006 Apr 3.
3.	RGMA and IL21R show association with experimental inflammation and multiple sclerosis.	Nohra R, etal., Genes Immun. 2010 Jun;11(4):279-93. Epub 2010 Jan 14.
4.	PID Annotation Import Pipeline	Pipeline to import Pathway Interaction Database annotations from NCI into RGD
5.	Data Import for Chemical-Gene Interactions	RGD automated import pipeline for gene-chemical interactions
6.	RGMA and neogenin protein expression are influenced by lens injury following optic nerve crush in the rat retina.	Schnichels S, etal., Graefes Arch Clin Exp Ophthalmol. 2012 Jan;250(1):39-50. doi: 10.1007/s00417-011-1791-9. Epub 2011 Sep 2.
7.	Potential roles of the RGMa-FAK-Ras pathway in hippocampal mossy fiber sprouting in the pentylenetetrazole kindling model.	Song MY, etal., Mol Med Rep. 2015 Mar;11(3):1738-44. doi: 10.3892/mmr.2014.2993. Epub 2014 Nov 21.
8.	Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.	Strausberg RL, etal., Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16899-903. Epub 2002 Dec 11.
9.	CRMP-2 is involved in axon growth inhibition induced by RGMa in vitro and in vivo.	Wang T, etal., Mol Neurobiol. 2013 Jun;47(3):903-13. doi: 10.1007/s12035-012-8385-3. Epub 2012 Dec 30.
10.	Electrical stimulation of olfactory bulb downregulates RGMa expression after ischemia/reperfusion injury in rats.	Zhang G, etal., Brain Res Bull. 2011 Oct 10;86(3-4):254-61. doi: 10.1016/j.brainresbull.2011.08.002. Epub 2011 Aug 5.

PMID:11076863	PMID:11230166	PMID:11256614	PMID:14702039	PMID:15084667	PMID:15258590	PMID:15489334	PMID:15489336	PMID:15975920	PMID:16169070	PMID:16216939	PMID:16303743
PMID:16344560	PMID:16381901	PMID:17472960	PMID:17606441	PMID:17615080	PMID:18367154	PMID:18485097	PMID:19273616	PMID:19303019	PMID:19458235	PMID:19698085	PMID:21044950
PMID:21183991	PMID:21467223	PMID:21617229	PMID:21873635	PMID:22076499	PMID:22367090	PMID:22396795	PMID:22566498	PMID:22728873	PMID:23028342	PMID:23376485	PMID:24024966
PMID:25133637	PMID:25938661	PMID:25940091	PMID:26496610	PMID:26721439	PMID:28842419	PMID:29478698	PMID:30798120	PMID:31899158	PMID:32296183	PMID:33997000	PMID:35028889
PMID:35255492	PMID:35748872	PMID:38762192

RGMA
(Homo sapiens - human)

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	15	93,035,271 - 93,089,211 (-)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	15	93,035,271 - 93,089,211 (-)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	15	93,578,501 - 93,632,440 (-)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	15	91,387,641 - 91,433,437 (-)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	15	91,387,640 - 91,433,437	NCBI
Celera	15	69,998,187 - 70,044,004 (-)	NCBI		Celera
Cytogenetic Map	15	q26.1	NCBI
HuRef	15	69,723,091 - 69,768,218 (-)	NCBI		HuRef
CHM1_1	15	93,427,333 - 93,473,451 (-)	NCBI		CHM1_1
T2T-CHM13v2.0	15	90,797,572 - 90,851,558 (-)	NCBI		T2T-CHM13v2.0

Rgma
(Mus musculus - house mouse)

Mouse Assembly	Chr	Position (strand)	Source	Genome Browsers
Mouse Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCm39	7	73,025,268 - 73,069,647 (+)	NCBI	GRCm39	GRCm39	mm39
GRCm39 Ensembl	7	73,025,257 - 73,069,647 (+)	Ensembl		GRCm39 Ensembl
GRCm38	7	73,375,520 - 73,419,899 (+)	NCBI	GRCm38	GRCm38	mm10	GRCm38
GRCm38.p6 Ensembl	7	73,375,509 - 73,419,899 (+)	Ensembl	GRCm38		mm10	GRCm38
MGSCv37	7	80,520,406 - 80,564,785 (+)	NCBI	GRCm37	MGSCv37	mm9	NCBIm37
MGSCv36	7	73,249,020 - 73,293,410 (+)	NCBI		MGSCv36	mm8
Celera	7	70,823,178 - 70,867,680 (+)	NCBI		Celera
Cytogenetic Map	7	D1	NCBI
cM Map	7	41.85	NCBI

Rgma
(Rattus norvegicus - Norway rat)

Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCr8	1	136,538,782 - 136,582,763 (+)	NCBI		GRCr8
mRatBN7.2	1	127,128,934 - 127,172,918 (+)	NCBI	mRatBN7.2	mRatBN7.2
mRatBN7.2 Ensembl	1	127,128,934 - 127,172,918 (+)	Ensembl		mRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx	1	135,121,700 - 135,165,733 (+)	NCBI	Rnor_SHR	UTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0	1	142,291,803 - 142,335,840 (+)	NCBI	Rnor_SHRSP	UTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0	1	135,115,277 - 135,159,262 (+)	NCBI	Rnor_WKY	UTH_Rnor_WKY_Bbb_1.0
Rnor_6.0	1	134,699,053 - 134,742,512 (+)	NCBI	Rnor6.0	Rnor_6.0	rn6	Rnor6.0
Rnor_6.0 Ensembl	1	134,699,299 - 134,742,514 (+)	Ensembl	Rnor6.0		rn6	Rnor6.0
Rnor_5.0	1	135,725,212 - 135,768,409 (+)	NCBI	Rnor5.0	Rnor_5.0	rn5	Rnor5.0
RGSC_v3.4	1	128,547,399 - 128,591,304 (+)	NCBI	RGSC3.4	RGSC_v3.4	rn4	RGSC3.4
RGSC_v3.1	1	128,641,975 - 128,668,760 (+)	NCBI
Celera	1	119,260,496 - 119,304,476 (+)	NCBI		Celera
Cytogenetic Map	1	q31	NCBI

Rgma
(Chinchilla lanigera - long-tailed chinchilla)

Chinchilla Assembly	Chr	Position (strand)	Source	Genome Browsers
Chinchilla Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChiLan1.0 Ensembl	NW_004955416	21,221,023 - 21,261,831 (-)	Ensembl	ChiLan1.0
ChiLan1.0	NW_004955416	21,221,023 - 21,261,831 (-)	NCBI	ChiLan1.0	ChiLan1.0

RGMA
(Pan paniscus - bonobo/pygmy chimpanzee)

Bonobo Assembly	Chr	Position (strand)	Source	Genome Browsers
Bonobo Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
NHGRI_mPanPan1-v2	16	82,590,158 - 82,635,904 (-)	NCBI		NHGRI_mPanPan1-v2
NHGRI_mPanPan1	15	86,288,195 - 86,333,861 (-)	NCBI		NHGRI_mPanPan1
Mhudiblu_PPA_v0	15	71,728,669 - 71,774,447 (-)	NCBI	Mhudiblu_PPA_v0	Mhudiblu_PPA_v0	panPan3
PanPan1.1	15	90,922,199 - 90,951,704 (-)	NCBI	panpan1.1	PanPan1.1	panPan2
PanPan1.1 Ensembl	15	90,922,199 - 90,956,179 (-)	Ensembl	panpan1.1		panPan2

RGMA
(Canis lupus familiaris - dog)

Dog Assembly	Chr	Position (strand)	Source	Genome Browsers
Dog Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
CanFam3.1	3	47,044,342 - 47,089,923 (+)	NCBI	CanFam3.1	CanFam3.1	canFam3	CanFam3.1
CanFam3.1 Ensembl	3	47,061,910 - 47,089,294 (+)	Ensembl	CanFam3.1		canFam3	CanFam3.1
Dog10K_Boxer_Tasha	3	49,744,736 - 49,788,688 (+)	NCBI		Dog10K_Boxer_Tasha
ROS_Cfam_1.0	3	47,453,705 - 47,497,710 (+)	NCBI		ROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl	3	47,453,784 - 47,498,695 (+)	Ensembl		ROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1	3	46,971,723 - 47,015,658 (+)	NCBI		UMICH_Zoey_3.1
UNSW_CanFamBas_1.0	3	47,203,068 - 47,247,025 (+)	NCBI		UNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0	3	47,534,393 - 47,578,334 (+)	NCBI		UU_Cfam_GSD_1.0

Rgma
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)

Squirrel Assembly	Chr	Position (strand)	Source	Genome Browsers
Squirrel Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HiC_Itri_2	NW_024408640	136,541,660 - 136,581,389 (-)	NCBI		HiC_Itri_2
SpeTri2.0 Ensembl	NW_004936483	9,766,275 - 9,793,001 (+)	Ensembl	SpeTri2.0	SpeTri2.0 Ensembl
SpeTri2.0	NW_004936483	9,753,112 - 9,792,817 (+)	NCBI	SpeTri2.0	SpeTri2.0		SpeTri2.0

RGMA
(Sus scrofa - pig)

Pig Assembly	Chr	Position (strand)	Source	Genome Browsers
Pig Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
Sscrofa11.1 Ensembl	7	85,921,594 - 85,968,888 (+)	Ensembl	Sscrofa11.1		susScr11	Sscrofa11.1
Sscrofa11.1	7	85,921,524 - 85,968,887 (+)	NCBI	Sscrofa11.1	Sscrofa11.1	susScr11	Sscrofa11.1
Sscrofa10.2	7	91,815,011 - 91,862,487 (+)	NCBI	Sscrofa10.2	Sscrofa10.2	susScr3

RGMA
(Chlorocebus sabaeus - green monkey)

Green Monkey Assembly	Chr	Position (strand)	Source	Genome Browsers
Green Monkey Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChlSab1.1	29	11,592,929 - 11,638,955 (-)	NCBI	ChlSab1.1	ChlSab1.1	chlSab2
ChlSab1.1 Ensembl	29	11,592,604 - 11,638,860 (-)	Ensembl	ChlSab1.1	ChlSab1.1 Ensembl	chlSab2
Vero_WHO_p1.0	NW_023666059	35,022,501 - 35,068,477 (+)	NCBI	Vero_WHO_p1.0	Vero_WHO_p1.0

Rgma
(Heterocephalus glaber - naked mole-rat)

Naked Mole-Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Naked Mole-Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HetGla_female_1.0 Ensembl	NW_004624768	10,751,991 - 10,778,050 (+)	Ensembl	HetGla_female_1.0	HetGla_female_1.0 Ensembl	hetGla2
HetGla 1.0	NW_004624768	10,739,674 - 10,778,036 (+)	NCBI	HetGla_female_1.0	HetGla 1.0	hetGla2

Variants in RGMA
58 total Variants

Name	Type	Condition(s)	Position(s)	Clinical significance
GRCh38/hg38 15q26.1-26.3(chr15:89679237-101978958)x3	copy number gain	See cases [RCV000052354]	Chr15:89679237..101978958 [GRCh38] Chr15:90222468..102519161 [GRCh37] Chr15:88023472..100336684 [NCBI36] Chr15:15q26.1-26.3	pathogenic
GRCh38/hg38 15q24.2-26.3(chr15:75307767-101723215)x3	copy number gain	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052346]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052346]\|See cases [RCV000052346]	Chr15:75307767..101723215 [GRCh38] Chr15:75600108..102263418 [GRCh37] Chr15:73387161..100080941 [NCBI36] Chr15:15q24.2-26.3	pathogenic
GRCh38/hg38 15q24.3-26.3(chr15:77543797-101843411)x3	copy number gain	See cases [RCV000052347]	Chr15:77543797..101843411 [GRCh38] Chr15:77836139..102383614 [GRCh37] Chr15:75623194..100201137 [NCBI36] Chr15:15q24.3-26.3	pathogenic
GRCh38/hg38 15q25.2-26.3(chr15:84169153-101904929)x3	copy number gain	See cases [RCV000052352]	Chr15:84169153..101904929 [GRCh38] Chr15:84837905..102445132 [GRCh37] Chr15:82628909..100262655 [NCBI36] Chr15:15q25.2-26.3	pathogenic
GRCh38/hg38 15q26.1(chr15:92780719-93487233)x3	copy number gain	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052135]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052135]\|See cases [RCV000052135]	Chr15:92780719..93487233 [GRCh38] Chr15:93323949..94030462 [GRCh37] Chr15:91124953..91831466 [NCBI36] Chr15:15q26.1	uncertain significance
GRCh38/hg38 15q26.1(chr15:92170113-93438995)x1	copy number loss	See cases [RCV000053225]	Chr15:92170113..93438995 [GRCh38] Chr15:92713343..93982224 [GRCh37] Chr15:90514347..91783228 [NCBI36] Chr15:15q26.1	pathogenic
GRCh38/hg38 15q25.2-26.3(chr15:83711377-101843270)x3	copy number gain	See cases [RCV000135858]	Chr15:83711377..101843270 [GRCh38] Chr15:84380129..102383473 [GRCh37] Chr15:82171133..100200996 [NCBI36] Chr15:15q25.2-26.3	pathogenic
GRCh38/hg38 15q25.3-26.3(chr15:87904735-101843270)x3	copy number gain	See cases [RCV000135568]	Chr15:87904735..101843270 [GRCh38] Chr15:88447966..102383473 [GRCh37] Chr15:86248970..100200996 [NCBI36] Chr15:15q25.3-26.3	pathogenic
GRCh38/hg38 15q25.2-26.3(chr15:82859676-101810992)x3	copy number gain	See cases [RCV000136849]	Chr15:82859676..101810992 [GRCh38] Chr15:83528428..102351195 [GRCh37] Chr15:81325482..100168718 [NCBI36] Chr15:15q25.2-26.3	pathogenic
GRCh38/hg38 15q25.3-26.3(chr15:85826665-101920998)x4	copy number gain	See cases [RCV000137264]	Chr15:85826665..101920998 [GRCh38] Chr15:86369896..102461201 [GRCh37] Chr15:84170900..100278724 [NCBI36] Chr15:15q25.3-26.3	pathogenic
GRCh38/hg38 15q26.1(chr15:93070246-93607464)x3	copy number gain	See cases [RCV000138876]	Chr15:93070246..93607464 [GRCh38] Chr15:93613475..94150693 [GRCh37] Chr15:91414479..91951697 [NCBI36] Chr15:15q26.1	uncertain significance
GRCh38/hg38 15q26.1(chr15:92900864-93043584)x1	copy number loss	See cases [RCV000139809]	Chr15:92900864..93043584 [GRCh38] Chr15:93444094..93586814 [GRCh37] Chr15:91245098..91387818 [NCBI36] Chr15:15q26.1	likely pathogenic\|uncertain significance
GRCh38/hg38 15q26.1-26.3(chr15:93041524-101941326)x3	copy number gain	See cases [RCV000141431]	Chr15:93041524..101941326 [GRCh38] Chr15:93584754..102481529 [GRCh37] Chr15:91385758..100299052 [NCBI36] Chr15:15q26.1-26.3	pathogenic
GRCh38/hg38 15q25.3-26.3(chr15:85397539-101888909)x3	copy number gain	See cases [RCV000141899]	Chr15:85397539..101888909 [GRCh38] Chr15:85940770..102429112 [GRCh37] Chr15:83741774..100246635 [NCBI36] Chr15:15q25.3-26.3	pathogenic
GRCh38/hg38 15q22.2-26.3(chr15:59828460-101920998)x3	copy number gain	See cases [RCV000142915]	Chr15:59828460..101920998 [GRCh38] Chr15:60120659..102461201 [GRCh37] Chr15:57907951..100278724 [NCBI36] Chr15:15q22.2-26.3	pathogenic
GRCh38/hg38 15q23-26.3(chr15:72154949-101920998)x3	copy number gain	See cases [RCV000143019]	Chr15:72154949..101920998 [GRCh38] Chr15:72447290..102461201 [GRCh37] Chr15:70234344..100278724 [NCBI36] Chr15:15q23-26.3	pathogenic
GRCh38/hg38 15q26.1-26.3(chr15:88676575-98364743)x3	copy number gain	See cases [RCV000142727]	Chr15:88676575..98364743 [GRCh38] Chr15:89219806..98907972 [GRCh37] Chr15:87020810..96725495 [NCBI36] Chr15:15q26.1-26.3	pathogenic
GRCh37/hg19 15q24.2-26.3(chr15:76061144-102429112)x3	copy number gain	See cases [RCV000511332]	Chr15:76061144..102429112 [GRCh37] Chr15:15q24.2-26.3	pathogenic
GRCh37/hg19 15q26.1-26.3(chr15:92197136-102354857)x1	copy number loss	See cases [RCV000240535]	Chr15:92197136..102354857 [GRCh37] Chr15:15q26.1-26.3	pathogenic
GRCh37/hg19 15q22.31-26.3(chr15:64637227-102509910)x3	copy number gain	See cases [RCV000240602]	Chr15:64637227..102509910 [GRCh37] Chr15:15q22.31-26.3	pathogenic
GRCh37/hg19 15q22.1-26.3(chr15:59297293-102480888)x3	copy number gain	not provided [RCV000415836]	Chr15:59297293..102480888 [GRCh37] Chr15:15q22.1-26.3	likely pathogenic
GRCh37/hg19 15q25.2-26.3(chr15:85089467-102495441)x3	copy number gain	See cases [RCV000449119]	Chr15:85089467..102495441 [GRCh37] Chr15:15q25.2-26.3	pathogenic
GRCh37/hg19 15q15.1-26.3(chr15:41745084-102354798)x4	copy number gain	See cases [RCV000447123]	Chr15:41745084..102354798 [GRCh37] Chr15:15q15.1-26.3	pathogenic
GRCh37/hg19 15q26.1-26.3(chr15:90346994-102354798)	copy number loss	See cases [RCV000447603]	Chr15:90346994..102354798 [GRCh37] Chr15:15q26.1-26.3	pathogenic
GRCh37/hg19 15q26.1-26.3(chr15:89924847-102429112)x3	copy number gain	See cases [RCV000445978]	Chr15:89924847..102429112 [GRCh37] Chr15:15q26.1-26.3	pathogenic
GRCh37/hg19 15q25.1-26.3(chr15:80648093-102429112)x3	copy number gain	See cases [RCV000445705]	Chr15:80648093..102429112 [GRCh37] Chr15:15q25.1-26.3	pathogenic
GRCh37/hg19 15q11.2-26.3(chr15:20733395-102511616)x4	copy number gain	See cases [RCV000447765]	Chr15:20733395..102511616 [GRCh37] Chr15:15q11.2-26.3	pathogenic
GRCh37/hg19 15q25.3-26.3(chr15:86148286-102511616)x3	copy number gain	See cases [RCV000448044]	Chr15:86148286..102511616 [GRCh37] Chr15:15q25.3-26.3	pathogenic
GRCh37/hg19 15q25.3-26.1(chr15:88295992-94215607)x1	copy number loss	See cases [RCV000448680]	Chr15:88295992..94215607 [GRCh37] Chr15:15q25.3-26.1	pathogenic
GRCh37/hg19 15q26.1(chr15:91589712-93889459)x1	copy number loss	See cases [RCV000448390]	Chr15:91589712..93889459 [GRCh37] Chr15:15q26.1	pathogenic
GRCh37/hg19 15q11.2-26.3(chr15:22770422-102429112)x3	copy number gain	See cases [RCV000510717]	Chr15:22770422..102429112 [GRCh37] Chr15:15q11.2-26.3	pathogenic
GRCh37/hg19 15q11.2-26.3(chr15:22770422-102429112)	copy number gain	See cases [RCV000512019]	Chr15:22770422..102429112 [GRCh37] Chr15:15q11.2-26.3	pathogenic
GRCh37/hg19 15q26.1-26.3(chr15:93148806-102429112)x3	copy number gain	See cases [RCV000511719]	Chr15:93148806..102429112 [GRCh37] Chr15:15q26.1-26.3	pathogenic
GRCh37/hg19 15q25.3-26.3(chr15:86899001-98734014)x3	copy number gain	See cases [RCV000511629]	Chr15:86899001..98734014 [GRCh37] Chr15:15q25.3-26.3	likely pathogenic
NM_020211.3(RGMA):c.1238T>C (p.Leu413Pro)	single nucleotide variant	not specified [RCV004290350]	Chr15:93045113 [GRCh38] Chr15:93588343 [GRCh37] Chr15:15q26.1	uncertain significance
Single allele	duplication	not provided [RCV000677926]	Chr15:31115047..102354857 [GRCh37] Chr15:15q13.2-26.3	pathogenic
GRCh37/hg19 15q26.1-26.3(chr15:89743929-102429112)x3	copy number gain	not provided [RCV000683718]	Chr15:89743929..102429112 [GRCh37] Chr15:15q26.1-26.3	pathogenic
GRCh37/hg19 15q23-26.3(chr15:71329220-102270758)x3	copy number gain	not provided [RCV000683703]	Chr15:71329220..102270758 [GRCh37] Chr15:15q23-26.3	pathogenic
GRCh37/hg19 15q24.3-26.3(chr15:77479244-102429112)x3	copy number gain	not provided [RCV000683710]	Chr15:77479244..102429112 [GRCh37] Chr15:15q24.3-26.3	pathogenic
GRCh37/hg19 15q25.3-26.3(chr15:88385150-102461162)x3	copy number gain	not provided [RCV000738864]	Chr15:88385150..102461162 [GRCh37] Chr15:15q25.3-26.3	pathogenic
GRCh37/hg19 15q11.1-26.3(chr15:20071673-102461162)x3	copy number gain	not provided [RCV000751156]	Chr15:20071673..102461162 [GRCh37] Chr15:15q11.1-26.3	pathogenic
GRCh37/hg19 15q26.1-26.3(chr15:90277151-102376761)x3	copy number gain	not provided [RCV000751387]	Chr15:90277151..102376761 [GRCh37] Chr15:15q26.1-26.3	pathogenic
GRCh37/hg19 15q11.1-26.3(chr15:20016811-102493540)x3	copy number gain	not provided [RCV000751155]	Chr15:20016811..102493540 [GRCh37] Chr15:15q11.1-26.3	pathogenic
NM_020211.3(RGMA):c.62G>A (p.Arg21Lys)	single nucleotide variant	not specified [RCV004319761]	Chr15:93072984 [GRCh38] Chr15:93616213 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.15-686T>C	single nucleotide variant	not provided [RCV000881400]	Chr15:93073717 [GRCh38] Chr15:93616946 [GRCh37] Chr15:15q26.1	benign
NM_020211.3(RGMA):c.924C>T (p.Asp308=)	single nucleotide variant	not provided [RCV000884063]	Chr15:93045427 [GRCh38] Chr15:93588657 [GRCh37] Chr15:15q26.1	benign
GRCh37/hg19 15q26.1-26.3(chr15:90288175-102429112)x3	copy number gain	not provided [RCV000846885]	Chr15:90288175..102429112 [GRCh37] Chr15:15q26.1-26.3	pathogenic
GRCh37/hg19 15q26.1(chr15:91229877-93677014)x1	copy number loss	not provided [RCV000847986]	Chr15:91229877..93677014 [GRCh37] Chr15:15q26.1	pathogenic
GRCh37/hg19 15q26.1(chr15:93498365-93714012)x3	copy number gain	not provided [RCV000849254]	Chr15:93498365..93714012 [GRCh37] Chr15:15q26.1	uncertain significance
GRCh37/hg19 15q26.1(chr15:93601771-94043109)x3	copy number gain	not provided [RCV000849988]	Chr15:93601771..94043109 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.1166A>G (p.Asn389Ser)	single nucleotide variant	not specified [RCV004300395]	Chr15:93045185 [GRCh38] Chr15:93588415 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.371C>T (p.Pro124Leu)	single nucleotide variant	not specified [RCV004294520]	Chr15:93052267 [GRCh38] Chr15:93595497 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.1057G>A (p.Glu353Lys)	single nucleotide variant	not specified [RCV004284268]	Chr15:93045294 [GRCh38] Chr15:93588524 [GRCh37] Chr15:15q26.1	uncertain significance
GRCh37/hg19 15q25.3-26.3(chr15:87189245-102429112)x1	copy number loss	not provided [RCV001006718]	Chr15:87189245..102429112 [GRCh37] Chr15:15q25.3-26.3	pathogenic
GRCh37/hg19 15q26.1(chr15:93451635-93885876)x3	copy number gain	not provided [RCV001006724]	Chr15:93451635..93885876 [GRCh37] Chr15:15q26.1	uncertain significance
GRCh37/hg19 15q26.1(chr15:93373121-93747449)x3	copy number gain	not provided [RCV001006723]	Chr15:93373121..93747449 [GRCh37] Chr15:15q26.1	uncertain significance
GRCh37/hg19 15q26.1-26.3(chr15:92335751-102399741)x1	copy number loss	not provided [RCV001537887]	Chr15:92335751..102399741 [GRCh37] Chr15:15q26.1-26.3	pathogenic
GRCh37/hg19 15q25.3-26.3(chr15:86962053-102531392)x1	copy number loss	See cases [RCV001263026]	Chr15:86962053..102531392 [GRCh37] Chr15:15q25.3-26.3	pathogenic
GRCh37/hg19 15q25.3-26.2(chr15:88465861-94411846)x1	copy number loss	not provided [RCV001795547]	Chr15:88465861..94411846 [GRCh37] Chr15:15q25.3-26.2	pathogenic
GRCh37/hg19 15q26.1(chr15:89520451-93926491)x1	copy number loss	not provided [RCV001827973]	Chr15:89520451..93926491 [GRCh37] Chr15:15q26.1	pathogenic
NM_020211.3(RGMA):c.482C>T (p.Thr161Met)	single nucleotide variant	not specified [RCV004233760]	Chr15:93052156 [GRCh38] Chr15:93595386 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.307G>A (p.Val103Ile)	single nucleotide variant	not specified [RCV004200175]	Chr15:93052331 [GRCh38] Chr15:93595561 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.711C>G (p.Asp237Glu)	single nucleotide variant	not specified [RCV004239940]	Chr15:93045640 [GRCh38] Chr15:93588870 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.15-695A>C	single nucleotide variant	not specified [RCV004138218]	Chr15:93073726 [GRCh38] Chr15:93616955 [GRCh37] Chr15:15q26.1	uncertain significance
GRCh37/hg19 15q24.3-26.3(chr15:77512817-102035027)x3	copy number gain	not provided [RCV002475797]	Chr15:77512817..102035027 [GRCh37] Chr15:15q24.3-26.3	pathogenic
NM_020211.3(RGMA):c.23T>C (p.Leu8Pro)	single nucleotide variant	not specified [RCV004141187]	Chr15:93073023 [GRCh38] Chr15:93616252 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.706A>G (p.Met236Val)	single nucleotide variant	not specified [RCV004124554]	Chr15:93045645 [GRCh38] Chr15:93588875 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.15-713G>A	single nucleotide variant	not specified [RCV004226693]	Chr15:93073744 [GRCh38] Chr15:93616973 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.464C>T (p.Ser155Leu)	single nucleotide variant	not specified [RCV004134851]	Chr15:93052174 [GRCh38] Chr15:93595404 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.1322C>T (p.Pro441Leu)	single nucleotide variant	not specified [RCV004080336]	Chr15:93045029 [GRCh38] Chr15:93588259 [GRCh37] Chr15:15q26.1	likely benign
NM_020211.3(RGMA):c.1058A>G (p.Glu353Gly)	single nucleotide variant	not specified [RCV004162065]	Chr15:93045293 [GRCh38] Chr15:93588523 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.40G>A (p.Ala14Thr)	single nucleotide variant	not specified [RCV004143610]	Chr15:93073006 [GRCh38] Chr15:93616235 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.1037G>T (p.Ser346Ile)	single nucleotide variant	not specified [RCV004109413]	Chr15:93045314 [GRCh38] Chr15:93588544 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.748G>A (p.Gly250Ser)	single nucleotide variant	not specified [RCV004121627]	Chr15:93045603 [GRCh38] Chr15:93588833 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.530G>A (p.Arg177His)	single nucleotide variant	not specified [RCV004195575]	Chr15:93052108 [GRCh38] Chr15:93595338 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.316A>G (p.Ile106Val)	single nucleotide variant	not specified [RCV004139967]	Chr15:93052322 [GRCh38] Chr15:93595552 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.67G>A (p.Ala23Thr)	single nucleotide variant	not specified [RCV004186415]	Chr15:93072979 [GRCh38] Chr15:93616208 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.74G>C (p.Arg25Pro)	single nucleotide variant	not specified [RCV004097894]	Chr15:93072972 [GRCh38] Chr15:93616201 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.1318G>A (p.Val440Ile)	single nucleotide variant	not specified [RCV004253613]	Chr15:93045033 [GRCh38] Chr15:93588263 [GRCh37] Chr15:15q26.1	likely benign
NM_020211.3(RGMA):c.383C>T (p.Thr128Met)	single nucleotide variant	not specified [RCV004276365]	Chr15:93052255 [GRCh38] Chr15:93595485 [GRCh37] Chr15:15q26.1	uncertain significance
GRCh37/hg19 15q25.2-26.3(chr15:84228005-102264590)x3	copy number gain	not provided [RCV003222840]	Chr15:84228005..102264590 [GRCh37] Chr15:15q25.2-26.3	pathogenic
NM_020211.3(RGMA):c.220G>A (p.Glu74Lys)	single nucleotide variant	not specified [RCV004280883]	Chr15:93052418 [GRCh38] Chr15:93595648 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.55A>G (p.Met19Val)	single nucleotide variant	not specified [RCV004274499]	Chr15:93072991 [GRCh38] Chr15:93616220 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.515G>A (p.Arg172Lys)	single nucleotide variant	not specified [RCV004265444]	Chr15:93052123 [GRCh38] Chr15:93595353 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.154A>C (p.Lys52Gln)	single nucleotide variant	not specified [RCV004269136]	Chr15:93052484 [GRCh38] Chr15:93595714 [GRCh37] Chr15:15q26.1	uncertain significance
GRCh37/hg19 15q24.1-26.3(chr15:75165490-102520892)x3	copy number gain	See cases [RCV003329502]	Chr15:75165490..102520892 [GRCh37] Chr15:15q24.1-26.3	pathogenic
NM_020211.3(RGMA):c.970C>G (p.Gln324Glu)	single nucleotide variant	not specified [RCV004361787]	Chr15:93045381 [GRCh38] Chr15:93588611 [GRCh37] Chr15:15q26.1	uncertain significance
GRCh37/hg19 15q26.1(chr15:93531889-93588745)x1	copy number loss	not specified [RCV003987124]	Chr15:93531889..93588745 [GRCh37] Chr15:15q26.1	pathogenic
NM_020211.3(RGMA):c.619G>A (p.Gly207Ser)	single nucleotide variant	not specified [RCV004448901]	Chr15:93052019 [GRCh38] Chr15:93595249 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.1298G>T (p.Arg433Leu)	single nucleotide variant	not specified [RCV004448900]	Chr15:93045053 [GRCh38] Chr15:93588283 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.754G>A (p.Asp252Asn)	single nucleotide variant	not specified [RCV004448902]	Chr15:93045597 [GRCh38] Chr15:93588827 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.310C>A (p.His104Asn)	single nucleotide variant	not specified [RCV004658385]	Chr15:93052328 [GRCh38] Chr15:93595558 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.977A>C (p.Asp326Ala)	single nucleotide variant	not specified [RCV004658388]	Chr15:93045374 [GRCh38] Chr15:93588604 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.1028C>G (p.Ala343Gly)	single nucleotide variant	not specified [RCV004658387]	Chr15:93045323 [GRCh38] Chr15:93588553 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.493C>G (p.Leu165Val)	single nucleotide variant	not specified [RCV004658389]	Chr15:93052145 [GRCh38] Chr15:93595375 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.178G>A (p.Ala60Thr)	single nucleotide variant	not specified [RCV004671911]	Chr15:93052460 [GRCh38] Chr15:93595690 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.1217C>T (p.Ser406Phe)	single nucleotide variant	not specified [RCV004671912]	Chr15:93045134 [GRCh38] Chr15:93588364 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.370C>T (p.Pro124Ser)	single nucleotide variant	not specified [RCV004658386]	Chr15:93052268 [GRCh38] Chr15:93595498 [GRCh37] Chr15:15q26.1	uncertain significance
GRCh37/hg19 15q26.1(chr15:93495444-93836167)x3	copy number gain	not provided [RCV004819619]	Chr15:93495444..93836167 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.421A>C (p.Ser141Arg)	single nucleotide variant	not specified [RCV004850187]	Chr15:93052217 [GRCh38] Chr15:93595447 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.712G>A (p.Glu238Lys)	single nucleotide variant	not specified [RCV004855295]	Chr15:93045639 [GRCh38] Chr15:93588869 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.155A>G (p.Lys52Arg)	single nucleotide variant	not specified [RCV004855297]	Chr15:93052483 [GRCh38] Chr15:93595713 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.395C>T (p.Ala132Val)	single nucleotide variant	not specified [RCV004855298]	Chr15:93052243 [GRCh38] Chr15:93595473 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.524C>G (p.Thr175Ser)	single nucleotide variant	not specified [RCV004855299]	Chr15:93052114 [GRCh38] Chr15:93595344 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.383C>G (p.Thr128Arg)	single nucleotide variant	not specified [RCV004850192]	Chr15:93052255 [GRCh38] Chr15:93595485 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.177C>A (p.Ser59Arg)	single nucleotide variant	not specified [RCV004850193]	Chr15:93052461 [GRCh38] Chr15:93595691 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.362C>G (p.Thr121Ser)	single nucleotide variant	not specified [RCV004850188]	Chr15:93052276 [GRCh38] Chr15:93595506 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.529C>T (p.Arg177Cys)	single nucleotide variant	not specified [RCV004850189]	Chr15:93052109 [GRCh38] Chr15:93595339 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.1207A>C (p.Met403Leu)	single nucleotide variant	not specified [RCV004850190]	Chr15:93045144 [GRCh38] Chr15:93588374 [GRCh37] Chr15:15q26.1	uncertain significance
NM_020211.3(RGMA):c.359C>A (p.Pro120His)	single nucleotide variant	not specified [RCV004850191]	Chr15:93052279 [GRCh38] Chr15:93595509 [GRCh37] Chr15:15q26.1	uncertain significance

Predicted Target Of

	Summary Value
Count of predictions:	10921
Count of miRNA genes:	1133
Interacting mature miRNAs:	1419
Transcripts:	ENST00000329082, ENST00000425933, ENST00000538818, ENST00000542321, ENST00000543599, ENST00000554387, ENST00000555584, ENST00000555598, ENST00000556087, ENST00000556658, ENST00000556950, ENST00000557301, ENST00000557420, ENST00000557608
Prediction methods:	Microtar, Miranda, Rnahybrid
Result types:	miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

The following QTLs overlap with this region.

RGD ID	Symbol	Name	LOD	P Value	Trait	Sub Trait	Chr	Start	Stop	Species
597199289	GWAS1295363_H	pregnancy disorder QTL GWAS1295363 (human)		5e-11	pregnancy disorder		15	93045079	93045080	Human
597172122	GWAS1268196_H	repulsive guidance molecule A measurement QTL GWAS1268196 (human)		6e-22	repulsive guidance molecule A measurement		15	93044800	93044801	Human
596981591	GWAS1101110_H	memory performance QTL GWAS1101110 (human)		0.0000008	memory performance		15	93063657	93063658	Human
597139413	GWAS1235487_H	diastolic blood pressure, systolic blood pressure QTL GWAS1235487 (human)		0.00001	diastolic blood pressure, systolic blood pressure	systolic blood pressure (CMO:0000004)	15	93067206	93067207	Human
597133937	GWAS1230011_H	memory performance QTL GWAS1230011 (human)		0.0000008	memory performance		15	93063657	93063658	Human
596981587	GWAS1101106_H	memory performance QTL GWAS1101106 (human)		0.0000004	memory performance		15	93064369	93064370	Human
597235551	GWAS1331625_H	blood protein measurement QTL GWAS1331625 (human)		2e-17	blood protein amount (VT:0005416)	blood protein measurement (CMO:0000028)	15	93066958	93066959	Human
597193844	GWAS1289918_H	memory performance QTL GWAS1289918 (human)		0.000001	memory performance		15	93063466	93063467	Human
597311380	GWAS1407454_H	COVID-19 QTL GWAS1407454 (human)		2e-08	COVID-19		15	93046840	93046841	Human
597311797	GWAS1407871_H	COVID-19 QTL GWAS1407871 (human)		9e-13	COVID-19		15	93046840	93046841	Human
597301397	GWAS1397471_H	repulsive guidance molecule A measurement QTL GWAS1397471 (human)		3e-16	repulsive guidance molecule A measurement		15	93072785	93072786	Human
597399914	GWAS1495988_H	repulsive guidance molecule A measurement QTL GWAS1495988 (human)		2e-11	repulsive guidance molecule A measurement		15	93066231	93066232	Human
597198571	GWAS1294645_H	repulsive guidance molecule A measurement QTL GWAS1294645 (human)		6e-14	repulsive guidance molecule A measurement		15	93044813	93044814	Human
597393160	GWAS1489234_H	blood protein measurement QTL GWAS1489234 (human)		2e-10	blood protein amount (VT:0005416)	blood protein measurement (CMO:0000028)	15	93066231	93066232	Human
597322092	GWAS1418166_H	diastolic blood pressure, systolic blood pressure QTL GWAS1418166 (human)		3e-08	diastolic blood pressure, systolic blood pressure	systolic blood pressure (CMO:0000004)	15	93067206	93067207	Human
596982178	GWAS1101697_H	memory performance QTL GWAS1101697 (human)		0.000001	memory performance		15	93063466	93063467	Human
597523973	GWAS1620047_H	hemojuvelin measurement QTL GWAS1620047 (human)		1e-34	hemojuvelin measurement		15	93066542	93066543	Human
597226402	GWAS1322476_H	heel bone mineral density QTL GWAS1322476 (human)		3e-12	heel bone mineral density	bone mineral density (CMO:0001226)	15	93045034	93045035	Human
597133933	GWAS1230007_H	memory performance QTL GWAS1230007 (human)		0.0000004	memory performance		15	93064369	93064370	Human
597150317	GWAS1246391_H	lifestyle measurement, anxiety disorder measurement QTL GWAS1246391 (human)		4e-08	anxiety-related behavior trait (VT:0010716)		15	93073604	93073605	Human
597035274	GWAS1131348_H	heel bone mineral density QTL GWAS1131348 (human)		6e-10	heel bone mineral density	bone mineral density (CMO:0001226)	15	93041192	93041193	Human
406945727	GWAS594703_H	heel bone mineral density QTL GWAS594703 (human)		7e-15	heel bone mineral density	bone mineral density (CMO:0001226)	15	93045034	93045035	Human
597527554	GWAS1623628_H	repulsive guidance molecule A measurement QTL GWAS1623628 (human)		3e-54	repulsive guidance molecule A measurement		15	93066542	93066543	Human

A008J37

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	15	93,587,471 - 93,587,683	UniSTS	GRCh37
Build 36	15	91,388,475 - 91,388,687	RGD	NCBI36
Celera	15	69,999,022 - 69,999,234	RGD
Cytogenetic Map	15	q26.1	UniSTS
HuRef	15	69,723,926 - 69,724,138	UniSTS
GeneMap99-GB4 RH Map	15	336.34	UniSTS
NCBI RH Map	15	720.2	UniSTS

G63723

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	15	93,626,957 - 93,627,058	UniSTS	GRCh37
Build 36	15	91,427,961 - 91,428,062	RGD	NCBI36
Celera	15	70,038,513 - 70,038,614	RGD
Cytogenetic Map	15	q26.1	UniSTS
HuRef	15	69,763,417 - 69,763,518	UniSTS
TNG Radiation Hybrid Map	15	37678.0	UniSTS

RGMA__6886

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	15	93,586,619 - 93,587,232	UniSTS	GRCh37
Build 36	15	91,387,623 - 91,388,236	RGD	NCBI36
Celera	15	69,998,170 - 69,998,783	RGD
HuRef	15	69,723,074 - 69,723,687	UniSTS

WI-17713

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	3	71,005,249 - 71,005,379	UniSTS	GRCh37
Build 36	3	71,087,939 - 71,088,069	RGD	NCBI36
Celera	3	70,932,173 - 70,932,303	RGD
Celera	15	70,030,106 - 70,030,235	UniSTS
Cytogenetic Map	15	q26.1	UniSTS
Cytogenetic Map	3	p14.1	UniSTS
HuRef	15	69,755,010 - 69,755,139	UniSTS
HuRef	3	71,004,166 - 71,004,296	UniSTS
GeneMap99-GB4 RH Map	3	215.23	UniSTS
Whitehead-RH Map	3	249.2	UniSTS

RH47538

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	15	93,586,702 - 93,586,791	UniSTS	GRCh37
Build 36	15	91,387,706 - 91,387,795	RGD	NCBI36
Celera	15	69,998,253 - 69,998,342	RGD
Cytogenetic Map	15	q26.1	UniSTS
HuRef	15	69,723,157 - 69,723,246	UniSTS
GeneMap99-GB4 RH Map	15	337.25	UniSTS
NCBI RH Map	15	720.2	UniSTS

Click on a value in the shaded box below the category label to view a detailed expression data table for that system.

Download All Expressed Objects for this Gene

adipose tissue	alimentary part of gastrointestinal system	appendage	circulatory system	ectoderm	endocrine system	endoderm	entire extraembryonic component	exocrine system	hemolymphoid system	hepatobiliary system	integumental system	mesenchyme	mesoderm	musculoskeletal system	nervous system	pharyngeal arch	renal system	reproductive system	respiratory system	sensory system	visual system
1204	2401	2788	2241	4958	1673	2279	6	576	1594	416	2259	6867	6124	46	3729	1	835	1734	1594	174	1


RefSeq Transcripts	NM_001166283	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_001166286	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_001166287	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_001166288	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_001166289	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_020211	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
GenBank Nucleotide	AC013394	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AC087641	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK074910	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK074966	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK074980	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK125047	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK125204	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK291365	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK299363	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK309814	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AL136826	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AL390083	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC015886	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC127826	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC140838	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC151132	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CH471101	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CP068263	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CQ782935	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CQ782957	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CQ783740	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	DA183348	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	DA295545	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	DA453869	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	DA512691	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	DA805034	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	DC317516	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	FJ515840	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	KF456122	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	KF511221	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles

Ensembl Acc Id:

ENST00000329082 ⟹ ENSP00000330005

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	15	93,035,271 - 93,089,211 (-)	Ensembl

Ensembl Acc Id:

ENST00000425933 ⟹ ENSP00000404442

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	15	93,043,406 - 93,073,710 (-)	Ensembl

Ensembl Acc Id:

ENST00000542321 ⟹ ENSP00000440025

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	15	93,043,416 - 93,073,148 (-)	Ensembl

Ensembl Acc Id:

ENST00000543599 ⟹ ENSP00000442498

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	15	93,043,406 - 93,088,523 (-)	Ensembl

Ensembl Acc Id:

ENST00000554387 ⟹ ENSP00000451505

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	15	93,043,417 - 93,073,680 (-)	Ensembl

Ensembl Acc Id:

ENST00000555584

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	15	93,052,272 - 93,063,069 (-)	Ensembl

Ensembl Acc Id:

ENST00000555598 ⟹ ENSP00000451709

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	15	93,052,320 - 93,088,523 (-)	Ensembl

Ensembl Acc Id:

ENST00000556658 ⟹ ENSP00000456290

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	15	93,044,956 - 93,073,663 (-)	Ensembl

Ensembl Acc Id:

ENST00000556950 ⟹ ENSP00000452350

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	15	93,072,967 - 93,088,653 (-)	Ensembl

Ensembl Acc Id:

ENST00000557301 ⟹ ENSP00000452126

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	15	93,044,818 - 93,074,128 (-)	Ensembl

Ensembl Acc Id:

ENST00000557420 ⟹ ENSP00000452170

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	15	93,044,947 - 93,073,145 (-)	Ensembl

Ensembl Acc Id:

ENST00000557608

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	15	93,066,006 - 93,073,134 (-)	Ensembl

Ensembl Acc Id:

ENST00000650169

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	15	93,044,749 - 93,058,841 (-)	Ensembl

RefSeq Acc Id:

NM_001166283 ⟹ NP_001159755

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	15	93,035,271 - 93,073,987 (-)	NCBI
GRCh37	15	93,586,636 - 93,632,443 (-)	ENTREZGENE
HuRef	15	69,723,091 - 69,768,218 (-)	ENTREZGENE
CHM1_1	15	93,427,333 - 93,458,219 (-)	NCBI
T2T-CHM13v2.0	15	90,797,572 - 90,836,331 (-)	NCBI

Sequence:

show sequence

CCATACTGAAGCCCTCCCAAGTGCAGCCTTGCGGGCCTCGCAGAGAGCGCCAAACCATCCGGCCCTGCGCGCCACGCGGACCGGCATAGCCATCTCTCTGGAGTGGCAGCTGTGCCAAGGTGGCAAGG
TTAGGCCCGCAGGCCCTCAGCACGGGGGCGCAGCCGGGGCAAGTCTTCAGGAAGCAGCGAGGTGCTTGAAGGGGGTGCTGGAGGCAGGCCAAACCCAGTCAGGATGGGTGGCCTGGGGCCACGACGGG
CGGGAACCTCGAGGGAGAGGCTAGTGGTAACAGGCCGAGCTGGATGGATGGGTATGGGGAGAGGGGCAGGACGTTCAGCCCTGGGATTCTGGCCGACCCTCGCCTTCCTTCTCTGCAGCTTCCCCGCA
GCCACCTCCCCGTGCAAGATCCTCAAGTGCAACTCTGAGTTCTGGAGCGCCACGTCGGGCAGCCACGCCCCAGCCTCAGACGACACCCCCGAGTTCTGTGCAGCCTTGCGCAGCTACGCCCTGTGCAC
GCGGCGGACGGCCCGCACCTGCCGGGGTGACCTGGCCTACCACTCGGCCGTCCATGGCATAGAGGACCTCATGAGCCAGCACAACTGCTCCAAGGATGGCCCCACCTCGCAGCCACGCCTGCGCACGC
TCCCACCGGCCGGAGACAGCCAGGAGCGCTCGGACAGCCCCGAGATCTGCCATTACGAGAAGAGCTTTCACAAGCACTCGGCCACCCCCAACTACACGCACTGTGGCCTCTTCGGGGACCCACACCTC
AGGACTTTCACCGACCGCTTCCAGACCTGCAAGGTGCAGGGCGCCTGGCCGCTCATCGACAATAATTACCTGAACGTGCAGGTCACCAACACGCCTGTGCTGCCCGGCTCAGCGGCCACTGCCACCAG
CAAGCTCACCATCATCTTCAAGAACTTCCAGGAGTGTGTGGACCAGAAGGTGTACCAGGCTGAGATGGACGAGCTCCCGGCCGCCTTCGTGGATGGCTCTAAGAACGGTGGGGACAAGCACGGGGCCA
ACAGCCTGAAGATCACTGAGAAGGTGTCAGGCCAGCACGTGGAGATCCAGGCCAAGTACATCGGCACCACCATCGTGGTGCGCCAGGTGGGCCGCTACCTGACCTTTGCCGTCCGCATGCCAGAGGAA
GTGGTCAATGCTGTGGAGGACTGGGACAGCCAGGGTCTCTACCTCTGCCTGCGGGGCTGCCCCCTCAACCAGCAGATCGACTTCCAGGCCTTCCACACCAATGCTGAGGGCACCGGTGCCCGCAGGCT
GGCAGCCGCCAGCCCTGCACCCACAGCCCCCGAGACCTTCCCATACGAGACAGCCGTGGCCAAGTGCAAGGAGAAGCTGCCGGTGGAGGACCTGTACTACCAGGCCTGCGTCTTCGACCTCCTCACCA
CGGGCGACGTGAACTTCACACTGGCCGCCTACTACGCGTTGGAGGATGTCAAGATGCTCCACTCCAACAAAGACAAACTGCACCTGTATGAGAGGACTCGGGACCTGCCAGGCAGGGCGGCTGCGGGG
CTGCCCCTGGCCCCCCGGCCCCTCCTGGGCGCCCTCGTCCCGCTCCTGGCCCTGCTCCCTGTGTTCTGCTAGACGCGTAGATGTGGAGGGAGGCGCGGGCTCCGTCCTCTCGGCTTCCCCATGTGTGG
GCTGGGACCGCCCACGGGGTGCAGATCTCCTGGCGTGTCCACCATGGCCCCGCAGAACGCCAGGGACCGCCTGCTGCCAAGGGCTCAGGCACGGACCCCTCCCCTTCTAGTGCACGTGACAAGGTTGT
GGTGACTGGTGCCATGATGTTTGACAGTAGAGCTGTGTGAGAGGGAGAGCAGCTCCCCTCGCCCCGCCCCTGCAGTGTGAATGTGTGAAACATCCCCTCAGGCTGAAGCCCCCCACCCCCACCAGAGA
CACACTGGGAACCGTCAGAGTCAGCTCCTTCCCCCTCGCAATGCACTGAAAGGCCCGGCCGACTGCTGCTCGCCGATCCGTGGGGCCCCCTGTGCCCGCCACACGCACGCACACACTCTTACACGAGA
GCACACTCGATCCCCCTAGGCCAGCGGGGACACCCCAGCCACACAGGGAGGCATCCTTGGGGCTTGGCCCCAGGCAGGGCAACCCCGGGGCGCTGCTTGGCACCTTAGCAGACTGCTGGAACCTTTTG
GCCAGTAGGTCGTGCCCGCCTGGTGCCTTCTGGCCTGTGGCCTCCCTGCCCATGTTCACCTGGCTGCTGTGGGTACCAGTGCAGGTCCCGGTTTTCAGGCACCTGCTCAGCTGCCCGTCTCTGGCCTG
GGCCCCTGCCCCTTCCACCCTGTGCTTAGAAAGTCGAAGTGCTTGGTTCTAAATGTCTAAACAGAGAAGAGATCCTTGACTTCTGTTCCTCTCTCTCCTGCAGATGCAAGAGCTCCTGGGCAGGGGTG
CCTGGGCCCCAGGGTGTGGCAGGAGACCCAGTGGATGGGGCCAGCTGGCCTGCCCTGATCCTCTGCTTCCTCCTCACAACCCCAAGAGCCCCCAGCCCGGTCCATCCACGTCTGGAGTCTGGGGAGAG
GAGCAGGGTCTTAGGACTCTCAGCTCTGAGCATCCCTGGCAGGGTCTTCAACCTCTAATCTCTTCCCTTAAGCCCTGTGGCCACACAGCCAGGAGAGACTTGCCGCTGGCTCCCGCCTCATTTCAGCC
CAGGGTGCTCATCCAGGGGCCCAGAACAGTCCCACCTGTGCTGCTGTGCCCACAGCACAAAGCCAGGCTTCACTCCCAAAAGTGCAGCCAGGCCCTGGAGGGTGATCCTGCCAGCAGCCCTACAGCTC
CACACCCTACCCACCCATCGGCAGCCCCTCTGCTGTTCCCCAGGGACCTCTCATACACTGGCCAGGAGGCTGCAGAACGTGTGTCTCCCCCTCCCTCCAAGAGGTCCTGCTCCCTCTGCCAGAACCGT
GTGTGGGCGGGTGGGAGGGCGCTCGGGGCCCGGCCCCTCCCTCTCCCTGCTGGTTTTAGTTGGTCCCTATGTTGGAAGTAAAAAGTGAAGCACTTTATTTTGGTTGTGTTTGCTCACGTTCTGCTTGG
AAGTGGGGACCCCTCACTGCGTCCACGTGTCTGCGACCTGTGTGGAGTGTCACCGCGTGTACATACTGTAAATTATTTATTAATGGCTAAATGCAAGTAAAGTTTGGTTTTTTTGTTATTTTCTTTTA
GACGTGTTGGAGTTTGTTTTCTGAACAGACTTTGGCTCCCTTGAGGCGGGTGGAGGATGGACTTTGGTGGTGGGATCCCCTGCAGCAAGTGTGTGTGTGTGCGCGCATGTGTGTGTGCGCGCATGTGT
GTATGCATGCCTGTGTGTGTGCGTGCCTGTGTGCGTGCATGTACGCATGTGTGCGCATGCCTGTGTGTGCGCCCATGCCTATGTGTGTGCATGTAGGCATGTGTGTGCGCATGTGTATGTGCGTGAGA
ATGGTGTGAAGGCGGATAGAAGATGCAGCAGTTTAACAGCCACCACACATTGCTTTTGTAAAGTCACTTTTCCTCCTCACGATGAGCTGTCTTTGGAGCTTGGCAGGCCCAGATCCTCTTGTTCTAGT
GACAGTGGAACACAGTCAGGGAGACAGGTGACTATGTGGTGGAGAGACATATGGTGCCCTCTGGGATGAGATGGGTGGGATAGCCTGAGATCTGGGATGACTCCCTCTCAGCCACTGCTATCAGCCTG
GAGCCCCAGCTGTTGGGACTGCCTGCCACCCTCCCTGCCAGTGCCCATCTTCTCATAGCCCGGGCGGAGCAGTGGTGCTGCAGGAGGCTGCTGTCCACGTCACTGTGGGACCAGGTTTATTGGCAGCT
GTGATCACATTTCATCTGTACAAACTACCCAGTGAATCAGGAAGAAATTCAGGCCCATTTTGCCGATGAAACAGACTCTGAGATTAACTGACTTGCCTAGGGCTCCTTAGCAACGGGAAGGACAACCT
GTGCACCTAGGTTAGTATTGTCCTGAAGCCCCTTCTCTTCAAACTAAATGCCATGAGGCAGAATAGCAGCACAGTTAAGCCAGCCTACATCCTGGCTTCTCCACCTCCCCAGCAGTGTGACCATGGGC
AAGTCACTTCACCTCTCTGAGCCTGCATGCTGTTCTCTGGAAGATGGGGGGGTGCCTGTCCCATACAGTTGTTTGGAGAGTCAGGAGTTCATTCCTGTAAATTGCTTAGGAGAGGGCGGGGCACACAT
GGCTTGTCTGGTCGTGGGGAGGGAGGGGGTGGTATTATCCCAAAGCAAGATAAATCAGTTAAGGGGAGAAGGAAAGGGGCGATACAGACCCTGGACTCTTGGGAGAGGTGAACCTGCAGGCTAGCAAG
GGGAGGAGTCCCAAGAGTGGCCAAGTTCATTAATCCCAGGCAGACCAGGAAGGCTGAAGAAAAAGGAGAACTTTATTTTATTTTTGAAATGGAGTCTGGCGTCTTGCTCTGTCGCCAGGCTGGAGTGC
AGTGGCACCATCCCAGCTCACTGCAGCCCCTGCCTCCCAGGTTCAAGCAATTCTCCTGCCTCAGCCTCCCAAGTAGCTGGGACTACAGGCACACACCACCACGCCTGGCTAATTTTTTGTATTTTAGT
AGAGATGGTGTTTCACCATGTTGACCAGTATGGTCTTGATCTCCTGACCTCGTGATCCGCCTGCCTTGGCCTCCCAAAGTGTTGGGATTACAGGCGTGAGCCACCACCGTGCCCGGCCAAAAAAGGAG
AACGTTCTAAAGCCCTGTTCTTGCAGGGCTCCCAGAGAGAACACGGGAGTTGGGTTTGGGAGGCAGGAACCAGACTGGAAAGGACAAAACGTACCCAGCATCTTCCCTGGCGGCCGGAACCGTCACTA
CAGGCCCCGTGCCCTTAGCAGTCCCAGGGACAGAGCGACTCAGGGAGGCAGCAAGGAGGAGCGGAGCCATTGGTGCTCGTCCGGCACAGAGAACAGTTCCTGAGAAGCCAGGGCACACAGAAGAAAAA
GAAAAAAGAAATCTCTACTAGACGAAAATGCTAAATGGCACTAGCCACAAAGTATTCTTGGTTTGGAATTTTTTTTCCAGGACCCTAAATGTAACCGGCTGGAATTCTTTCCCAAGTGCCATGCTACT
TACTACTGGTTGCCCTCACGAGCATGGAAATGCCGTCGTGAATATGGAACACAGCATCCTGAGCTAAAAGATTCCCAAGAAGCAGCTTCATCTTGCAGGACGGGCTAGGTTGGGAGCCTCTGGAGGTT
CCTGGCTGCCAGCTCCGCGGAGGCCTGCGGCCTGGAGGTAAATGCATTAGCACACGGAGGTGGGCGCCTCTCCCCGCCCCATCCTGTCTCACTGATGTGTTGCCGAGAACTGGAGTTCTTGTTTAGCT
AACCAGAATGTGCAAGGCTATAGGACAGGAGAGAAATGGCCTTTAAAACAAATGAATGAGAGTCACGATGAAGGGGGCAGACGGGGGGGTGAAAATCATTACCAGAACACTTGGGCAGAGACCCGTCA
GAGCCAGGCAGGAGACAGTCATCAGAGCTGTGCCAGCAAGTGGCATGGAGCAGGGGTGGCACTTGGGCTCGGGCTGCAGGCAAACTTGGCGTCAAAACTGGCTCAACCCGTCGCGAGCTGTGTGGTCT
CCTTGGGATTTTTTGAGCCTTAGATTCCTTATTTGTAAAATGGATTTGTGAGTCTCCACCTCCCGAGGTCAGTATGGAAATCCAGTGAGCTAACACTCGTCAATGGCCTCGCACATGGCCCTGGCACC
ACGCATGGAGGCCGCCAAAAGTGGCCGCCTCCTCTCTGCAATTGCATTTATTTATCCATTTGATAACTCTATTGGGTGTCTACCCAGCATTGTTCAGGGGGGTGTGAGGGGCTACCGCAATGACCCAG
ACAGACTGCTGTGCATTCTTATTGGAAAGACAAGGCAATAAACCACAGTTACAAAACCCAGGGTCCCATGGTAACGAGCTCCACAGAGAAAAGGGAAGTGGGCCAGAGGTTCCGAGAGACACACATTT
TGGATTGCAGGAGGGTGAGAAGGGGCATTCATCTGTGGTGGGGTTAAGGGGAGGCCTCCGACTAGCTCACCTGCATGAATTTCAGGAACAAGCCATGCAGAGCCGGACAGAGCATTCTGTGCAGAGAA
AACAGTGTAACAGCCCTAGAGCAGCAGCAGCAAAGGGGGAGTTTAAGGGATGGTGGGAAGCCACTGTCACTGGACAGTAGCAAGTGGACAGACCAGGGGTCCCAGGTGAGGCCACAGAGCAGCCAAAG
TACTGCAGGGCTCTCCGGCTCCGGGAGGACTTGATGTTTGACTCCAGTTGCCAGAGGAAGCCGTTCACGGGCTTTGAGTGTAGGAATGATGTGTCCGACTTGGGTCTTTTTATTGTTCTTTTTTAGAG
ACAGGGTCTCACTCTGTCACCCAGGCTGGAGTGCAGCGGCACAATCACAGCTCACTGCAGCCTCCACTTCCTGGGCTCAAGCAATCCTCCCACTTCAGCCACTCAAGTAGCTGGGATTACAGGTGCCT
GCCGTCACACCCGGCTAATTGTTAAATTTTTTTGGAGAGACAGGATCTTGCTGTTTTCCCAGGCTGATCTTGAACTCCTGGGCTCAAGCGAGACGTCTGTTTCAGCCTCCCAAAGTGCTGGGATAACA
GGTGTGAGCCACTGGGCCTGCCTTGGCTTGGGTATTAAAGGAATTGTTCTAGTTACTATATGGAGGTGACTTGGGGCCGCTGGGGAAGAAAGAGGAAGTCAGGAGCCAGTCTGAGGCAGTGGCAATGC
AGCGATTATCAGAAATAATGGGCTCAATGATAGACTGGATAAAGAAAATGTGGCACATATACGCCATGGAGTACTATGCAGCCATAAAAAGGGATGAGTTCATGTCCTTTGCAGGGACATGGATGAAG
CTGGAAACCATCATTCTCAGCAAACTAACACAAGAACAGAAAACCAAACACCGCATGTTCTCACTCGTAAGTGGGAGTTGAACAATGAGAACACATGGACACAGGGAAGGGAACATCACACACTGGGG
CCTGTCAGTGGGTGGGGGGCTGGGGGAGGGAGAGCATCAGGAGAAATACCCAATGTAGATGATGACGGGTTCATAGGTGCAGCAAACCACCATGGCACGTGTATACCTATGTAACAAACTTGTGCGTT
CTGCACGTGTACCCCATAACTGAAAGTATAATCATAATTTTAAGAAAAGAAATGATGGCCTTTGGGGTCTAATAAGAAGGTGGGGCTGACAGGGCTTGGGGAGAGAGCGAGCTTGACAGGAGACCACG
ATGTCTTCCCCAGGGGTCTGAGCACCTGGGGAAATGGTGGTGCCATTTACCATGACTGGAAAGATCATGGGAGGAGCAGGTTTGGGACACTGAAGGCCCGAGAGCCCCTGGCAAACCACCAGTGTAAG
TCCAAGAGTCCAAAAGCTGAAGAACTTGGAGTCCAATGTTTGAGGGTAAAAAACAGCCAGCATGAGAAAAAGATGAAGGCCAGAAGACTCGTCCAGTCTAGCCCTTCCACATTCCTCTGCCCGCTTTT
ATCCTAGCCTCGCTGGCAGGTGATTAGATGGTGCCCACCCAGGTTAAGCGTGGGTCTCTGTCTCCCAGTTCACTGACTCAAATGTTAATTTCCTTTGGCGACAGCCTCACAGACACACCCAGGAACGA
TACTTTGCATCCTCCAATCCAATCAAGTTGGCACTCAATATTAAACAGTTTCGGCCGGGAGCGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCCAAAGCGGGCAGATCACTAAGTCAGGAGA
TCGAGACCATCCTGGCTAACACGGTGAAACCCCATCTCTACTAAAAATACAAAAAATTAGCCAGGCGTGGTGGTGGGCGCCTGTAGTCCCAGCTACTCGGGAGGCTGAGGCAAGAGAGTGGCGTGAAC
CCGGGAGGCAGAACTTGCAGCAAGCAGAGATCGCACCACTGCACTCCAGCCTCCAGCCTGGGCGACAGAGCAAGACACCGTCTCAAAAAAAAAAAAAAAACAACTAACAGTTTCGTTCATTAAGGCAA
TGTCCATGGGGCAGCTCCTGCATGCCACGCCACCCCTGCCCTGACATACTCCCAGGCTGACCAGCCAGAACTGGGGAGAGGGCATCTTGAAGAAACAGTCCACCCTCCGCCCTCGCATACCTGTGTCT
CCCAGCAGACAAGACACACAAGGGCAGGGACTGCACTTTCCTGTGTGCAAATCTCAGGTATGGTCCAGAAATCACATCTCTTTGGTCTGATTGGCCTTACTTACCAAACCCTTGAAACAATGGAAAGA
AGCTTGCTGCAATGGGAAGACCCCTGCCCCCCAAACCCTCTAACCAGGAGTCTACAGACCTCATTCCGTGGAAGTTCCCATTGTCCCCTGGGAAACCACCACCTTCTGAATCGGCACAGCCAAGGCCC
CCAACCCTGCTATCAACAGCTTTCCTTAGCCACCTTCCCCATCCTGCAGGGCTTTTCAACATTTCGACTTTTTAATCCTTCCCTCCCTAAGATATAGACATGGTGTTAGTAGCAGAACCCTGAAGGCA
AAGGAACAGAAACTAACACTCTCAGAAAGTCCTAGCAGGATGGTCTGAATTAATAGACAGCTGCAGGCAGCCAGTGTGCAAGGCACGCTCGTAATGTCAGTGGCGTTCCGGAATGAGGGCTGTGATCC
CAGGCAGCCCAGATCCCAAGGCGAAAACATTCATGTCGCCCAGCATCACCCTGTCCTTGCCCAGGGTGACCCTGAGACGGCACTTGGATTCTTCCACATCTGAACTCAAACCTGCTCCCTCAGCTCTC
CCCAGCAGGAATTGGAGCCCTCTCCAGGCCGTTCAGCCAAAGCAGAATGTGTCTGGCCAAGCAGATCTGCCCAGAGAAGAACAAAGACGTGTTCAGACACTGTCTGGGGAATTGGTTTTGAGCTCACT
CTGAGCTCCATCTGTGCAACAAGGCCAGCGTCAGCTGTTACAGAGAAGGGGCTTGTGGCAGTTTATTACCCTGGTGAGCTGGCTCGGGGCCATGCTGACCGCAGGACTGTAAAGGACATAAGGCAGTT
GGCAATATGGGAAGCAGCAGTCCCCAAAGCACCCCGTCAAGGAAACGATGCAAGAGCTCTGTCCACTGGACCAGCCCCACCCTACCCCGCCACGCCCTGGCCTAGGGGGAGGGACCTTGTGTTTCACG
GGCCTGGATGGCCAGGGATGGACAGTGGCATGGGCACAGACACACCCAGACCGAAGGAAGGGCCCGGGCTCCAGAACCAGACCCGATCCAGGCTCCCAGCTCTGTCACCTACTGGCTGCATGAAAAGG
GTGGGTTTTCCTTGTTTTGCAGCCTCAGCTATCTCAGCTGTGAGGGAACAATGACGCCACCTCCCTCACGTGGCGGTCCTGAAGATGAAATGTAATGCATGCAGCGCGGCGGCCGGCCCACCGTGTGC
TCTTAGTAACTGGCCGCTGTTCTCTTCAGCCCTCCCGTTACTGACCACCTCGAGGGCACCGTTCCTCCAAGCTGACCATTTCCTGCCAGTCACCCACTGCCCAGCTCGCCCAGCCATGGAGTGGGCTC
TGGTCCACGTGCATGGTGAGCTGCCATCTTTGTCGTCCTCTGGACACCACGTCTACCTCCTTGGGAAATAGAAACGAGTCCTGCATTGCTTTGTCAAATTTCACAAAAACCCTAGAAAGCAGATATTG
CCCTGGTTTACAGACGGACAGACAGAAGCAAAGAGAAGCCAACTGACCCACTCCAGGTTACAAGCAGGGTCTGGTAGGAGAGCACGCGTCCACCCCACCGCTCACTGCGCCCACCTACTCCTCGCTTG
AGGGCAGAGAACGAGCTGGGGCGGGGCGCTCCAGGGGGCACAGGCAGCCTGTGTTCAAGGCATGCTCGTGAGCCCCACAGCAGGGGCGGAGTCAAACCAGGGCTCTGGTTCTGGGGTGAGCAGAGGGT
GGGGCCAGGCCCCCACTGGGAGGCTGACTGAGGAGGGGCTCAAAGGGCAGGCAGGCTCCATCAGAGCGGTTTGATGAGCAGGGCCGCTGAGTGGCCCTCAGGTCAAGGCTGGGGCCGGGACCACCAGG
GACCAGGTCTGCGGGGCCAGGGGTCCCTCCCCAGGGTGGAGCAGGAAAACTCCGGCAACCGCCTTCTTGAGTGGACTTGACCTTCCCTTTCTCTGCTAATGATCTCAGATTAATCCCTTAAGGCAAGT
GCCCCAGGGTGGGTGTTGGTTGCATAAAACAAGAGGAGTCCTTCTTCCCTTCCTTCCTGGCACAAACATTTGTAGGCCACCCCCGATGTGGCTGGTCGTAGTCTGGATTTGGGGGCACATTCAGGCAT
TCAACAAATACGTCATGAGGCCCCGTGATGAGCTGGGGGGCTATGCTTGATGTCGGCAGTACAGCTGTGGTCGCTCGAATGAATGTGCCCGCCCTCACGGGACTGACCTCTAGTGGTGAGAGACAGAC
ACTAACCGAGTCACATGTGTGATTACACGTGTAATCATACTTACATATGTAACAACACGAGTTACACGTGCAGTGTGGGGAGGGGGCCCTTCACGGTGACCAGCCCATCAGGGAAGGGGATGCGGGTG
GCAGAAGGAAGCGGCACACCCTTGTCCTCACGGAGCTCACAGGAGGTTCTCTGACCCTCATCTTAAGCCACAGGCTGTGTCTGAGCCTCACTGCCCTAGCTATCAACTGGGTGCAGGACTAGGCCTTA
ATCACTGGGCAGCGGGAAGAACTACATAAGCTCATACTGGCGCAAAGCCCCTTGGGAGACCGCAGGGAAAGCCATTGCATGAGGTGGTGACAGGCTCGGCCTTCAGAGTCGGGCTAGAATCTGAGTTC
TGACAATGATCCCCGCCTTGACCCATCTCTCCTCAGGCCGCCCTGAGCCTTCCAGTTAGGCCTGGGCTTTGGGCTTCCGTGTTTGTCTCTGGATTGTTCGGTTTTAGCAAGAGTCCTGCTAAATTGGT
CTTGCTGGAATCCTCCGCCCTCCACATCTGATTGCCCTTCCTGTCTGATCGTGGTCTTCATGCCCCACGGCCTCCAGGGGACGTCTGATCACCTGGCCTGCCTTCAGCAAGAATCCCCCCAGGTGTTT
CCTCTTAAGAGGTTTTCCATCCACTGAGCCCACCCTGCTCCTTGGCCATCAATTCCCACTTGCCTGTACTGTATTCAGAGGGGACCCCAATCTCTCTTCCCAGCTGCAGCGGTCCCTGTCCAACACTG
CCCCCCACCTCAAATAAAGTCTTTCTTACTGTCTTTAACATATGCCGTCAATAAAGTTTTAGCAGATCCAA

hide sequence

RefSeq Acc Id:

NM_001166286 ⟹ NP_001159758

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	15	93,035,271 - 93,073,156 (-)	NCBI
GRCh37	15	93,586,636 - 93,632,443 (-)	ENTREZGENE
HuRef	15	69,723,091 - 69,768,218 (-)	ENTREZGENE
CHM1_1	15	93,427,333 - 93,457,392 (-)	NCBI
T2T-CHM13v2.0	15	90,797,572 - 90,835,500 (-)	NCBI

Sequence:

show sequence

GCGCCGGGCGCCCGCGGCCGAGGTGGACGGAGCCTCCCGGCTCGCTGCTCCCGCCGGCGGAGCGAGGCTGCCCTTTCTTCGCAGCGTGATTTATTTTCTTCTTTTTTTCTGAACTCTTCTTCCAGGGA
GAGGCTAGTGGTAACAGGCCGAGCTGGATGGATGGGTATGGGGAGAGGGGCAGGACGTTCAGCCCTGGGATTCTGGCCGACCCTCGCCTTCCTTCTCTGCAGCTTCCCCGCAGCCACCTCCCCGTGCA
AGATCCTCAAGTGCAACTCTGAGTTCTGGAGCGCCACGTCGGGCAGCCACGCCCCAGCCTCAGACGACACCCCCGAGTTCTGTGCAGCCTTGCGCAGCTACGCCCTGTGCACGCGGCGGACGGCCCGC
ACCTGCCGGGGTGACCTGGCCTACCACTCGGCCGTCCATGGCATAGAGGACCTCATGAGCCAGCACAACTGCTCCAAGGATGGCCCCACCTCGCAGCCACGCCTGCGCACGCTCCCACCGGCCGGAGA
CAGCCAGGAGCGCTCGGACAGCCCCGAGATCTGCCATTACGAGAAGAGCTTTCACAAGCACTCGGCCACCCCCAACTACACGCACTGTGGCCTCTTCGGGGACCCACACCTCAGGACTTTCACCGACC
GCTTCCAGACCTGCAAGGTGCAGGGCGCCTGGCCGCTCATCGACAATAATTACCTGAACGTGCAGGTCACCAACACGCCTGTGCTGCCCGGCTCAGCGGCCACTGCCACCAGCAAGCTCACCATCATC
TTCAAGAACTTCCAGGAGTGTGTGGACCAGAAGGTGTACCAGGCTGAGATGGACGAGCTCCCGGCCGCCTTCGTGGATGGCTCTAAGAACGGTGGGGACAAGCACGGGGCCAACAGCCTGAAGATCAC
TGAGAAGGTGTCAGGCCAGCACGTGGAGATCCAGGCCAAGTACATCGGCACCACCATCGTGGTGCGCCAGGTGGGCCGCTACCTGACCTTTGCCGTCCGCATGCCAGAGGAAGTGGTCAATGCTGTGG
AGGACTGGGACAGCCAGGGTCTCTACCTCTGCCTGCGGGGCTGCCCCCTCAACCAGCAGATCGACTTCCAGGCCTTCCACACCAATGCTGAGGGCACCGGTGCCCGCAGGCTGGCAGCCGCCAGCCCT
GCACCCACAGCCCCCGAGACCTTCCCATACGAGACAGCCGTGGCCAAGTGCAAGGAGAAGCTGCCGGTGGAGGACCTGTACTACCAGGCCTGCGTCTTCGACCTCCTCACCACGGGCGACGTGAACTT
CACACTGGCCGCCTACTACGCGTTGGAGGATGTCAAGATGCTCCACTCCAACAAAGACAAACTGCACCTGTATGAGAGGACTCGGGACCTGCCAGGCAGGGCGGCTGCGGGGCTGCCCCTGGCCCCCC
GGCCCCTCCTGGGCGCCCTCGTCCCGCTCCTGGCCCTGCTCCCTGTGTTCTGCTAGACGCGTAGATGTGGAGGGAGGCGCGGGCTCCGTCCTCTCGGCTTCCCCATGTGTGGGCTGGGACCGCCCACG
GGGTGCAGATCTCCTGGCGTGTCCACCATGGCCCCGCAGAACGCCAGGGACCGCCTGCTGCCAAGGGCTCAGGCACGGACCCCTCCCCTTCTAGTGCACGTGACAAGGTTGTGGTGACTGGTGCCATG
ATGTTTGACAGTAGAGCTGTGTGAGAGGGAGAGCAGCTCCCCTCGCCCCGCCCCTGCAGTGTGAATGTGTGAAACATCCCCTCAGGCTGAAGCCCCCCACCCCCACCAGAGACACACTGGGAACCGTC
AGAGTCAGCTCCTTCCCCCTCGCAATGCACTGAAAGGCCCGGCCGACTGCTGCTCGCCGATCCGTGGGGCCCCCTGTGCCCGCCACACGCACGCACACACTCTTACACGAGAGCACACTCGATCCCCC
TAGGCCAGCGGGGACACCCCAGCCACACAGGGAGGCATCCTTGGGGCTTGGCCCCAGGCAGGGCAACCCCGGGGCGCTGCTTGGCACCTTAGCAGACTGCTGGAACCTTTTGGCCAGTAGGTCGTGCC
CGCCTGGTGCCTTCTGGCCTGTGGCCTCCCTGCCCATGTTCACCTGGCTGCTGTGGGTACCAGTGCAGGTCCCGGTTTTCAGGCACCTGCTCAGCTGCCCGTCTCTGGCCTGGGCCCCTGCCCCTTCC
ACCCTGTGCTTAGAAAGTCGAAGTGCTTGGTTCTAAATGTCTAAACAGAGAAGAGATCCTTGACTTCTGTTCCTCTCTCTCCTGCAGATGCAAGAGCTCCTGGGCAGGGGTGCCTGGGCCCCAGGGTG
TGGCAGGAGACCCAGTGGATGGGGCCAGCTGGCCTGCCCTGATCCTCTGCTTCCTCCTCACAACCCCAAGAGCCCCCAGCCCGGTCCATCCACGTCTGGAGTCTGGGGAGAGGAGCAGGGTCTTAGGA
CTCTCAGCTCTGAGCATCCCTGGCAGGGTCTTCAACCTCTAATCTCTTCCCTTAAGCCCTGTGGCCACACAGCCAGGAGAGACTTGCCGCTGGCTCCCGCCTCATTTCAGCCCAGGGTGCTCATCCAG
GGGCCCAGAACAGTCCCACCTGTGCTGCTGTGCCCACAGCACAAAGCCAGGCTTCACTCCCAAAAGTGCAGCCAGGCCCTGGAGGGTGATCCTGCCAGCAGCCCTACAGCTCCACACCCTACCCACCC
ATCGGCAGCCCCTCTGCTGTTCCCCAGGGACCTCTCATACACTGGCCAGGAGGCTGCAGAACGTGTGTCTCCCCCTCCCTCCAAGAGGTCCTGCTCCCTCTGCCAGAACCGTGTGTGGGCGGGTGGGA
GGGCGCTCGGGGCCCGGCCCCTCCCTCTCCCTGCTGGTTTTAGTTGGTCCCTATGTTGGAAGTAAAAAGTGAAGCACTTTATTTTGGTTGTGTTTGCTCACGTTCTGCTTGGAAGTGGGGACCCCTCA
CTGCGTCCACGTGTCTGCGACCTGTGTGGAGTGTCACCGCGTGTACATACTGTAAATTATTTATTAATGGCTAAATGCAAGTAAAGTTTGGTTTTTTTGTTATTTTCTTTTAGACGTGTTGGAGTTTG
TTTTCTGAACAGACTTTGGCTCCCTTGAGGCGGGTGGAGGATGGACTTTGGTGGTGGGATCCCCTGCAGCAAGTGTGTGTGTGTGCGCGCATGTGTGTGTGCGCGCATGTGTGTATGCATGCCTGTGT
GTGTGCGTGCCTGTGTGCGTGCATGTACGCATGTGTGCGCATGCCTGTGTGTGCGCCCATGCCTATGTGTGTGCATGTAGGCATGTGTGTGCGCATGTGTATGTGCGTGAGAATGGTGTGAAGGCGGA
TAGAAGATGCAGCAGTTTAACAGCCACCACACATTGCTTTTGTAAAGTCACTTTTCCTCCTCACGATGAGCTGTCTTTGGAGCTTGGCAGGCCCAGATCCTCTTGTTCTAGTGACAGTGGAACACAGT
CAGGGAGACAGGTGACTATGTGGTGGAGAGACATATGGTGCCCTCTGGGATGAGATGGGTGGGATAGCCTGAGATCTGGGATGACTCCCTCTCAGCCACTGCTATCAGCCTGGAGCCCCAGCTGTTGG
GACTGCCTGCCACCCTCCCTGCCAGTGCCCATCTTCTCATAGCCCGGGCGGAGCAGTGGTGCTGCAGGAGGCTGCTGTCCACGTCACTGTGGGACCAGGTTTATTGGCAGCTGTGATCACATTTCATC
TGTACAAACTACCCAGTGAATCAGGAAGAAATTCAGGCCCATTTTGCCGATGAAACAGACTCTGAGATTAACTGACTTGCCTAGGGCTCCTTAGCAACGGGAAGGACAACCTGTGCACCTAGGTTAGT
ATTGTCCTGAAGCCCCTTCTCTTCAAACTAAATGCCATGAGGCAGAATAGCAGCACAGTTAAGCCAGCCTACATCCTGGCTTCTCCACCTCCCCAGCAGTGTGACCATGGGCAAGTCACTTCACCTCT
CTGAGCCTGCATGCTGTTCTCTGGAAGATGGGGGGGTGCCTGTCCCATACAGTTGTTTGGAGAGTCAGGAGTTCATTCCTGTAAATTGCTTAGGAGAGGGCGGGGCACACATGGCTTGTCTGGTCGTG
GGGAGGGAGGGGGTGGTATTATCCCAAAGCAAGATAAATCAGTTAAGGGGAGAAGGAAAGGGGCGATACAGACCCTGGACTCTTGGGAGAGGTGAACCTGCAGGCTAGCAAGGGGAGGAGTCCCAAGA
GTGGCCAAGTTCATTAATCCCAGGCAGACCAGGAAGGCTGAAGAAAAAGGAGAACTTTATTTTATTTTTGAAATGGAGTCTGGCGTCTTGCTCTGTCGCCAGGCTGGAGTGCAGTGGCACCATCCCAG
CTCACTGCAGCCCCTGCCTCCCAGGTTCAAGCAATTCTCCTGCCTCAGCCTCCCAAGTAGCTGGGACTACAGGCACACACCACCACGCCTGGCTAATTTTTTGTATTTTAGTAGAGATGGTGTTTCAC
CATGTTGACCAGTATGGTCTTGATCTCCTGACCTCGTGATCCGCCTGCCTTGGCCTCCCAAAGTGTTGGGATTACAGGCGTGAGCCACCACCGTGCCCGGCCAAAAAAGGAGAACGTTCTAAAGCCCT
GTTCTTGCAGGGCTCCCAGAGAGAACACGGGAGTTGGGTTTGGGAGGCAGGAACCAGACTGGAAAGGACAAAACGTACCCAGCATCTTCCCTGGCGGCCGGAACCGTCACTACAGGCCCCGTGCCCTT
AGCAGTCCCAGGGACAGAGCGACTCAGGGAGGCAGCAAGGAGGAGCGGAGCCATTGGTGCTCGTCCGGCACAGAGAACAGTTCCTGAGAAGCCAGGGCACACAGAAGAAAAAGAAAAAAGAAATCTCT
ACTAGACGAAAATGCTAAATGGCACTAGCCACAAAGTATTCTTGGTTTGGAATTTTTTTTCCAGGACCCTAAATGTAACCGGCTGGAATTCTTTCCCAAGTGCCATGCTACTTACTACTGGTTGCCCT
CACGAGCATGGAAATGCCGTCGTGAATATGGAACACAGCATCCTGAGCTAAAAGATTCCCAAGAAGCAGCTTCATCTTGCAGGACGGGCTAGGTTGGGAGCCTCTGGAGGTTCCTGGCTGCCAGCTCC
GCGGAGGCCTGCGGCCTGGAGGTAAATGCATTAGCACACGGAGGTGGGCGCCTCTCCCCGCCCCATCCTGTCTCACTGATGTGTTGCCGAGAACTGGAGTTCTTGTTTAGCTAACCAGAATGTGCAAG
GCTATAGGACAGGAGAGAAATGGCCTTTAAAACAAATGAATGAGAGTCACGATGAAGGGGGCAGACGGGGGGGTGAAAATCATTACCAGAACACTTGGGCAGAGACCCGTCAGAGCCAGGCAGGAGAC
AGTCATCAGAGCTGTGCCAGCAAGTGGCATGGAGCAGGGGTGGCACTTGGGCTCGGGCTGCAGGCAAACTTGGCGTCAAAACTGGCTCAACCCGTCGCGAGCTGTGTGGTCTCCTTGGGATTTTTTGA
GCCTTAGATTCCTTATTTGTAAAATGGATTTGTGAGTCTCCACCTCCCGAGGTCAGTATGGAAATCCAGTGAGCTAACACTCGTCAATGGCCTCGCACATGGCCCTGGCACCACGCATGGAGGCCGCC
AAAAGTGGCCGCCTCCTCTCTGCAATTGCATTTATTTATCCATTTGATAACTCTATTGGGTGTCTACCCAGCATTGTTCAGGGGGGTGTGAGGGGCTACCGCAATGACCCAGACAGACTGCTGTGCAT
TCTTATTGGAAAGACAAGGCAATAAACCACAGTTACAAAACCCAGGGTCCCATGGTAACGAGCTCCACAGAGAAAAGGGAAGTGGGCCAGAGGTTCCGAGAGACACACATTTTGGATTGCAGGAGGGT
GAGAAGGGGCATTCATCTGTGGTGGGGTTAAGGGGAGGCCTCCGACTAGCTCACCTGCATGAATTTCAGGAACAAGCCATGCAGAGCCGGACAGAGCATTCTGTGCAGAGAAAACAGTGTAACAGCCC
TAGAGCAGCAGCAGCAAAGGGGGAGTTTAAGGGATGGTGGGAAGCCACTGTCACTGGACAGTAGCAAGTGGACAGACCAGGGGTCCCAGGTGAGGCCACAGAGCAGCCAAAGTACTGCAGGGCTCTCC
GGCTCCGGGAGGACTTGATGTTTGACTCCAGTTGCCAGAGGAAGCCGTTCACGGGCTTTGAGTGTAGGAATGATGTGTCCGACTTGGGTCTTTTTATTGTTCTTTTTTAGAGACAGGGTCTCACTCTG
TCACCCAGGCTGGAGTGCAGCGGCACAATCACAGCTCACTGCAGCCTCCACTTCCTGGGCTCAAGCAATCCTCCCACTTCAGCCACTCAAGTAGCTGGGATTACAGGTGCCTGCCGTCACACCCGGCT
AATTGTTAAATTTTTTTGGAGAGACAGGATCTTGCTGTTTTCCCAGGCTGATCTTGAACTCCTGGGCTCAAGCGAGACGTCTGTTTCAGCCTCCCAAAGTGCTGGGATAACAGGTGTGAGCCACTGGG
CCTGCCTTGGCTTGGGTATTAAAGGAATTGTTCTAGTTACTATATGGAGGTGACTTGGGGCCGCTGGGGAAGAAAGAGGAAGTCAGGAGCCAGTCTGAGGCAGTGGCAATGCAGCGATTATCAGAAAT
AATGGGCTCAATGATAGACTGGATAAAGAAAATGTGGCACATATACGCCATGGAGTACTATGCAGCCATAAAAAGGGATGAGTTCATGTCCTTTGCAGGGACATGGATGAAGCTGGAAACCATCATTC
TCAGCAAACTAACACAAGAACAGAAAACCAAACACCGCATGTTCTCACTCGTAAGTGGGAGTTGAACAATGAGAACACATGGACACAGGGAAGGGAACATCACACACTGGGGCCTGTCAGTGGGTGGG
GGGCTGGGGGAGGGAGAGCATCAGGAGAAATACCCAATGTAGATGATGACGGGTTCATAGGTGCAGCAAACCACCATGGCACGTGTATACCTATGTAACAAACTTGTGCGTTCTGCACGTGTACCCCA
TAACTGAAAGTATAATCATAATTTTAAGAAAAGAAATGATGGCCTTTGGGGTCTAATAAGAAGGTGGGGCTGACAGGGCTTGGGGAGAGAGCGAGCTTGACAGGAGACCACGATGTCTTCCCCAGGGG
TCTGAGCACCTGGGGAAATGGTGGTGCCATTTACCATGACTGGAAAGATCATGGGAGGAGCAGGTTTGGGACACTGAAGGCCCGAGAGCCCCTGGCAAACCACCAGTGTAAGTCCAAGAGTCCAAAAG
CTGAAGAACTTGGAGTCCAATGTTTGAGGGTAAAAAACAGCCAGCATGAGAAAAAGATGAAGGCCAGAAGACTCGTCCAGTCTAGCCCTTCCACATTCCTCTGCCCGCTTTTATCCTAGCCTCGCTGG
CAGGTGATTAGATGGTGCCCACCCAGGTTAAGCGTGGGTCTCTGTCTCCCAGTTCACTGACTCAAATGTTAATTTCCTTTGGCGACAGCCTCACAGACACACCCAGGAACGATACTTTGCATCCTCCA
ATCCAATCAAGTTGGCACTCAATATTAAACAGTTTCGGCCGGGAGCGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCCAAAGCGGGCAGATCACTAAGTCAGGAGATCGAGACCATCCTGGC
TAACACGGTGAAACCCCATCTCTACTAAAAATACAAAAAATTAGCCAGGCGTGGTGGTGGGCGCCTGTAGTCCCAGCTACTCGGGAGGCTGAGGCAAGAGAGTGGCGTGAACCCGGGAGGCAGAACTT
GCAGCAAGCAGAGATCGCACCACTGCACTCCAGCCTCCAGCCTGGGCGACAGAGCAAGACACCGTCTCAAAAAAAAAAAAAAAACAACTAACAGTTTCGTTCATTAAGGCAATGTCCATGGGGCAGCT
CCTGCATGCCACGCCACCCCTGCCCTGACATACTCCCAGGCTGACCAGCCAGAACTGGGGAGAGGGCATCTTGAAGAAACAGTCCACCCTCCGCCCTCGCATACCTGTGTCTCCCAGCAGACAAGACA
CACAAGGGCAGGGACTGCACTTTCCTGTGTGCAAATCTCAGGTATGGTCCAGAAATCACATCTCTTTGGTCTGATTGGCCTTACTTACCAAACCCTTGAAACAATGGAAAGAAGCTTGCTGCAATGGG
AAGACCCCTGCCCCCCAAACCCTCTAACCAGGAGTCTACAGACCTCATTCCGTGGAAGTTCCCATTGTCCCCTGGGAAACCACCACCTTCTGAATCGGCACAGCCAAGGCCCCCAACCCTGCTATCAA
CAGCTTTCCTTAGCCACCTTCCCCATCCTGCAGGGCTTTTCAACATTTCGACTTTTTAATCCTTCCCTCCCTAAGATATAGACATGGTGTTAGTAGCAGAACCCTGAAGGCAAAGGAACAGAAACTAA
CACTCTCAGAAAGTCCTAGCAGGATGGTCTGAATTAATAGACAGCTGCAGGCAGCCAGTGTGCAAGGCACGCTCGTAATGTCAGTGGCGTTCCGGAATGAGGGCTGTGATCCCAGGCAGCCCAGATCC
CAAGGCGAAAACATTCATGTCGCCCAGCATCACCCTGTCCTTGCCCAGGGTGACCCTGAGACGGCACTTGGATTCTTCCACATCTGAACTCAAACCTGCTCCCTCAGCTCTCCCCAGCAGGAATTGGA
GCCCTCTCCAGGCCGTTCAGCCAAAGCAGAATGTGTCTGGCCAAGCAGATCTGCCCAGAGAAGAACAAAGACGTGTTCAGACACTGTCTGGGGAATTGGTTTTGAGCTCACTCTGAGCTCCATCTGTG
CAACAAGGCCAGCGTCAGCTGTTACAGAGAAGGGGCTTGTGGCAGTTTATTACCCTGGTGAGCTGGCTCGGGGCCATGCTGACCGCAGGACTGTAAAGGACATAAGGCAGTTGGCAATATGGGAAGCA
GCAGTCCCCAAAGCACCCCGTCAAGGAAACGATGCAAGAGCTCTGTCCACTGGACCAGCCCCACCCTACCCCGCCACGCCCTGGCCTAGGGGGAGGGACCTTGTGTTTCACGGGCCTGGATGGCCAGG
GATGGACAGTGGCATGGGCACAGACACACCCAGACCGAAGGAAGGGCCCGGGCTCCAGAACCAGACCCGATCCAGGCTCCCAGCTCTGTCACCTACTGGCTGCATGAAAAGGGTGGGTTTTCCTTGTT
TTGCAGCCTCAGCTATCTCAGCTGTGAGGGAACAATGACGCCACCTCCCTCACGTGGCGGTCCTGAAGATGAAATGTAATGCATGCAGCGCGGCGGCCGGCCCACCGTGTGCTCTTAGTAACTGGCCG
CTGTTCTCTTCAGCCCTCCCGTTACTGACCACCTCGAGGGCACCGTTCCTCCAAGCTGACCATTTCCTGCCAGTCACCCACTGCCCAGCTCGCCCAGCCATGGAGTGGGCTCTGGTCCACGTGCATGG
TGAGCTGCCATCTTTGTCGTCCTCTGGACACCACGTCTACCTCCTTGGGAAATAGAAACGAGTCCTGCATTGCTTTGTCAAATTTCACAAAAACCCTAGAAAGCAGATATTGCCCTGGTTTACAGACG
GACAGACAGAAGCAAAGAGAAGCCAACTGACCCACTCCAGGTTACAAGCAGGGTCTGGTAGGAGAGCACGCGTCCACCCCACCGCTCACTGCGCCCACCTACTCCTCGCTTGAGGGCAGAGAACGAGC
TGGGGCGGGGCGCTCCAGGGGGCACAGGCAGCCTGTGTTCAAGGCATGCTCGTGAGCCCCACAGCAGGGGCGGAGTCAAACCAGGGCTCTGGTTCTGGGGTGAGCAGAGGGTGGGGCCAGGCCCCCAC
TGGGAGGCTGACTGAGGAGGGGCTCAAAGGGCAGGCAGGCTCCATCAGAGCGGTTTGATGAGCAGGGCCGCTGAGTGGCCCTCAGGTCAAGGCTGGGGCCGGGACCACCAGGGACCAGGTCTGCGGGG
CCAGGGGTCCCTCCCCAGGGTGGAGCAGGAAAACTCCGGCAACCGCCTTCTTGAGTGGACTTGACCTTCCCTTTCTCTGCTAATGATCTCAGATTAATCCCTTAAGGCAAGTGCCCCAGGGTGGGTGT
TGGTTGCATAAAACAAGAGGAGTCCTTCTTCCCTTCCTTCCTGGCACAAACATTTGTAGGCCACCCCCGATGTGGCTGGTCGTAGTCTGGATTTGGGGGCACATTCAGGCATTCAACAAATACGTCAT
GAGGCCCCGTGATGAGCTGGGGGGCTATGCTTGATGTCGGCAGTACAGCTGTGGTCGCTCGAATGAATGTGCCCGCCCTCACGGGACTGACCTCTAGTGGTGAGAGACAGACACTAACCGAGTCACAT
GTGTGATTACACGTGTAATCATACTTACATATGTAACAACACGAGTTACACGTGCAGTGTGGGGAGGGGGCCCTTCACGGTGACCAGCCCATCAGGGAAGGGGATGCGGGTGGCAGAAGGAAGCGGCA
CACCCTTGTCCTCACGGAGCTCACAGGAGGTTCTCTGACCCTCATCTTAAGCCACAGGCTGTGTCTGAGCCTCACTGCCCTAGCTATCAACTGGGTGCAGGACTAGGCCTTAATCACTGGGCAGCGGG
AAGAACTACATAAGCTCATACTGGCGCAAAGCCCCTTGGGAGACCGCAGGGAAAGCCATTGCATGAGGTGGTGACAGGCTCGGCCTTCAGAGTCGGGCTAGAATCTGAGTTCTGACAATGATCCCCGC
CTTGACCCATCTCTCCTCAGGCCGCCCTGAGCCTTCCAGTTAGGCCTGGGCTTTGGGCTTCCGTGTTTGTCTCTGGATTGTTCGGTTTTAGCAAGAGTCCTGCTAAATTGGTCTTGCTGGAATCCTCC
GCCCTCCACATCTGATTGCCCTTCCTGTCTGATCGTGGTCTTCATGCCCCACGGCCTCCAGGGGACGTCTGATCACCTGGCCTGCCTTCAGCAAGAATCCCCCCAGGTGTTTCCTCTTAAGAGGTTTT
CCATCCACTGAGCCCACCCTGCTCCTTGGCCATCAATTCCCACTTGCCTGTACTGTATTCAGAGGGGACCCCAATCTCTCTTCCCAGCTGCAGCGGTCCCTGTCCAACACTGCCCCCCACCTCAAATA
AAGTCTTTCTTACTGTCTTTAACATATGCCGTCAATAAAGTTTTAGCAGATCCAA

hide sequence

RefSeq Acc Id:

NM_001166287 ⟹ NP_001159759

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	15	93,035,271 - 93,088,523 (-)	NCBI
GRCh37	15	93,586,636 - 93,632,443 (-)	ENTREZGENE
HuRef	15	69,723,091 - 69,768,218 (-)	ENTREZGENE
CHM1_1	15	93,427,333 - 93,472,760 (-)	NCBI
T2T-CHM13v2.0	15	90,797,572 - 90,850,870 (-)	NCBI

Sequence:

show sequence

CTCCCGCTCGACGCCCGGCTGCGGAGCTGCCTGGCCATCTCCTGCCCTCGGGGATGTCGGCGCA
GTGCACCGCGTGGGCTCGCGTCCCGGCGGCCCTTTGCCTCGGCGCGCCGGCGTACGGGAAGGTGCGGACCTTGGATTGAGGGCCGAGGATGCCCATTGCCAAGCCGCCCCGGCTTTCCTAAGTGGACG
GGAGGGCACGGCGACGATTCAGCGCCGGCTCGCGCCGCAGCTCAACCCAGGGGAGAGGCTAGTGGTAACAGGCCGAGCTGGATGGATGGGTATGGGGAGAGGGGCAGGACGTTCAGCCCTGGGATTCT
GGCCGACCCTCGCCTTCCTTCTCTGCAGCTTCCCCGCAGCCACCTCCCCGTGCAAGATCCTCAAGTGCAACTCTGAGTTCTGGAGCGCCACGTCGGGCAGCCACGCCCCAGCCTCAGACGACACCCCC
GAGTTCTGTGCAGCCTTGCGCAGCTACGCCCTGTGCACGCGGCGGACGGCCCGCACCTGCCGGGGTGACCTGGCCTACCACTCGGCCGTCCATGGCATAGAGGACCTCATGAGCCAGCACAACTGCTC
CAAGGATGGCCCCACCTCGCAGCCACGCCTGCGCACGCTCCCACCGGCCGGAGACAGCCAGGAGCGCTCGGACAGCCCCGAGATCTGCCATTACGAGAAGAGCTTTCACAAGCACTCGGCCACCCCCA
ACTACACGCACTGTGGCCTCTTCGGGGACCCACACCTCAGGACTTTCACCGACCGCTTCCAGACCTGCAAGGTGCAGGGCGCCTGGCCGCTCATCGACAATAATTACCTGAACGTGCAGGTCACCAAC
ACGCCTGTGCTGCCCGGCTCAGCGGCCACTGCCACCAGCAAGCTCACCATCATCTTCAAGAACTTCCAGGAGTGTGTGGACCAGAAGGTGTACCAGGCTGAGATGGACGAGCTCCCGGCCGCCTTCGT
GGATGGCTCTAAGAACGGTGGGGACAAGCACGGGGCCAACAGCCTGAAGATCACTGAGAAGGTGTCAGGCCAGCACGTGGAGATCCAGGCCAAGTACATCGGCACCACCATCGTGGTGCGCCAGGTGG
GCCGCTACCTGACCTTTGCCGTCCGCATGCCAGAGGAAGTGGTCAATGCTGTGGAGGACTGGGACAGCCAGGGTCTCTACCTCTGCCTGCGGGGCTGCCCCCTCAACCAGCAGATCGACTTCCAGGCC
TTCCACACCAATGCTGAGGGCACCGGTGCCCGCAGGCTGGCAGCCGCCAGCCCTGCACCCACAGCCCCCGAGACCTTCCCATACGAGACAGCCGTGGCCAAGTGCAAGGAGAAGCTGCCGGTGGAGGA
CCTGTACTACCAGGCCTGCGTCTTCGACCTCCTCACCACGGGCGACGTGAACTTCACACTGGCCGCCTACTACGCGTTGGAGGATGTCAAGATGCTCCACTCCAACAAAGACAAACTGCACCTGTATG
AGAGGACTCGGGACCTGCCAGGCAGGGCGGCTGCGGGGCTGCCCCTGGCCCCCCGGCCCCTCCTGGGCGCCCTCGTCCCGCTCCTGGCCCTGCTCCCTGTGTTCTGCTAGACGCGTAGATGTGGAGGG
AGGCGCGGGCTCCGTCCTCTCGGCTTCCCCATGTGTGGGCTGGGACCGCCCACGGGGTGCAGATCTCCTGGCGTGTCCACCATGGCCCCGCAGAACGCCAGGGACCGCCTGCTGCCAAGGGCTCAGGC
ACGGACCCCTCCCCTTCTAGTGCACGTGACAAGGTTGTGGTGACTGGTGCCATGATGTTTGACAGTAGAGCTGTGTGAGAGGGAGAGCAGCTCCCCTCGCCCCGCCCCTGCAGTGTGAATGTGTGAAA
CATCCCCTCAGGCTGAAGCCCCCCACCCCCACCAGAGACACACTGGGAACCGTCAGAGTCAGCTCCTTCCCCCTCGCAATGCACTGAAAGGCCCGGCCGACTGCTGCTCGCCGATCCGTGGGGCCCCC
TGTGCCCGCCACACGCACGCACACACTCTTACACGAGAGCACACTCGATCCCCCTAGGCCAGCGGGGACACCCCAGCCACACAGGGAGGCATCCTTGGGGCTTGGCCCCAGGCAGGGCAACCCCGGGG
CGCTGCTTGGCACCTTAGCAGACTGCTGGAACCTTTTGGCCAGTAGGTCGTGCCCGCCTGGTGCCTTCTGGCCTGTGGCCTCCCTGCCCATGTTCACCTGGCTGCTGTGGGTACCAGTGCAGGTCCCG
GTTTTCAGGCACCTGCTCAGCTGCCCGTCTCTGGCCTGGGCCCCTGCCCCTTCCACCCTGTGCTTAGAAAGTCGAAGTGCTTGGTTCTAAATGTCTAAACAGAGAAGAGATCCTTGACTTCTGTTCCT
CTCTCTCCTGCAGATGCAAGAGCTCCTGGGCAGGGGTGCCTGGGCCCCAGGGTGTGGCAGGAGACCCAGTGGATGGGGCCAGCTGGCCTGCCCTGATCCTCTGCTTCCTCCTCACAACCCCAAGAGCC
CCCAGCCCGGTCCATCCACGTCTGGAGTCTGGGGAGAGGAGCAGGGTCTTAGGACTCTCAGCTCTGAGCATCCCTGGCAGGGTCTTCAACCTCTAATCTCTTCCCTTAAGCCCTGTGGCCACACAGCC
AGGAGAGACTTGCCGCTGGCTCCCGCCTCATTTCAGCCCAGGGTGCTCATCCAGGGGCCCAGAACAGTCCCACCTGTGCTGCTGTGCCCACAGCACAAAGCCAGGCTTCACTCCCAAAAGTGCAGCCA
GGCCCTGGAGGGTGATCCTGCCAGCAGCCCTACAGCTCCACACCCTACCCACCCATCGGCAGCCCCTCTGCTGTTCCCCAGGGACCTCTCATACACTGGCCAGGAGGCTGCAGAACGTGTGTCTCCCC
CTCCCTCCAAGAGGTCCTGCTCCCTCTGCCAGAACCGTGTGTGGGCGGGTGGGAGGGCGCTCGGGGCCCGGCCCCTCCCTCTCCCTGCTGGTTTTAGTTGGTCCCTATGTTGGAAGTAAAAAGTGAAG
CACTTTATTTTGGTTGTGTTTGCTCACGTTCTGCTTGGAAGTGGGGACCCCTCACTGCGTCCACGTGTCTGCGACCTGTGTGGAGTGTCACCGCGTGTACATACTGTAAATTATTTATTAATGGCTAA
ATGCAAGTAAAGTTTGGTTTTTTTGTTATTTTCTTTTAGACGTGTTGGAGTTTGTTTTCTGAACAGACTTTGGCTCCCTTGAGGCGGGTGGAGGATGGACTTTGGTGGTGGGATCCCCTGCAGCAAGT
GTGTGTGTGTGCGCGCATGTGTGTGTGCGCGCATGTGTGTATGCATGCCTGTGTGTGTGCGTGCCTGTGTGCGTGCATGTACGCATGTGTGCGCATGCCTGTGTGTGCGCCCATGCCTATGTGTGTGC
ATGTAGGCATGTGTGTGCGCATGTGTATGTGCGTGAGAATGGTGTGAAGGCGGATAGAAGATGCAGCAGTTTAACAGCCACCACACATTGCTTTTGTAAAGTCACTTTTCCTCCTCACGATGAGCTGT
CTTTGGAGCTTGGCAGGCCCAGATCCTCTTGTTCTAGTGACAGTGGAACACAGTCAGGGAGACAGGTGACTATGTGGTGGAGAGACATATGGTGCCCTCTGGGATGAGATGGGTGGGATAGCCTGAGA
TCTGGGATGACTCCCTCTCAGCCACTGCTATCAGCCTGGAGCCCCAGCTGTTGGGACTGCCTGCCACCCTCCCTGCCAGTGCCCATCTTCTCATAGCCCGGGCGGAGCAGTGGTGCTGCAGGAGGCTG
CTGTCCACGTCACTGTGGGACCAGGTTTATTGGCAGCTGTGATCACATTTCATCTGTACAAACTACCCAGTGAATCAGGAAGAAATTCAGGCCCATTTTGCCGATGAAACAGACTCTGAGATTAACTG
ACTTGCCTAGGGCTCCTTAGCAACGGGAAGGACAACCTGTGCACCTAGGTTAGTATTGTCCTGAAGCCCCTTCTCTTCAAACTAAATGCCATGAGGCAGAATAGCAGCACAGTTAAGCCAGCCTACAT
CCTGGCTTCTCCACCTCCCCAGCAGTGTGACCATGGGCAAGTCACTTCACCTCTCTGAGCCTGCATGCTGTTCTCTGGAAGATGGGGGGGTGCCTGTCCCATACAGTTGTTTGGAGAGTCAGGAGTTC
ATTCCTGTAAATTGCTTAGGAGAGGGCGGGGCACACATGGCTTGTCTGGTCGTGGGGAGGGAGGGGGTGGTATTATCCCAAAGCAAGATAAATCAGTTAAGGGGAGAAGGAAAGGGGCGATACAGACC
CTGGACTCTTGGGAGAGGTGAACCTGCAGGCTAGCAAGGGGAGGAGTCCCAAGAGTGGCCAAGTTCATTAATCCCAGGCAGACCAGGAAGGCTGAAGAAAAAGGAGAACTTTATTTTATTTTTGAAAT
GGAGTCTGGCGTCTTGCTCTGTCGCCAGGCTGGAGTGCAGTGGCACCATCCCAGCTCACTGCAGCCCCTGCCTCCCAGGTTCAAGCAATTCTCCTGCCTCAGCCTCCCAAGTAGCTGGGACTACAGGC
ACACACCACCACGCCTGGCTAATTTTTTGTATTTTAGTAGAGATGGTGTTTCACCATGTTGACCAGTATGGTCTTGATCTCCTGACCTCGTGATCCGCCTGCCTTGGCCTCCCAAAGTGTTGGGATTA
CAGGCGTGAGCCACCACCGTGCCCGGCCAAAAAAGGAGAACGTTCTAAAGCCCTGTTCTTGCAGGGCTCCCAGAGAGAACACGGGAGTTGGGTTTGGGAGGCAGGAACCAGACTGGAAAGGACAAAAC
GTACCCAGCATCTTCCCTGGCGGCCGGAACCGTCACTACAGGCCCCGTGCCCTTAGCAGTCCCAGGGACAGAGCGACTCAGGGAGGCAGCAAGGAGGAGCGGAGCCATTGGTGCTCGTCCGGCACAGA
GAACAGTTCCTGAGAAGCCAGGGCACACAGAAGAAAAAGAAAAAAGAAATCTCTACTAGACGAAAATGCTAAATGGCACTAGCCACAAAGTATTCTTGGTTTGGAATTTTTTTTCCAGGACCCTAAAT
GTAACCGGCTGGAATTCTTTCCCAAGTGCCATGCTACTTACTACTGGTTGCCCTCACGAGCATGGAAATGCCGTCGTGAATATGGAACACAGCATCCTGAGCTAAAAGATTCCCAAGAAGCAGCTTCA
TCTTGCAGGACGGGCTAGGTTGGGAGCCTCTGGAGGTTCCTGGCTGCCAGCTCCGCGGAGGCCTGCGGCCTGGAGGTAAATGCATTAGCACACGGAGGTGGGCGCCTCTCCCCGCCCCATCCTGTCTC
ACTGATGTGTTGCCGAGAACTGGAGTTCTTGTTTAGCTAACCAGAATGTGCAAGGCTATAGGACAGGAGAGAAATGGCCTTTAAAACAAATGAATGAGAGTCACGATGAAGGGGGCAGACGGGGGGGT
GAAAATCATTACCAGAACACTTGGGCAGAGACCCGTCAGAGCCAGGCAGGAGACAGTCATCAGAGCTGTGCCAGCAAGTGGCATGGAGCAGGGGTGGCACTTGGGCTCGGGCTGCAGGCAAACTTGGC
GTCAAAACTGGCTCAACCCGTCGCGAGCTGTGTGGTCTCCTTGGGATTTTTTGAGCCTTAGATTCCTTATTTGTAAAATGGATTTGTGAGTCTCCACCTCCCGAGGTCAGTATGGAAATCCAGTGAGC
TAACACTCGTCAATGGCCTCGCACATGGCCCTGGCACCACGCATGGAGGCCGCCAAAAGTGGCCGCCTCCTCTCTGCAATTGCATTTATTTATCCATTTGATAACTCTATTGGGTGTCTACCCAGCAT
TGTTCAGGGGGGTGTGAGGGGCTACCGCAATGACCCAGACAGACTGCTGTGCATTCTTATTGGAAAGACAAGGCAATAAACCACAGTTACAAAACCCAGGGTCCCATGGTAACGAGCTCCACAGAGAA
AAGGGAAGTGGGCCAGAGGTTCCGAGAGACACACATTTTGGATTGCAGGAGGGTGAGAAGGGGCATTCATCTGTGGTGGGGTTAAGGGGAGGCCTCCGACTAGCTCACCTGCATGAATTTCAGGAACA
AGCCATGCAGAGCCGGACAGAGCATTCTGTGCAGAGAAAACAGTGTAACAGCCCTAGAGCAGCAGCAGCAAAGGGGGAGTTTAAGGGATGGTGGGAAGCCACTGTCACTGGACAGTAGCAAGTGGACA
GACCAGGGGTCCCAGGTGAGGCCACAGAGCAGCCAAAGTACTGCAGGGCTCTCCGGCTCCGGGAGGACTTGATGTTTGACTCCAGTTGCCAGAGGAAGCCGTTCACGGGCTTTGAGTGTAGGAATGAT
GTGTCCGACTTGGGTCTTTTTATTGTTCTTTTTTAGAGACAGGGTCTCACTCTGTCACCCAGGCTGGAGTGCAGCGGCACAATCACAGCTCACTGCAGCCTCCACTTCCTGGGCTCAAGCAATCCTCC
CACTTCAGCCACTCAAGTAGCTGGGATTACAGGTGCCTGCCGTCACACCCGGCTAATTGTTAAATTTTTTTGGAGAGACAGGATCTTGCTGTTTTCCCAGGCTGATCTTGAACTCCTGGGCTCAAGCG
AGACGTCTGTTTCAGCCTCCCAAAGTGCTGGGATAACAGGTGTGAGCCACTGGGCCTGCCTTGGCTTGGGTATTAAAGGAATTGTTCTAGTTACTATATGGAGGTGACTTGGGGCCGCTGGGGAAGAA
AGAGGAAGTCAGGAGCCAGTCTGAGGCAGTGGCAATGCAGCGATTATCAGAAATAATGGGCTCAATGATAGACTGGATAAAGAAAATGTGGCACATATACGCCATGGAGTACTATGCAGCCATAAAAA
GGGATGAGTTCATGTCCTTTGCAGGGACATGGATGAAGCTGGAAACCATCATTCTCAGCAAACTAACACAAGAACAGAAAACCAAACACCGCATGTTCTCACTCGTAAGTGGGAGTTGAACAATGAGA
ACACATGGACACAGGGAAGGGAACATCACACACTGGGGCCTGTCAGTGGGTGGGGGGCTGGGGGAGGGAGAGCATCAGGAGAAATACCCAATGTAGATGATGACGGGTTCATAGGTGCAGCAAACCAC
CATGGCACGTGTATACCTATGTAACAAACTTGTGCGTTCTGCACGTGTACCCCATAACTGAAAGTATAATCATAATTTTAAGAAAAGAAATGATGGCCTTTGGGGTCTAATAAGAAGGTGGGGCTGAC
AGGGCTTGGGGAGAGAGCGAGCTTGACAGGAGACCACGATGTCTTCCCCAGGGGTCTGAGCACCTGGGGAAATGGTGGTGCCATTTACCATGACTGGAAAGATCATGGGAGGAGCAGGTTTGGGACAC
TGAAGGCCCGAGAGCCCCTGGCAAACCACCAGTGTAAGTCCAAGAGTCCAAAAGCTGAAGAACTTGGAGTCCAATGTTTGAGGGTAAAAAACAGCCAGCATGAGAAAAAGATGAAGGCCAGAAGACTC
GTCCAGTCTAGCCCTTCCACATTCCTCTGCCCGCTTTTATCCTAGCCTCGCTGGCAGGTGATTAGATGGTGCCCACCCAGGTTAAGCGTGGGTCTCTGTCTCCCAGTTCACTGACTCAAATGTTAATT
TCCTTTGGCGACAGCCTCACAGACACACCCAGGAACGATACTTTGCATCCTCCAATCCAATCAAGTTGGCACTCAATATTAAACAGTTTCGGCCGGGAGCGGTGGCTCACGCCTGTAATCCCAGCACT
TTGGGAGGCCAAAGCGGGCAGATCACTAAGTCAGGAGATCGAGACCATCCTGGCTAACACGGTGAAACCCCATCTCTACTAAAAATACAAAAAATTAGCCAGGCGTGGTGGTGGGCGCCTGTAGTCCC
AGCTACTCGGGAGGCTGAGGCAAGAGAGTGGCGTGAACCCGGGAGGCAGAACTTGCAGCAAGCAGAGATCGCACCACTGCACTCCAGCCTCCAGCCTGGGCGACAGAGCAAGACACCGTCTCAAAAAA
AAAAAAAAAACAACTAACAGTTTCGTTCATTAAGGCAATGTCCATGGGGCAGCTCCTGCATGCCACGCCACCCCTGCCCTGACATACTCCCAGGCTGACCAGCCAGAACTGGGGAGAGGGCATCTTGA
AGAAACAGTCCACCCTCCGCCCTCGCATACCTGTGTCTCCCAGCAGACAAGACACACAAGGGCAGGGACTGCACTTTCCTGTGTGCAAATCTCAGGTATGGTCCAGAAATCACATCTCTTTGGTCTGA
TTGGCCTTACTTACCAAACCCTTGAAACAATGGAAAGAAGCTTGCTGCAATGGGAAGACCCCTGCCCCCCAAACCCTCTAACCAGGAGTCTACAGACCTCATTCCGTGGAAGTTCCCATTGTCCCCTG
GGAAACCACCACCTTCTGAATCGGCACAGCCAAGGCCCCCAACCCTGCTATCAACAGCTTTCCTTAGCCACCTTCCCCATCCTGCAGGGCTTTTCAACATTTCGACTTTTTAATCCTTCCCTCCCTAA
GATATAGACATGGTGTTAGTAGCAGAACCCTGAAGGCAAAGGAACAGAAACTAACACTCTCAGAAAGTCCTAGCAGGATGGTCTGAATTAATAGACAGCTGCAGGCAGCCAGTGTGCAAGGCACGCTC
GTAATGTCAGTGGCGTTCCGGAATGAGGGCTGTGATCCCAGGCAGCCCAGATCCCAAGGCGAAAACATTCATGTCGCCCAGCATCACCCTGTCCTTGCCCAGGGTGACCCTGAGACGGCACTTGGATT
CTTCCACATCTGAACTCAAACCTGCTCCCTCAGCTCTCCCCAGCAGGAATTGGAGCCCTCTCCAGGCCGTTCAGCCAAAGCAGAATGTGTCTGGCCAAGCAGATCTGCCCAGAGAAGAACAAAGACGT
GTTCAGACACTGTCTGGGGAATTGGTTTTGAGCTCACTCTGAGCTCCATCTGTGCAACAAGGCCAGCGTCAGCTGTTACAGAGAAGGGGCTTGTGGCAGTTTATTACCCTGGTGAGCTGGCTCGGGGC
CATGCTGACCGCAGGACTGTAAAGGACATAAGGCAGTTGGCAATATGGGAAGCAGCAGTCCCCAAAGCACCCCGTCAAGGAAACGATGCAAGAGCTCTGTCCACTGGACCAGCCCCACCCTACCCCGC
CACGCCCTGGCCTAGGGGGAGGGACCTTGTGTTTCACGGGCCTGGATGGCCAGGGATGGACAGTGGCATGGGCACAGACACACCCAGACCGAAGGAAGGGCCCGGGCTCCAGAACCAGACCCGATCCA
GGCTCCCAGCTCTGTCACCTACTGGCTGCATGAAAAGGGTGGGTTTTCCTTGTTTTGCAGCCTCAGCTATCTCAGCTGTGAGGGAACAATGACGCCACCTCCCTCACGTGGCGGTCCTGAAGATGAAA
TGTAATGCATGCAGCGCGGCGGCCGGCCCACCGTGTGCTCTTAGTAACTGGCCGCTGTTCTCTTCAGCCCTCCCGTTACTGACCACCTCGAGGGCACCGTTCCTCCAAGCTGACCATTTCCTGCCAGT
CACCCACTGCCCAGCTCGCCCAGCCATGGAGTGGGCTCTGGTCCACGTGCATGGTGAGCTGCCATCTTTGTCGTCCTCTGGACACCACGTCTACCTCCTTGGGAAATAGAAACGAGTCCTGCATTGCT
TTGTCAAATTTCACAAAAACCCTAGAAAGCAGATATTGCCCTGGTTTACAGACGGACAGACAGAAGCAAAGAGAAGCCAACTGACCCACTCCAGGTTACAAGCAGGGTCTGGTAGGAGAGCACGCGTC
CACCCCACCGCTCACTGCGCCCACCTACTCCTCGCTTGAGGGCAGAGAACGAGCTGGGGCGGGGCGCTCCAGGGGGCACAGGCAGCCTGTGTTCAAGGCATGCTCGTGAGCCCCACAGCAGGGGCGGA
GTCAAACCAGGGCTCTGGTTCTGGGGTGAGCAGAGGGTGGGGCCAGGCCCCCACTGGGAGGCTGACTGAGGAGGGGCTCAAAGGGCAGGCAGGCTCCATCAGAGCGGTTTGATGAGCAGGGCCGCTGA
GTGGCCCTCAGGTCAAGGCTGGGGCCGGGACCACCAGGGACCAGGTCTGCGGGGCCAGGGGTCCCTCCCCAGGGTGGAGCAGGAAAACTCCGGCAACCGCCTTCTTGAGTGGACTTGACCTTCCCTTT
CTCTGCTAATGATCTCAGATTAATCCCTTAAGGCAAGTGCCCCAGGGTGGGTGTTGGTTGCATAAAACAAGAGGAGTCCTTCTTCCCTTCCTTCCTGGCACAAACATTTGTAGGCCACCCCCGATGTG
GCTGGTCGTAGTCTGGATTTGGGGGCACATTCAGGCATTCAACAAATACGTCATGAGGCCCCGTGATGAGCTGGGGGGCTATGCTTGATGTCGGCAGTACAGCTGTGGTCGCTCGAATGAATGTGCCC
GCCCTCACGGGACTGACCTCTAGTGGTGAGAGACAGACACTAACCGAGTCACATGTGTGATTACACGTGTAATCATACTTACATATGTAACAACACGAGTTACACGTGCAGTGTGGGGAGGGGGCCCT
TCACGGTGACCAGCCCATCAGGGAAGGGGATGCGGGTGGCAGAAGGAAGCGGCACACCCTTGTCCTCACGGAGCTCACAGGAGGTTCTCTGACCCTCATCTTAAGCCACAGGCTGTGTCTGAGCCTCA
CTGCCCTAGCTATCAACTGGGTGCAGGACTAGGCCTTAATCACTGGGCAGCGGGAAGAACTACATAAGCTCATACTGGCGCAAAGCCCCTTGGGAGACCGCAGGGAAAGCCATTGCATGAGGTGGTGA
CAGGCTCGGCCTTCAGAGTCGGGCTAGAATCTGAGTTCTGACAATGATCCCCGCCTTGACCCATCTCTCCTCAGGCCGCCCTGAGCCTTCCAGTTAGGCCTGGGCTTTGGGCTTCCGTGTTTGTCTCT
GGATTGTTCGGTTTTAGCAAGAGTCCTGCTAAATTGGTCTTGCTGGAATCCTCCGCCCTCCACATCTGATTGCCCTTCCTGTCTGATCGTGGTCTTCATGCCCCACGGCCTCCAGGGGACGTCTGATC
ACCTGGCCTGCCTTCAGCAAGAATCCCCCCAGGTGTTTCCTCTTAAGAGGTTTTCCATCCACTGAGCCCACCCTGCTCCTTGGCCATCAATTCCCACTTGCCTGTACTGTATTCAGAGGGGACCCCAA
TCTCTCTTCCCAGCTGCAGCGGTCCCTGTCCAACACTGCCCCCCACCTCAAATAAAGTCTTTCTTACTGTCTTTAACATATGCCGTCAATAAAGTTTTAGCAGATCCAA

hide sequence

RefSeq Acc Id:

NM_001166288 ⟹ NP_001159760

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	15	93,035,271 - 93,073,680 (-)	NCBI
GRCh37	15	93,586,636 - 93,632,443 (-)	ENTREZGENE
HuRef	15	69,723,091 - 69,768,218 (-)	ENTREZGENE
CHM1_1	15	93,427,333 - 93,457,942 (-)	NCBI
T2T-CHM13v2.0	15	90,797,572 - 90,836,024 (-)	NCBI

Sequence:

show sequence

AGACCTAGACAACTCGGAAGTGGGTTTTTCAGCCTCCTGCACCGGTGTCGCGTCTGAGTGCGACTGATGAGCCAGGGGGCGTCGGTGGAAGCTTGGGGGAGAGGCTAGTGGTAACAGGCCGAGCTGGA
TGGATGGGTATGGGGAGAGGGGCAGGACGTTCAGCCCTGGGATTCTGGCCGACCCTCGCCTTCCTTCTCTGCAGCTTCCCCGCAGCCACCTCCCCGTGCAAGATCCTCAAGTGCAACTCTGAGTTCTG
GAGCGCCACGTCGGGCAGCCACGCCCCAGCCTCAGACGACACCCCCGAGTTCTGTGCAGCCTTGCGCAGCTACGCCCTGTGCACGCGGCGGACGGCCCGCACCTGCCGGGGTGACCTGGCCTACCACT
CGGCCGTCCATGGCATAGAGGACCTCATGAGCCAGCACAACTGCTCCAAGGATGGCCCCACCTCGCAGCCACGCCTGCGCACGCTCCCACCGGCCGGAGACAGCCAGGAGCGCTCGGACAGCCCCGAG
ATCTGCCATTACGAGAAGAGCTTTCACAAGCACTCGGCCACCCCCAACTACACGCACTGTGGCCTCTTCGGGGACCCACACCTCAGGACTTTCACCGACCGCTTCCAGACCTGCAAGGTGCAGGGCGC
CTGGCCGCTCATCGACAATAATTACCTGAACGTGCAGGTCACCAACACGCCTGTGCTGCCCGGCTCAGCGGCCACTGCCACCAGCAAGCTCACCATCATCTTCAAGAACTTCCAGGAGTGTGTGGACC
AGAAGGTGTACCAGGCTGAGATGGACGAGCTCCCGGCCGCCTTCGTGGATGGCTCTAAGAACGGTGGGGACAAGCACGGGGCCAACAGCCTGAAGATCACTGAGAAGGTGTCAGGCCAGCACGTGGAG
ATCCAGGCCAAGTACATCGGCACCACCATCGTGGTGCGCCAGGTGGGCCGCTACCTGACCTTTGCCGTCCGCATGCCAGAGGAAGTGGTCAATGCTGTGGAGGACTGGGACAGCCAGGGTCTCTACCT
CTGCCTGCGGGGCTGCCCCCTCAACCAGCAGATCGACTTCCAGGCCTTCCACACCAATGCTGAGGGCACCGGTGCCCGCAGGCTGGCAGCCGCCAGCCCTGCACCCACAGCCCCCGAGACCTTCCCAT
ACGAGACAGCCGTGGCCAAGTGCAAGGAGAAGCTGCCGGTGGAGGACCTGTACTACCAGGCCTGCGTCTTCGACCTCCTCACCACGGGCGACGTGAACTTCACACTGGCCGCCTACTACGCGTTGGAG
GATGTCAAGATGCTCCACTCCAACAAAGACAAACTGCACCTGTATGAGAGGACTCGGGACCTGCCAGGCAGGGCGGCTGCGGGGCTGCCCCTGGCCCCCCGGCCCCTCCTGGGCGCCCTCGTCCCGCT
CCTGGCCCTGCTCCCTGTGTTCTGCTAGACGCGTAGATGTGGAGGGAGGCGCGGGCTCCGTCCTCTCGGCTTCCCCATGTGTGGGCTGGGACCGCCCACGGGGTGCAGATCTCCTGGCGTGTCCACCA
TGGCCCCGCAGAACGCCAGGGACCGCCTGCTGCCAAGGGCTCAGGCACGGACCCCTCCCCTTCTAGTGCACGTGACAAGGTTGTGGTGACTGGTGCCATGATGTTTGACAGTAGAGCTGTGTGAGAGG
GAGAGCAGCTCCCCTCGCCCCGCCCCTGCAGTGTGAATGTGTGAAACATCCCCTCAGGCTGAAGCCCCCCACCCCCACCAGAGACACACTGGGAACCGTCAGAGTCAGCTCCTTCCCCCTCGCAATGC
ACTGAAAGGCCCGGCCGACTGCTGCTCGCCGATCCGTGGGGCCCCCTGTGCCCGCCACACGCACGCACACACTCTTACACGAGAGCACACTCGATCCCCCTAGGCCAGCGGGGACACCCCAGCCACAC
AGGGAGGCATCCTTGGGGCTTGGCCCCAGGCAGGGCAACCCCGGGGCGCTGCTTGGCACCTTAGCAGACTGCTGGAACCTTTTGGCCAGTAGGTCGTGCCCGCCTGGTGCCTTCTGGCCTGTGGCCTC
CCTGCCCATGTTCACCTGGCTGCTGTGGGTACCAGTGCAGGTCCCGGTTTTCAGGCACCTGCTCAGCTGCCCGTCTCTGGCCTGGGCCCCTGCCCCTTCCACCCTGTGCTTAGAAAGTCGAAGTGCTT
GGTTCTAAATGTCTAAACAGAGAAGAGATCCTTGACTTCTGTTCCTCTCTCTCCTGCAGATGCAAGAGCTCCTGGGCAGGGGTGCCTGGGCCCCAGGGTGTGGCAGGAGACCCAGTGGATGGGGCCAG
CTGGCCTGCCCTGATCCTCTGCTTCCTCCTCACAACCCCAAGAGCCCCCAGCCCGGTCCATCCACGTCTGGAGTCTGGGGAGAGGAGCAGGGTCTTAGGACTCTCAGCTCTGAGCATCCCTGGCAGGG
TCTTCAACCTCTAATCTCTTCCCTTAAGCCCTGTGGCCACACAGCCAGGAGAGACTTGCCGCTGGCTCCCGCCTCATTTCAGCCCAGGGTGCTCATCCAGGGGCCCAGAACAGTCCCACCTGTGCTGC
TGTGCCCACAGCACAAAGCCAGGCTTCACTCCCAAAAGTGCAGCCAGGCCCTGGAGGGTGATCCTGCCAGCAGCCCTACAGCTCCACACCCTACCCACCCATCGGCAGCCCCTCTGCTGTTCCCCAGG
GACCTCTCATACACTGGCCAGGAGGCTGCAGAACGTGTGTCTCCCCCTCCCTCCAAGAGGTCCTGCTCCCTCTGCCAGAACCGTGTGTGGGCGGGTGGGAGGGCGCTCGGGGCCCGGCCCCTCCCTCT
CCCTGCTGGTTTTAGTTGGTCCCTATGTTGGAAGTAAAAAGTGAAGCACTTTATTTTGGTTGTGTTTGCTCACGTTCTGCTTGGAAGTGGGGACCCCTCACTGCGTCCACGTGTCTGCGACCTGTGTG
GAGTGTCACCGCGTGTACATACTGTAAATTATTTATTAATGGCTAAATGCAAGTAAAGTTTGGTTTTTTTGTTATTTTCTTTTAGACGTGTTGGAGTTTGTTTTCTGAACAGACTTTGGCTCCCTTGA
GGCGGGTGGAGGATGGACTTTGGTGGTGGGATCCCCTGCAGCAAGTGTGTGTGTGTGCGCGCATGTGTGTGTGCGCGCATGTGTGTATGCATGCCTGTGTGTGTGCGTGCCTGTGTGCGTGCATGTAC
GCATGTGTGCGCATGCCTGTGTGTGCGCCCATGCCTATGTGTGTGCATGTAGGCATGTGTGTGCGCATGTGTATGTGCGTGAGAATGGTGTGAAGGCGGATAGAAGATGCAGCAGTTTAACAGCCACC
ACACATTGCTTTTGTAAAGTCACTTTTCCTCCTCACGATGAGCTGTCTTTGGAGCTTGGCAGGCCCAGATCCTCTTGTTCTAGTGACAGTGGAACACAGTCAGGGAGACAGGTGACTATGTGGTGGAG
AGACATATGGTGCCCTCTGGGATGAGATGGGTGGGATAGCCTGAGATCTGGGATGACTCCCTCTCAGCCACTGCTATCAGCCTGGAGCCCCAGCTGTTGGGACTGCCTGCCACCCTCCCTGCCAGTGC
CCATCTTCTCATAGCCCGGGCGGAGCAGTGGTGCTGCAGGAGGCTGCTGTCCACGTCACTGTGGGACCAGGTTTATTGGCAGCTGTGATCACATTTCATCTGTACAAACTACCCAGTGAATCAGGAAG
AAATTCAGGCCCATTTTGCCGATGAAACAGACTCTGAGATTAACTGACTTGCCTAGGGCTCCTTAGCAACGGGAAGGACAACCTGTGCACCTAGGTTAGTATTGTCCTGAAGCCCCTTCTCTTCAAAC
TAAATGCCATGAGGCAGAATAGCAGCACAGTTAAGCCAGCCTACATCCTGGCTTCTCCACCTCCCCAGCAGTGTGACCATGGGCAAGTCACTTCACCTCTCTGAGCCTGCATGCTGTTCTCTGGAAGA
TGGGGGGGTGCCTGTCCCATACAGTTGTTTGGAGAGTCAGGAGTTCATTCCTGTAAATTGCTTAGGAGAGGGCGGGGCACACATGGCTTGTCTGGTCGTGGGGAGGGAGGGGGTGGTATTATCCCAAA
GCAAGATAAATCAGTTAAGGGGAGAAGGAAAGGGGCGATACAGACCCTGGACTCTTGGGAGAGGTGAACCTGCAGGCTAGCAAGGGGAGGAGTCCCAAGAGTGGCCAAGTTCATTAATCCCAGGCAGA
CCAGGAAGGCTGAAGAAAAAGGAGAACTTTATTTTATTTTTGAAATGGAGTCTGGCGTCTTGCTCTGTCGCCAGGCTGGAGTGCAGTGGCACCATCCCAGCTCACTGCAGCCCCTGCCTCCCAGGTTC
AAGCAATTCTCCTGCCTCAGCCTCCCAAGTAGCTGGGACTACAGGCACACACCACCACGCCTGGCTAATTTTTTGTATTTTAGTAGAGATGGTGTTTCACCATGTTGACCAGTATGGTCTTGATCTCC
TGACCTCGTGATCCGCCTGCCTTGGCCTCCCAAAGTGTTGGGATTACAGGCGTGAGCCACCACCGTGCCCGGCCAAAAAAGGAGAACGTTCTAAAGCCCTGTTCTTGCAGGGCTCCCAGAGAGAACAC
GGGAGTTGGGTTTGGGAGGCAGGAACCAGACTGGAAAGGACAAAACGTACCCAGCATCTTCCCTGGCGGCCGGAACCGTCACTACAGGCCCCGTGCCCTTAGCAGTCCCAGGGACAGAGCGACTCAGG
GAGGCAGCAAGGAGGAGCGGAGCCATTGGTGCTCGTCCGGCACAGAGAACAGTTCCTGAGAAGCCAGGGCACACAGAAGAAAAAGAAAAAAGAAATCTCTACTAGACGAAAATGCTAAATGGCACTAG
CCACAAAGTATTCTTGGTTTGGAATTTTTTTTCCAGGACCCTAAATGTAACCGGCTGGAATTCTTTCCCAAGTGCCATGCTACTTACTACTGGTTGCCCTCACGAGCATGGAAATGCCGTCGTGAATA
TGGAACACAGCATCCTGAGCTAAAAGATTCCCAAGAAGCAGCTTCATCTTGCAGGACGGGCTAGGTTGGGAGCCTCTGGAGGTTCCTGGCTGCCAGCTCCGCGGAGGCCTGCGGCCTGGAGGTAAATG
CATTAGCACACGGAGGTGGGCGCCTCTCCCCGCCCCATCCTGTCTCACTGATGTGTTGCCGAGAACTGGAGTTCTTGTTTAGCTAACCAGAATGTGCAAGGCTATAGGACAGGAGAGAAATGGCCTTT
AAAACAAATGAATGAGAGTCACGATGAAGGGGGCAGACGGGGGGGTGAAAATCATTACCAGAACACTTGGGCAGAGACCCGTCAGAGCCAGGCAGGAGACAGTCATCAGAGCTGTGCCAGCAAGTGGC
ATGGAGCAGGGGTGGCACTTGGGCTCGGGCTGCAGGCAAACTTGGCGTCAAAACTGGCTCAACCCGTCGCGAGCTGTGTGGTCTCCTTGGGATTTTTTGAGCCTTAGATTCCTTATTTGTAAAATGGA
TTTGTGAGTCTCCACCTCCCGAGGTCAGTATGGAAATCCAGTGAGCTAACACTCGTCAATGGCCTCGCACATGGCCCTGGCACCACGCATGGAGGCCGCCAAAAGTGGCCGCCTCCTCTCTGCAATTG
CATTTATTTATCCATTTGATAACTCTATTGGGTGTCTACCCAGCATTGTTCAGGGGGGTGTGAGGGGCTACCGCAATGACCCAGACAGACTGCTGTGCATTCTTATTGGAAAGACAAGGCAATAAACC
ACAGTTACAAAACCCAGGGTCCCATGGTAACGAGCTCCACAGAGAAAAGGGAAGTGGGCCAGAGGTTCCGAGAGACACACATTTTGGATTGCAGGAGGGTGAGAAGGGGCATTCATCTGTGGTGGGGT
TAAGGGGAGGCCTCCGACTAGCTCACCTGCATGAATTTCAGGAACAAGCCATGCAGAGCCGGACAGAGCATTCTGTGCAGAGAAAACAGTGTAACAGCCCTAGAGCAGCAGCAGCAAAGGGGGAGTTT
AAGGGATGGTGGGAAGCCACTGTCACTGGACAGTAGCAAGTGGACAGACCAGGGGTCCCAGGTGAGGCCACAGAGCAGCCAAAGTACTGCAGGGCTCTCCGGCTCCGGGAGGACTTGATGTTTGACTC
CAGTTGCCAGAGGAAGCCGTTCACGGGCTTTGAGTGTAGGAATGATGTGTCCGACTTGGGTCTTTTTATTGTTCTTTTTTAGAGACAGGGTCTCACTCTGTCACCCAGGCTGGAGTGCAGCGGCACAA
TCACAGCTCACTGCAGCCTCCACTTCCTGGGCTCAAGCAATCCTCCCACTTCAGCCACTCAAGTAGCTGGGATTACAGGTGCCTGCCGTCACACCCGGCTAATTGTTAAATTTTTTTGGAGAGACAGG
ATCTTGCTGTTTTCCCAGGCTGATCTTGAACTCCTGGGCTCAAGCGAGACGTCTGTTTCAGCCTCCCAAAGTGCTGGGATAACAGGTGTGAGCCACTGGGCCTGCCTTGGCTTGGGTATTAAAGGAAT
TGTTCTAGTTACTATATGGAGGTGACTTGGGGCCGCTGGGGAAGAAAGAGGAAGTCAGGAGCCAGTCTGAGGCAGTGGCAATGCAGCGATTATCAGAAATAATGGGCTCAATGATAGACTGGATAAAG
AAAATGTGGCACATATACGCCATGGAGTACTATGCAGCCATAAAAAGGGATGAGTTCATGTCCTTTGCAGGGACATGGATGAAGCTGGAAACCATCATTCTCAGCAAACTAACACAAGAACAGAAAAC
CAAACACCGCATGTTCTCACTCGTAAGTGGGAGTTGAACAATGAGAACACATGGACACAGGGAAGGGAACATCACACACTGGGGCCTGTCAGTGGGTGGGGGGCTGGGGGAGGGAGAGCATCAGGAGA
AATACCCAATGTAGATGATGACGGGTTCATAGGTGCAGCAAACCACCATGGCACGTGTATACCTATGTAACAAACTTGTGCGTTCTGCACGTGTACCCCATAACTGAAAGTATAATCATAATTTTAAG
AAAAGAAATGATGGCCTTTGGGGTCTAATAAGAAGGTGGGGCTGACAGGGCTTGGGGAGAGAGCGAGCTTGACAGGAGACCACGATGTCTTCCCCAGGGGTCTGAGCACCTGGGGAAATGGTGGTGCC
ATTTACCATGACTGGAAAGATCATGGGAGGAGCAGGTTTGGGACACTGAAGGCCCGAGAGCCCCTGGCAAACCACCAGTGTAAGTCCAAGAGTCCAAAAGCTGAAGAACTTGGAGTCCAATGTTTGAG
GGTAAAAAACAGCCAGCATGAGAAAAAGATGAAGGCCAGAAGACTCGTCCAGTCTAGCCCTTCCACATTCCTCTGCCCGCTTTTATCCTAGCCTCGCTGGCAGGTGATTAGATGGTGCCCACCCAGGT
TAAGCGTGGGTCTCTGTCTCCCAGTTCACTGACTCAAATGTTAATTTCCTTTGGCGACAGCCTCACAGACACACCCAGGAACGATACTTTGCATCCTCCAATCCAATCAAGTTGGCACTCAATATTAA
ACAGTTTCGGCCGGGAGCGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCCAAAGCGGGCAGATCACTAAGTCAGGAGATCGAGACCATCCTGGCTAACACGGTGAAACCCCATCTCTACTAA
AAATACAAAAAATTAGCCAGGCGTGGTGGTGGGCGCCTGTAGTCCCAGCTACTCGGGAGGCTGAGGCAAGAGAGTGGCGTGAACCCGGGAGGCAGAACTTGCAGCAAGCAGAGATCGCACCACTGCAC
TCCAGCCTCCAGCCTGGGCGACAGAGCAAGACACCGTCTCAAAAAAAAAAAAAAAACAACTAACAGTTTCGTTCATTAAGGCAATGTCCATGGGGCAGCTCCTGCATGCCACGCCACCCCTGCCCTGA
CATACTCCCAGGCTGACCAGCCAGAACTGGGGAGAGGGCATCTTGAAGAAACAGTCCACCCTCCGCCCTCGCATACCTGTGTCTCCCAGCAGACAAGACACACAAGGGCAGGGACTGCACTTTCCTGT
GTGCAAATCTCAGGTATGGTCCAGAAATCACATCTCTTTGGTCTGATTGGCCTTACTTACCAAACCCTTGAAACAATGGAAAGAAGCTTGCTGCAATGGGAAGACCCCTGCCCCCCAAACCCTCTAAC
CAGGAGTCTACAGACCTCATTCCGTGGAAGTTCCCATTGTCCCCTGGGAAACCACCACCTTCTGAATCGGCACAGCCAAGGCCCCCAACCCTGCTATCAACAGCTTTCCTTAGCCACCTTCCCCATCC
TGCAGGGCTTTTCAACATTTCGACTTTTTAATCCTTCCCTCCCTAAGATATAGACATGGTGTTAGTAGCAGAACCCTGAAGGCAAAGGAACAGAAACTAACACTCTCAGAAAGTCCTAGCAGGATGGT
CTGAATTAATAGACAGCTGCAGGCAGCCAGTGTGCAAGGCACGCTCGTAATGTCAGTGGCGTTCCGGAATGAGGGCTGTGATCCCAGGCAGCCCAGATCCCAAGGCGAAAACATTCATGTCGCCCAGC
ATCACCCTGTCCTTGCCCAGGGTGACCCTGAGACGGCACTTGGATTCTTCCACATCTGAACTCAAACCTGCTCCCTCAGCTCTCCCCAGCAGGAATTGGAGCCCTCTCCAGGCCGTTCAGCCAAAGCA
GAATGTGTCTGGCCAAGCAGATCTGCCCAGAGAAGAACAAAGACGTGTTCAGACACTGTCTGGGGAATTGGTTTTGAGCTCACTCTGAGCTCCATCTGTGCAACAAGGCCAGCGTCAGCTGTTACAGA
GAAGGGGCTTGTGGCAGTTTATTACCCTGGTGAGCTGGCTCGGGGCCATGCTGACCGCAGGACTGTAAAGGACATAAGGCAGTTGGCAATATGGGAAGCAGCAGTCCCCAAAGCACCCCGTCAAGGAA
ACGATGCAAGAGCTCTGTCCACTGGACCAGCCCCACCCTACCCCGCCACGCCCTGGCCTAGGGGGAGGGACCTTGTGTTTCACGGGCCTGGATGGCCAGGGATGGACAGTGGCATGGGCACAGACACA
CCCAGACCGAAGGAAGGGCCCGGGCTCCAGAACCAGACCCGATCCAGGCTCCCAGCTCTGTCACCTACTGGCTGCATGAAAAGGGTGGGTTTTCCTTGTTTTGCAGCCTCAGCTATCTCAGCTGTGAG
GGAACAATGACGCCACCTCCCTCACGTGGCGGTCCTGAAGATGAAATGTAATGCATGCAGCGCGGCGGCCGGCCCACCGTGTGCTCTTAGTAACTGGCCGCTGTTCTCTTCAGCCCTCCCGTTACTGA
CCACCTCGAGGGCACCGTTCCTCCAAGCTGACCATTTCCTGCCAGTCACCCACTGCCCAGCTCGCCCAGCCATGGAGTGGGCTCTGGTCCACGTGCATGGTGAGCTGCCATCTTTGTCGTCCTCTGGA
CACCACGTCTACCTCCTTGGGAAATAGAAACGAGTCCTGCATTGCTTTGTCAAATTTCACAAAAACCCTAGAAAGCAGATATTGCCCTGGTTTACAGACGGACAGACAGAAGCAAAGAGAAGCCAACT
GACCCACTCCAGGTTACAAGCAGGGTCTGGTAGGAGAGCACGCGTCCACCCCACCGCTCACTGCGCCCACCTACTCCTCGCTTGAGGGCAGAGAACGAGCTGGGGCGGGGCGCTCCAGGGGGCACAGG
CAGCCTGTGTTCAAGGCATGCTCGTGAGCCCCACAGCAGGGGCGGAGTCAAACCAGGGCTCTGGTTCTGGGGTGAGCAGAGGGTGGGGCCAGGCCCCCACTGGGAGGCTGACTGAGGAGGGGCTCAAA
GGGCAGGCAGGCTCCATCAGAGCGGTTTGATGAGCAGGGCCGCTGAGTGGCCCTCAGGTCAAGGCTGGGGCCGGGACCACCAGGGACCAGGTCTGCGGGGCCAGGGGTCCCTCCCCAGGGTGGAGCAG
GAAAACTCCGGCAACCGCCTTCTTGAGTGGACTTGACCTTCCCTTTCTCTGCTAATGATCTCAGATTAATCCCTTAAGGCAAGTGCCCCAGGGTGGGTGTTGGTTGCATAAAACAAGAGGAGTCCTTC
TTCCCTTCCTTCCTGGCACAAACATTTGTAGGCCACCCCCGATGTGGCTGGTCGTAGTCTGGATTTGGGGGCACATTCAGGCATTCAACAAATACGTCATGAGGCCCCGTGATGAGCTGGGGGGCTAT
GCTTGATGTCGGCAGTACAGCTGTGGTCGCTCGAATGAATGTGCCCGCCCTCACGGGACTGACCTCTAGTGGTGAGAGACAGACACTAACCGAGTCACATGTGTGATTACACGTGTAATCATACTTAC
ATATGTAACAACACGAGTTACACGTGCAGTGTGGGGAGGGGGCCCTTCACGGTGACCAGCCCATCAGGGAAGGGGATGCGGGTGGCAGAAGGAAGCGGCACACCCTTGTCCTCACGGAGCTCACAGGA
GGTTCTCTGACCCTCATCTTAAGCCACAGGCTGTGTCTGAGCCTCACTGCCCTAGCTATCAACTGGGTGCAGGACTAGGCCTTAATCACTGGGCAGCGGGAAGAACTACATAAGCTCATACTGGCGCA
AAGCCCCTTGGGAGACCGCAGGGAAAGCCATTGCATGAGGTGGTGACAGGCTCGGCCTTCAGAGTCGGGCTAGAATCTGAGTTCTGACAATGATCCCCGCCTTGACCCATCTCTCCTCAGGCCGCCCT
GAGCCTTCCAGTTAGGCCTGGGCTTTGGGCTTCCGTGTTTGTCTCTGGATTGTTCGGTTTTAGCAAGAGTCCTGCTAAATTGGTCTTGCTGGAATCCTCCGCCCTCCACATCTGATTGCCCTTCCTGT
CTGATCGTGGTCTTCATGCCCCACGGCCTCCAGGGGACGTCTGATCACCTGGCCTGCCTTCAGCAAGAATCCCCCCAGGTGTTTCCTCTTAAGAGGTTTTCCATCCACTGAGCCCACCCTGCTCCTTG
GCCATCAATTCCCACTTGCCTGTACTGTATTCAGAGGGGACCCCAATCTCTCTTCCCAGCTGCAGCGGTCCCTGTCCAACACTGCCCCCCACCTCAAATAAAGTCTTTCTTACTGTCTTTAACATATG
CCGTCAATAAAGTTTTAGCAGATCCAA

hide sequence

RefSeq Acc Id:

NM_001166289 ⟹ NP_001159761

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	15	93,035,271 - 93,073,710 (-)	NCBI
GRCh37	15	93,586,636 - 93,632,443 (-)	ENTREZGENE
HuRef	15	69,723,091 - 69,768,218 (-)	ENTREZGENE
CHM1_1	15	93,427,333 - 93,457,942 (-)	NCBI
T2T-CHM13v2.0	15	90,797,572 - 90,836,054 (-)	NCBI

Sequence:

show sequence

GTAGCTGAGATGCAGAGAGCCATCCTGCCCAGACCTAGACAACTCGGAAGTGGGTTTTTCAGCC
TCCTGCACCGGTGTCGCGTCTGAGTGCGACTGATGAGCCAGGGGGCGTCGGTGGAAGCTTGGGGTCGGCAGTCTGGTTGGAAAGGAGAGGCTAGTGGTAACAGGCCGAGCTGGATGGATGGGTATGGG
GAGAGGGGCAGGACGTTCAGCCCTGGGATTCTGGCCGACCCTCGCCTTCCTTCTCTGCAGCTTCCCCGCAGCCACCTCCCCGTGCAAGATCCTCAAGTGCAACTCTGAGTTCTGGAGCGCCACGTCGG
GCAGCCACGCCCCAGCCTCAGACGACACCCCCGAGTTCTGTGCAGCCTTGCGCAGCTACGCCCTGTGCACGCGGCGGACGGCCCGCACCTGCCGGGGTGACCTGGCCTACCACTCGGCCGTCCATGGC
ATAGAGGACCTCATGAGCCAGCACAACTGCTCCAAGGATGGCCCCACCTCGCAGCCACGCCTGCGCACGCTCCCACCGGCCGGAGACAGCCAGGAGCGCTCGGACAGCCCCGAGATCTGCCATTACGA
GAAGAGCTTTCACAAGCACTCGGCCACCCCCAACTACACGCACTGTGGCCTCTTCGGGGACCCACACCTCAGGACTTTCACCGACCGCTTCCAGACCTGCAAGGTGCAGGGCGCCTGGCCGCTCATCG
ACAATAATTACCTGAACGTGCAGGTCACCAACACGCCTGTGCTGCCCGGCTCAGCGGCCACTGCCACCAGCAAGCTCACCATCATCTTCAAGAACTTCCAGGAGTGTGTGGACCAGAAGGTGTACCAG
GCTGAGATGGACGAGCTCCCGGCCGCCTTCGTGGATGGCTCTAAGAACGGTGGGGACAAGCACGGGGCCAACAGCCTGAAGATCACTGAGAAGGTGTCAGGCCAGCACGTGGAGATCCAGGCCAAGTA
CATCGGCACCACCATCGTGGTGCGCCAGGTGGGCCGCTACCTGACCTTTGCCGTCCGCATGCCAGAGGAAGTGGTCAATGCTGTGGAGGACTGGGACAGCCAGGGTCTCTACCTCTGCCTGCGGGGCT
GCCCCCTCAACCAGCAGATCGACTTCCAGGCCTTCCACACCAATGCTGAGGGCACCGGTGCCCGCAGGCTGGCAGCCGCCAGCCCTGCACCCACAGCCCCCGAGACCTTCCCATACGAGACAGCCGTG
GCCAAGTGCAAGGAGAAGCTGCCGGTGGAGGACCTGTACTACCAGGCCTGCGTCTTCGACCTCCTCACCACGGGCGACGTGAACTTCACACTGGCCGCCTACTACGCGTTGGAGGATGTCAAGATGCT
CCACTCCAACAAAGACAAACTGCACCTGTATGAGAGGACTCGGGACCTGCCAGGCAGGGCGGCTGCGGGGCTGCCCCTGGCCCCCCGGCCCCTCCTGGGCGCCCTCGTCCCGCTCCTGGCCCTGCTCC
CTGTGTTCTGCTAGACGCGTAGATGTGGAGGGAGGCGCGGGCTCCGTCCTCTCGGCTTCCCCATGTGTGGGCTGGGACCGCCCACGGGGTGCAGATCTCCTGGCGTGTCCACCATGGCCCCGCAGAAC
GCCAGGGACCGCCTGCTGCCAAGGGCTCAGGCACGGACCCCTCCCCTTCTAGTGCACGTGACAAGGTTGTGGTGACTGGTGCCATGATGTTTGACAGTAGAGCTGTGTGAGAGGGAGAGCAGCTCCCC
TCGCCCCGCCCCTGCAGTGTGAATGTGTGAAACATCCCCTCAGGCTGAAGCCCCCCACCCCCACCAGAGACACACTGGGAACCGTCAGAGTCAGCTCCTTCCCCCTCGCAATGCACTGAAAGGCCCGG
CCGACTGCTGCTCGCCGATCCGTGGGGCCCCCTGTGCCCGCCACACGCACGCACACACTCTTACACGAGAGCACACTCGATCCCCCTAGGCCAGCGGGGACACCCCAGCCACACAGGGAGGCATCCTT
GGGGCTTGGCCCCAGGCAGGGCAACCCCGGGGCGCTGCTTGGCACCTTAGCAGACTGCTGGAACCTTTTGGCCAGTAGGTCGTGCCCGCCTGGTGCCTTCTGGCCTGTGGCCTCCCTGCCCATGTTCA
CCTGGCTGCTGTGGGTACCAGTGCAGGTCCCGGTTTTCAGGCACCTGCTCAGCTGCCCGTCTCTGGCCTGGGCCCCTGCCCCTTCCACCCTGTGCTTAGAAAGTCGAAGTGCTTGGTTCTAAATGTCT
AAACAGAGAAGAGATCCTTGACTTCTGTTCCTCTCTCTCCTGCAGATGCAAGAGCTCCTGGGCAGGGGTGCCTGGGCCCCAGGGTGTGGCAGGAGACCCAGTGGATGGGGCCAGCTGGCCTGCCCTGA
TCCTCTGCTTCCTCCTCACAACCCCAAGAGCCCCCAGCCCGGTCCATCCACGTCTGGAGTCTGGGGAGAGGAGCAGGGTCTTAGGACTCTCAGCTCTGAGCATCCCTGGCAGGGTCTTCAACCTCTAA
TCTCTTCCCTTAAGCCCTGTGGCCACACAGCCAGGAGAGACTTGCCGCTGGCTCCCGCCTCATTTCAGCCCAGGGTGCTCATCCAGGGGCCCAGAACAGTCCCACCTGTGCTGCTGTGCCCACAGCAC
AAAGCCAGGCTTCACTCCCAAAAGTGCAGCCAGGCCCTGGAGGGTGATCCTGCCAGCAGCCCTACAGCTCCACACCCTACCCACCCATCGGCAGCCCCTCTGCTGTTCCCCAGGGACCTCTCATACAC
TGGCCAGGAGGCTGCAGAACGTGTGTCTCCCCCTCCCTCCAAGAGGTCCTGCTCCCTCTGCCAGAACCGTGTGTGGGCGGGTGGGAGGGCGCTCGGGGCCCGGCCCCTCCCTCTCCCTGCTGGTTTTA
GTTGGTCCCTATGTTGGAAGTAAAAAGTGAAGCACTTTATTTTGGTTGTGTTTGCTCACGTTCTGCTTGGAAGTGGGGACCCCTCACTGCGTCCACGTGTCTGCGACCTGTGTGGAGTGTCACCGCGT
GTACATACTGTAAATTATTTATTAATGGCTAAATGCAAGTAAAGTTTGGTTTTTTTGTTATTTTCTTTTAGACGTGTTGGAGTTTGTTTTCTGAACAGACTTTGGCTCCCTTGAGGCGGGTGGAGGAT
GGACTTTGGTGGTGGGATCCCCTGCAGCAAGTGTGTGTGTGTGCGCGCATGTGTGTGTGCGCGCATGTGTGTATGCATGCCTGTGTGTGTGCGTGCCTGTGTGCGTGCATGTACGCATGTGTGCGCAT
GCCTGTGTGTGCGCCCATGCCTATGTGTGTGCATGTAGGCATGTGTGTGCGCATGTGTATGTGCGTGAGAATGGTGTGAAGGCGGATAGAAGATGCAGCAGTTTAACAGCCACCACACATTGCTTTTG
TAAAGTCACTTTTCCTCCTCACGATGAGCTGTCTTTGGAGCTTGGCAGGCCCAGATCCTCTTGTTCTAGTGACAGTGGAACACAGTCAGGGAGACAGGTGACTATGTGGTGGAGAGACATATGGTGCC
CTCTGGGATGAGATGGGTGGGATAGCCTGAGATCTGGGATGACTCCCTCTCAGCCACTGCTATCAGCCTGGAGCCCCAGCTGTTGGGACTGCCTGCCACCCTCCCTGCCAGTGCCCATCTTCTCATAG
CCCGGGCGGAGCAGTGGTGCTGCAGGAGGCTGCTGTCCACGTCACTGTGGGACCAGGTTTATTGGCAGCTGTGATCACATTTCATCTGTACAAACTACCCAGTGAATCAGGAAGAAATTCAGGCCCAT
TTTGCCGATGAAACAGACTCTGAGATTAACTGACTTGCCTAGGGCTCCTTAGCAACGGGAAGGACAACCTGTGCACCTAGGTTAGTATTGTCCTGAAGCCCCTTCTCTTCAAACTAAATGCCATGAGG
CAGAATAGCAGCACAGTTAAGCCAGCCTACATCCTGGCTTCTCCACCTCCCCAGCAGTGTGACCATGGGCAAGTCACTTCACCTCTCTGAGCCTGCATGCTGTTCTCTGGAAGATGGGGGGGTGCCTG
TCCCATACAGTTGTTTGGAGAGTCAGGAGTTCATTCCTGTAAATTGCTTAGGAGAGGGCGGGGCACACATGGCTTGTCTGGTCGTGGGGAGGGAGGGGGTGGTATTATCCCAAAGCAAGATAAATCAG
TTAAGGGGAGAAGGAAAGGGGCGATACAGACCCTGGACTCTTGGGAGAGGTGAACCTGCAGGCTAGCAAGGGGAGGAGTCCCAAGAGTGGCCAAGTTCATTAATCCCAGGCAGACCAGGAAGGCTGAA
GAAAAAGGAGAACTTTATTTTATTTTTGAAATGGAGTCTGGCGTCTTGCTCTGTCGCCAGGCTGGAGTGCAGTGGCACCATCCCAGCTCACTGCAGCCCCTGCCTCCCAGGTTCAAGCAATTCTCCTG
CCTCAGCCTCCCAAGTAGCTGGGACTACAGGCACACACCACCACGCCTGGCTAATTTTTTGTATTTTAGTAGAGATGGTGTTTCACCATGTTGACCAGTATGGTCTTGATCTCCTGACCTCGTGATCC
GCCTGCCTTGGCCTCCCAAAGTGTTGGGATTACAGGCGTGAGCCACCACCGTGCCCGGCCAAAAAAGGAGAACGTTCTAAAGCCCTGTTCTTGCAGGGCTCCCAGAGAGAACACGGGAGTTGGGTTTG
GGAGGCAGGAACCAGACTGGAAAGGACAAAACGTACCCAGCATCTTCCCTGGCGGCCGGAACCGTCACTACAGGCCCCGTGCCCTTAGCAGTCCCAGGGACAGAGCGACTCAGGGAGGCAGCAAGGAG
GAGCGGAGCCATTGGTGCTCGTCCGGCACAGAGAACAGTTCCTGAGAAGCCAGGGCACACAGAAGAAAAAGAAAAAAGAAATCTCTACTAGACGAAAATGCTAAATGGCACTAGCCACAAAGTATTCT
TGGTTTGGAATTTTTTTTCCAGGACCCTAAATGTAACCGGCTGGAATTCTTTCCCAAGTGCCATGCTACTTACTACTGGTTGCCCTCACGAGCATGGAAATGCCGTCGTGAATATGGAACACAGCATC
CTGAGCTAAAAGATTCCCAAGAAGCAGCTTCATCTTGCAGGACGGGCTAGGTTGGGAGCCTCTGGAGGTTCCTGGCTGCCAGCTCCGCGGAGGCCTGCGGCCTGGAGGTAAATGCATTAGCACACGGA
GGTGGGCGCCTCTCCCCGCCCCATCCTGTCTCACTGATGTGTTGCCGAGAACTGGAGTTCTTGTTTAGCTAACCAGAATGTGCAAGGCTATAGGACAGGAGAGAAATGGCCTTTAAAACAAATGAATG
AGAGTCACGATGAAGGGGGCAGACGGGGGGGTGAAAATCATTACCAGAACACTTGGGCAGAGACCCGTCAGAGCCAGGCAGGAGACAGTCATCAGAGCTGTGCCAGCAAGTGGCATGGAGCAGGGGTG
GCACTTGGGCTCGGGCTGCAGGCAAACTTGGCGTCAAAACTGGCTCAACCCGTCGCGAGCTGTGTGGTCTCCTTGGGATTTTTTGAGCCTTAGATTCCTTATTTGTAAAATGGATTTGTGAGTCTCCA
CCTCCCGAGGTCAGTATGGAAATCCAGTGAGCTAACACTCGTCAATGGCCTCGCACATGGCCCTGGCACCACGCATGGAGGCCGCCAAAAGTGGCCGCCTCCTCTCTGCAATTGCATTTATTTATCCA
TTTGATAACTCTATTGGGTGTCTACCCAGCATTGTTCAGGGGGGTGTGAGGGGCTACCGCAATGACCCAGACAGACTGCTGTGCATTCTTATTGGAAAGACAAGGCAATAAACCACAGTTACAAAACC
CAGGGTCCCATGGTAACGAGCTCCACAGAGAAAAGGGAAGTGGGCCAGAGGTTCCGAGAGACACACATTTTGGATTGCAGGAGGGTGAGAAGGGGCATTCATCTGTGGTGGGGTTAAGGGGAGGCCTC
CGACTAGCTCACCTGCATGAATTTCAGGAACAAGCCATGCAGAGCCGGACAGAGCATTCTGTGCAGAGAAAACAGTGTAACAGCCCTAGAGCAGCAGCAGCAAAGGGGGAGTTTAAGGGATGGTGGGA
AGCCACTGTCACTGGACAGTAGCAAGTGGACAGACCAGGGGTCCCAGGTGAGGCCACAGAGCAGCCAAAGTACTGCAGGGCTCTCCGGCTCCGGGAGGACTTGATGTTTGACTCCAGTTGCCAGAGGA
AGCCGTTCACGGGCTTTGAGTGTAGGAATGATGTGTCCGACTTGGGTCTTTTTATTGTTCTTTTTTAGAGACAGGGTCTCACTCTGTCACCCAGGCTGGAGTGCAGCGGCACAATCACAGCTCACTGC
AGCCTCCACTTCCTGGGCTCAAGCAATCCTCCCACTTCAGCCACTCAAGTAGCTGGGATTACAGGTGCCTGCCGTCACACCCGGCTAATTGTTAAATTTTTTTGGAGAGACAGGATCTTGCTGTTTTC
CCAGGCTGATCTTGAACTCCTGGGCTCAAGCGAGACGTCTGTTTCAGCCTCCCAAAGTGCTGGGATAACAGGTGTGAGCCACTGGGCCTGCCTTGGCTTGGGTATTAAAGGAATTGTTCTAGTTACTA
TATGGAGGTGACTTGGGGCCGCTGGGGAAGAAAGAGGAAGTCAGGAGCCAGTCTGAGGCAGTGGCAATGCAGCGATTATCAGAAATAATGGGCTCAATGATAGACTGGATAAAGAAAATGTGGCACAT
ATACGCCATGGAGTACTATGCAGCCATAAAAAGGGATGAGTTCATGTCCTTTGCAGGGACATGGATGAAGCTGGAAACCATCATTCTCAGCAAACTAACACAAGAACAGAAAACCAAACACCGCATGT
TCTCACTCGTAAGTGGGAGTTGAACAATGAGAACACATGGACACAGGGAAGGGAACATCACACACTGGGGCCTGTCAGTGGGTGGGGGGCTGGGGGAGGGAGAGCATCAGGAGAAATACCCAATGTAG
ATGATGACGGGTTCATAGGTGCAGCAAACCACCATGGCACGTGTATACCTATGTAACAAACTTGTGCGTTCTGCACGTGTACCCCATAACTGAAAGTATAATCATAATTTTAAGAAAAGAAATGATGG
CCTTTGGGGTCTAATAAGAAGGTGGGGCTGACAGGGCTTGGGGAGAGAGCGAGCTTGACAGGAGACCACGATGTCTTCCCCAGGGGTCTGAGCACCTGGGGAAATGGTGGTGCCATTTACCATGACTG
GAAAGATCATGGGAGGAGCAGGTTTGGGACACTGAAGGCCCGAGAGCCCCTGGCAAACCACCAGTGTAAGTCCAAGAGTCCAAAAGCTGAAGAACTTGGAGTCCAATGTTTGAGGGTAAAAAACAGCC
AGCATGAGAAAAAGATGAAGGCCAGAAGACTCGTCCAGTCTAGCCCTTCCACATTCCTCTGCCCGCTTTTATCCTAGCCTCGCTGGCAGGTGATTAGATGGTGCCCACCCAGGTTAAGCGTGGGTCTC
TGTCTCCCAGTTCACTGACTCAAATGTTAATTTCCTTTGGCGACAGCCTCACAGACACACCCAGGAACGATACTTTGCATCCTCCAATCCAATCAAGTTGGCACTCAATATTAAACAGTTTCGGCCGG
GAGCGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCCAAAGCGGGCAGATCACTAAGTCAGGAGATCGAGACCATCCTGGCTAACACGGTGAAACCCCATCTCTACTAAAAATACAAAAAATT
AGCCAGGCGTGGTGGTGGGCGCCTGTAGTCCCAGCTACTCGGGAGGCTGAGGCAAGAGAGTGGCGTGAACCCGGGAGGCAGAACTTGCAGCAAGCAGAGATCGCACCACTGCACTCCAGCCTCCAGCC
TGGGCGACAGAGCAAGACACCGTCTCAAAAAAAAAAAAAAAACAACTAACAGTTTCGTTCATTAAGGCAATGTCCATGGGGCAGCTCCTGCATGCCACGCCACCCCTGCCCTGACATACTCCCAGGCT
GACCAGCCAGAACTGGGGAGAGGGCATCTTGAAGAAACAGTCCACCCTCCGCCCTCGCATACCTGTGTCTCCCAGCAGACAAGACACACAAGGGCAGGGACTGCACTTTCCTGTGTGCAAATCTCAGG
TATGGTCCAGAAATCACATCTCTTTGGTCTGATTGGCCTTACTTACCAAACCCTTGAAACAATGGAAAGAAGCTTGCTGCAATGGGAAGACCCCTGCCCCCCAAACCCTCTAACCAGGAGTCTACAGA
CCTCATTCCGTGGAAGTTCCCATTGTCCCCTGGGAAACCACCACCTTCTGAATCGGCACAGCCAAGGCCCCCAACCCTGCTATCAACAGCTTTCCTTAGCCACCTTCCCCATCCTGCAGGGCTTTTCA
ACATTTCGACTTTTTAATCCTTCCCTCCCTAAGATATAGACATGGTGTTAGTAGCAGAACCCTGAAGGCAAAGGAACAGAAACTAACACTCTCAGAAAGTCCTAGCAGGATGGTCTGAATTAATAGAC
AGCTGCAGGCAGCCAGTGTGCAAGGCACGCTCGTAATGTCAGTGGCGTTCCGGAATGAGGGCTGTGATCCCAGGCAGCCCAGATCCCAAGGCGAAAACATTCATGTCGCCCAGCATCACCCTGTCCTT
GCCCAGGGTGACCCTGAGACGGCACTTGGATTCTTCCACATCTGAACTCAAACCTGCTCCCTCAGCTCTCCCCAGCAGGAATTGGAGCCCTCTCCAGGCCGTTCAGCCAAAGCAGAATGTGTCTGGCC
AAGCAGATCTGCCCAGAGAAGAACAAAGACGTGTTCAGACACTGTCTGGGGAATTGGTTTTGAGCTCACTCTGAGCTCCATCTGTGCAACAAGGCCAGCGTCAGCTGTTACAGAGAAGGGGCTTGTGG
CAGTTTATTACCCTGGTGAGCTGGCTCGGGGCCATGCTGACCGCAGGACTGTAAAGGACATAAGGCAGTTGGCAATATGGGAAGCAGCAGTCCCCAAAGCACCCCGTCAAGGAAACGATGCAAGAGCT
CTGTCCACTGGACCAGCCCCACCCTACCCCGCCACGCCCTGGCCTAGGGGGAGGGACCTTGTGTTTCACGGGCCTGGATGGCCAGGGATGGACAGTGGCATGGGCACAGACACACCCAGACCGAAGGA
AGGGCCCGGGCTCCAGAACCAGACCCGATCCAGGCTCCCAGCTCTGTCACCTACTGGCTGCATGAAAAGGGTGGGTTTTCCTTGTTTTGCAGCCTCAGCTATCTCAGCTGTGAGGGAACAATGACGCC
ACCTCCCTCACGTGGCGGTCCTGAAGATGAAATGTAATGCATGCAGCGCGGCGGCCGGCCCACCGTGTGCTCTTAGTAACTGGCCGCTGTTCTCTTCAGCCCTCCCGTTACTGACCACCTCGAGGGCA
CCGTTCCTCCAAGCTGACCATTTCCTGCCAGTCACCCACTGCCCAGCTCGCCCAGCCATGGAGTGGGCTCTGGTCCACGTGCATGGTGAGCTGCCATCTTTGTCGTCCTCTGGACACCACGTCTACCT
CCTTGGGAAATAGAAACGAGTCCTGCATTGCTTTGTCAAATTTCACAAAAACCCTAGAAAGCAGATATTGCCCTGGTTTACAGACGGACAGACAGAAGCAAAGAGAAGCCAACTGACCCACTCCAGGT
TACAAGCAGGGTCTGGTAGGAGAGCACGCGTCCACCCCACCGCTCACTGCGCCCACCTACTCCTCGCTTGAGGGCAGAGAACGAGCTGGGGCGGGGCGCTCCAGGGGGCACAGGCAGCCTGTGTTCAA
GGCATGCTCGTGAGCCCCACAGCAGGGGCGGAGTCAAACCAGGGCTCTGGTTCTGGGGTGAGCAGAGGGTGGGGCCAGGCCCCCACTGGGAGGCTGACTGAGGAGGGGCTCAAAGGGCAGGCAGGCTC
CATCAGAGCGGTTTGATGAGCAGGGCCGCTGAGTGGCCCTCAGGTCAAGGCTGGGGCCGGGACCACCAGGGACCAGGTCTGCGGGGCCAGGGGTCCCTCCCCAGGGTGGAGCAGGAAAACTCCGGCAA
CCGCCTTCTTGAGTGGACTTGACCTTCCCTTTCTCTGCTAATGATCTCAGATTAATCCCTTAAGGCAAGTGCCCCAGGGTGGGTGTTGGTTGCATAAAACAAGAGGAGTCCTTCTTCCCTTCCTTCCT
GGCACAAACATTTGTAGGCCACCCCCGATGTGGCTGGTCGTAGTCTGGATTTGGGGGCACATTCAGGCATTCAACAAATACGTCATGAGGCCCCGTGATGAGCTGGGGGGCTATGCTTGATGTCGGCA
GTACAGCTGTGGTCGCTCGAATGAATGTGCCCGCCCTCACGGGACTGACCTCTAGTGGTGAGAGACAGACACTAACCGAGTCACATGTGTGATTACACGTGTAATCATACTTACATATGTAACAACAC
GAGTTACACGTGCAGTGTGGGGAGGGGGCCCTTCACGGTGACCAGCCCATCAGGGAAGGGGATGCGGGTGGCAGAAGGAAGCGGCACACCCTTGTCCTCACGGAGCTCACAGGAGGTTCTCTGACCCT
CATCTTAAGCCACAGGCTGTGTCTGAGCCTCACTGCCCTAGCTATCAACTGGGTGCAGGACTAGGCCTTAATCACTGGGCAGCGGGAAGAACTACATAAGCTCATACTGGCGCAAAGCCCCTTGGGAG
ACCGCAGGGAAAGCCATTGCATGAGGTGGTGACAGGCTCGGCCTTCAGAGTCGGGCTAGAATCTGAGTTCTGACAATGATCCCCGCCTTGACCCATCTCTCCTCAGGCCGCCCTGAGCCTTCCAGTTA
GGCCTGGGCTTTGGGCTTCCGTGTTTGTCTCTGGATTGTTCGGTTTTAGCAAGAGTCCTGCTAAATTGGTCTTGCTGGAATCCTCCGCCCTCCACATCTGATTGCCCTTCCTGTCTGATCGTGGTCTT
CATGCCCCACGGCCTCCAGGGGACGTCTGATCACCTGGCCTGCCTTCAGCAAGAATCCCCCCAGGTGTTTCCTCTTAAGAGGTTTTCCATCCACTGAGCCCACCCTGCTCCTTGGCCATCAATTCCCA
CTTGCCTGTACTGTATTCAGAGGGGACCCCAATCTCTCTTCCCAGCTGCAGCGGTCCCTGTCCAACACTGCCCCCCACCTCAAATAAAGTCTTTCTTACTGTCTTTAACATATGCCGTCAATAAAGTT
TTAGCAGATCCAA

hide sequence

RefSeq Acc Id:

NM_020211 ⟹ NP_064596

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	15	93,035,271 - 93,089,211 (-)	NCBI
GRCh37	15	93,586,636 - 93,632,443 (-)	ENTREZGENE
Build 36	15	91,387,641 - 91,433,437 (-)	NCBI Archive
HuRef	15	69,723,091 - 69,768,218 (-)	ENTREZGENE
CHM1_1	15	93,427,333 - 93,473,451 (-)	NCBI
T2T-CHM13v2.0	15	90,797,572 - 90,851,558 (-)	NCBI

Sequence:

show sequence

ACTCTGCAGTTGTCTCCCGAGCGCTGGCTGCGCCGCCCGAGCCGCTGGGCCGGGGAAGCACTGG
CCGTTCGCTCCCGGGCCGGCTCCGCCAGGCGCTCGCAGGCATGCAGCCCGGGAGCAGGAGGCGCTCCCCGGGCCGCTGCTGAGCCGGCCGGGGCGGCGGGGACCAGCGCCAGCGGAGCCCCTCCCACC
TTGCCCCGGGGCAGACGAGCGGCGCCCCGACACCCCCTCTTCTCCCGCAGCCCCGCCAGCGCCACCCCCCGCGGGCCGCAGGGGCTCATGCAGCCGCCAAGGGAGAGGCTAGTGGTAACAGGCCGAGC
TGGATGGATGGGTATGGGGAGAGGGGCAGGACGTTCAGCCCTGGGATTCTGGCCGACCCTCGCCTTCCTTCTCTGCAGCTTCCCCGCAGCCACCTCCCCGTGCAAGATCCTCAAGTGCAACTCTGAGT
TCTGGAGCGCCACGTCGGGCAGCCACGCCCCAGCCTCAGACGACACCCCCGAGTTCTGTGCAGCCTTGCGCAGCTACGCCCTGTGCACGCGGCGGACGGCCCGCACCTGCCGGGGTGACCTGGCCTAC
CACTCGGCCGTCCATGGCATAGAGGACCTCATGAGCCAGCACAACTGCTCCAAGGATGGCCCCACCTCGCAGCCACGCCTGCGCACGCTCCCACCGGCCGGAGACAGCCAGGAGCGCTCGGACAGCCC
CGAGATCTGCCATTACGAGAAGAGCTTTCACAAGCACTCGGCCACCCCCAACTACACGCACTGTGGCCTCTTCGGGGACCCACACCTCAGGACTTTCACCGACCGCTTCCAGACCTGCAAGGTGCAGG
GCGCCTGGCCGCTCATCGACAATAATTACCTGAACGTGCAGGTCACCAACACGCCTGTGCTGCCCGGCTCAGCGGCCACTGCCACCAGCAAGCTCACCATCATCTTCAAGAACTTCCAGGAGTGTGTG
GACCAGAAGGTGTACCAGGCTGAGATGGACGAGCTCCCGGCCGCCTTCGTGGATGGCTCTAAGAACGGTGGGGACAAGCACGGGGCCAACAGCCTGAAGATCACTGAGAAGGTGTCAGGCCAGCACGT
GGAGATCCAGGCCAAGTACATCGGCACCACCATCGTGGTGCGCCAGGTGGGCCGCTACCTGACCTTTGCCGTCCGCATGCCAGAGGAAGTGGTCAATGCTGTGGAGGACTGGGACAGCCAGGGTCTCT
ACCTCTGCCTGCGGGGCTGCCCCCTCAACCAGCAGATCGACTTCCAGGCCTTCCACACCAATGCTGAGGGCACCGGTGCCCGCAGGCTGGCAGCCGCCAGCCCTGCACCCACAGCCCCCGAGACCTTC
CCATACGAGACAGCCGTGGCCAAGTGCAAGGAGAAGCTGCCGGTGGAGGACCTGTACTACCAGGCCTGCGTCTTCGACCTCCTCACCACGGGCGACGTGAACTTCACACTGGCCGCCTACTACGCGTT
GGAGGATGTCAAGATGCTCCACTCCAACAAAGACAAACTGCACCTGTATGAGAGGACTCGGGACCTGCCAGGCAGGGCGGCTGCGGGGCTGCCCCTGGCCCCCCGGCCCCTCCTGGGCGCCCTCGTCC
CGCTCCTGGCCCTGCTCCCTGTGTTCTGCTAGACGCGTAGATGTGGAGGGAGGCGCGGGCTCCGTCCTCTCGGCTTCCCCATGTGTGGGCTGGGACCGCCCACGGGGTGCAGATCTCCTGGCGTGTCC
ACCATGGCCCCGCAGAACGCCAGGGACCGCCTGCTGCCAAGGGCTCAGGCACGGACCCCTCCCCTTCTAGTGCACGTGACAAGGTTGTGGTGACTGGTGCCATGATGTTTGACAGTAGAGCTGTGTGA
GAGGGAGAGCAGCTCCCCTCGCCCCGCCCCTGCAGTGTGAATGTGTGAAACATCCCCTCAGGCTGAAGCCCCCCACCCCCACCAGAGACACACTGGGAACCGTCAGAGTCAGCTCCTTCCCCCTCGCA
ATGCACTGAAAGGCCCGGCCGACTGCTGCTCGCCGATCCGTGGGGCCCCCTGTGCCCGCCACACGCACGCACACACTCTTACACGAGAGCACACTCGATCCCCCTAGGCCAGCGGGGACACCCCAGCC
ACACAGGGAGGCATCCTTGGGGCTTGGCCCCAGGCAGGGCAACCCCGGGGCGCTGCTTGGCACCTTAGCAGACTGCTGGAACCTTTTGGCCAGTAGGTCGTGCCCGCCTGGTGCCTTCTGGCCTGTGG
CCTCCCTGCCCATGTTCACCTGGCTGCTGTGGGTACCAGTGCAGGTCCCGGTTTTCAGGCACCTGCTCAGCTGCCCGTCTCTGGCCTGGGCCCCTGCCCCTTCCACCCTGTGCTTAGAAAGTCGAAGT
GCTTGGTTCTAAATGTCTAAACAGAGAAGAGATCCTTGACTTCTGTTCCTCTCTCTCCTGCAGATGCAAGAGCTCCTGGGCAGGGGTGCCTGGGCCCCAGGGTGTGGCAGGAGACCCAGTGGATGGGG
CCAGCTGGCCTGCCCTGATCCTCTGCTTCCTCCTCACAACCCCAAGAGCCCCCAGCCCGGTCCATCCACGTCTGGAGTCTGGGGAGAGGAGCAGGGTCTTAGGACTCTCAGCTCTGAGCATCCCTGGC
AGGGTCTTCAACCTCTAATCTCTTCCCTTAAGCCCTGTGGCCACACAGCCAGGAGAGACTTGCCGCTGGCTCCCGCCTCATTTCAGCCCAGGGTGCTCATCCAGGGGCCCAGAACAGTCCCACCTGTG
CTGCTGTGCCCACAGCACAAAGCCAGGCTTCACTCCCAAAAGTGCAGCCAGGCCCTGGAGGGTGATCCTGCCAGCAGCCCTACAGCTCCACACCCTACCCACCCATCGGCAGCCCCTCTGCTGTTCCC
CAGGGACCTCTCATACACTGGCCAGGAGGCTGCAGAACGTGTGTCTCCCCCTCCCTCCAAGAGGTCCTGCTCCCTCTGCCAGAACCGTGTGTGGGCGGGTGGGAGGGCGCTCGGGGCCCGGCCCCTCC
CTCTCCCTGCTGGTTTTAGTTGGTCCCTATGTTGGAAGTAAAAAGTGAAGCACTTTATTTTGGTTGTGTTTGCTCACGTTCTGCTTGGAAGTGGGGACCCCTCACTGCGTCCACGTGTCTGCGACCTG
TGTGGAGTGTCACCGCGTGTACATACTGTAAATTATTTATTAATGGCTAAATGCAAGTAAAGTTTGGTTTTTTTGTTATTTTCTTTTAGACGTGTTGGAGTTTGTTTTCTGAACAGACTTTGGCTCCC
TTGAGGCGGGTGGAGGATGGACTTTGGTGGTGGGATCCCCTGCAGCAAGTGTGTGTGTGTGCGCGCATGTGTGTGTGCGCGCATGTGTGTATGCATGCCTGTGTGTGTGCGTGCCTGTGTGCGTGCAT
GTACGCATGTGTGCGCATGCCTGTGTGTGCGCCCATGCCTATGTGTGTGCATGTAGGCATGTGTGTGCGCATGTGTATGTGCGTGAGAATGGTGTGAAGGCGGATAGAAGATGCAGCAGTTTAACAGC
CACCACACATTGCTTTTGTAAAGTCACTTTTCCTCCTCACGATGAGCTGTCTTTGGAGCTTGGCAGGCCCAGATCCTCTTGTTCTAGTGACAGTGGAACACAGTCAGGGAGACAGGTGACTATGTGGT
GGAGAGACATATGGTGCCCTCTGGGATGAGATGGGTGGGATAGCCTGAGATCTGGGATGACTCCCTCTCAGCCACTGCTATCAGCCTGGAGCCCCAGCTGTTGGGACTGCCTGCCACCCTCCCTGCCA
GTGCCCATCTTCTCATAGCCCGGGCGGAGCAGTGGTGCTGCAGGAGGCTGCTGTCCACGTCACTGTGGGACCAGGTTTATTGGCAGCTGTGATCACATTTCATCTGTACAAACTACCCAGTGAATCAG
GAAGAAATTCAGGCCCATTTTGCCGATGAAACAGACTCTGAGATTAACTGACTTGCCTAGGGCTCCTTAGCAACGGGAAGGACAACCTGTGCACCTAGGTTAGTATTGTCCTGAAGCCCCTTCTCTTC
AAACTAAATGCCATGAGGCAGAATAGCAGCACAGTTAAGCCAGCCTACATCCTGGCTTCTCCACCTCCCCAGCAGTGTGACCATGGGCAAGTCACTTCACCTCTCTGAGCCTGCATGCTGTTCTCTGG
AAGATGGGGGGGTGCCTGTCCCATACAGTTGTTTGGAGAGTCAGGAGTTCATTCCTGTAAATTGCTTAGGAGAGGGCGGGGCACACATGGCTTGTCTGGTCGTGGGGAGGGAGGGGGTGGTATTATCC
CAAAGCAAGATAAATCAGTTAAGGGGAGAAGGAAAGGGGCGATACAGACCCTGGACTCTTGGGAGAGGTGAACCTGCAGGCTAGCAAGGGGAGGAGTCCCAAGAGTGGCCAAGTTCATTAATCCCAGG
CAGACCAGGAAGGCTGAAGAAAAAGGAGAACTTTATTTTATTTTTGAAATGGAGTCTGGCGTCTTGCTCTGTCGCCAGGCTGGAGTGCAGTGGCACCATCCCAGCTCACTGCAGCCCCTGCCTCCCAG
GTTCAAGCAATTCTCCTGCCTCAGCCTCCCAAGTAGCTGGGACTACAGGCACACACCACCACGCCTGGCTAATTTTTTGTATTTTAGTAGAGATGGTGTTTCACCATGTTGACCAGTATGGTCTTGAT
CTCCTGACCTCGTGATCCGCCTGCCTTGGCCTCCCAAAGTGTTGGGATTACAGGCGTGAGCCACCACCGTGCCCGGCCAAAAAAGGAGAACGTTCTAAAGCCCTGTTCTTGCAGGGCTCCCAGAGAGA
ACACGGGAGTTGGGTTTGGGAGGCAGGAACCAGACTGGAAAGGACAAAACGTACCCAGCATCTTCCCTGGCGGCCGGAACCGTCACTACAGGCCCCGTGCCCTTAGCAGTCCCAGGGACAGAGCGACT
CAGGGAGGCAGCAAGGAGGAGCGGAGCCATTGGTGCTCGTCCGGCACAGAGAACAGTTCCTGAGAAGCCAGGGCACACAGAAGAAAAAGAAAAAAGAAATCTCTACTAGACGAAAATGCTAAATGGCA
CTAGCCACAAAGTATTCTTGGTTTGGAATTTTTTTTCCAGGACCCTAAATGTAACCGGCTGGAATTCTTTCCCAAGTGCCATGCTACTTACTACTGGTTGCCCTCACGAGCATGGAAATGCCGTCGTG
AATATGGAACACAGCATCCTGAGCTAAAAGATTCCCAAGAAGCAGCTTCATCTTGCAGGACGGGCTAGGTTGGGAGCCTCTGGAGGTTCCTGGCTGCCAGCTCCGCGGAGGCCTGCGGCCTGGAGGTA
AATGCATTAGCACACGGAGGTGGGCGCCTCTCCCCGCCCCATCCTGTCTCACTGATGTGTTGCCGAGAACTGGAGTTCTTGTTTAGCTAACCAGAATGTGCAAGGCTATAGGACAGGAGAGAAATGGC
CTTTAAAACAAATGAATGAGAGTCACGATGAAGGGGGCAGACGGGGGGGTGAAAATCATTACCAGAACACTTGGGCAGAGACCCGTCAGAGCCAGGCAGGAGACAGTCATCAGAGCTGTGCCAGCAAG
TGGCATGGAGCAGGGGTGGCACTTGGGCTCGGGCTGCAGGCAAACTTGGCGTCAAAACTGGCTCAACCCGTCGCGAGCTGTGTGGTCTCCTTGGGATTTTTTGAGCCTTAGATTCCTTATTTGTAAAA
TGGATTTGTGAGTCTCCACCTCCCGAGGTCAGTATGGAAATCCAGTGAGCTAACACTCGTCAATGGCCTCGCACATGGCCCTGGCACCACGCATGGAGGCCGCCAAAAGTGGCCGCCTCCTCTCTGCA
ATTGCATTTATTTATCCATTTGATAACTCTATTGGGTGTCTACCCAGCATTGTTCAGGGGGGTGTGAGGGGCTACCGCAATGACCCAGACAGACTGCTGTGCATTCTTATTGGAAAGACAAGGCAATA
AACCACAGTTACAAAACCCAGGGTCCCATGGTAACGAGCTCCACAGAGAAAAGGGAAGTGGGCCAGAGGTTCCGAGAGACACACATTTTGGATTGCAGGAGGGTGAGAAGGGGCATTCATCTGTGGTG
GGGTTAAGGGGAGGCCTCCGACTAGCTCACCTGCATGAATTTCAGGAACAAGCCATGCAGAGCCGGACAGAGCATTCTGTGCAGAGAAAACAGTGTAACAGCCCTAGAGCAGCAGCAGCAAAGGGGGA
GTTTAAGGGATGGTGGGAAGCCACTGTCACTGGACAGTAGCAAGTGGACAGACCAGGGGTCCCAGGTGAGGCCACAGAGCAGCCAAAGTACTGCAGGGCTCTCCGGCTCCGGGAGGACTTGATGTTTG
ACTCCAGTTGCCAGAGGAAGCCGTTCACGGGCTTTGAGTGTAGGAATGATGTGTCCGACTTGGGTCTTTTTATTGTTCTTTTTTAGAGACAGGGTCTCACTCTGTCACCCAGGCTGGAGTGCAGCGGC
ACAATCACAGCTCACTGCAGCCTCCACTTCCTGGGCTCAAGCAATCCTCCCACTTCAGCCACTCAAGTAGCTGGGATTACAGGTGCCTGCCGTCACACCCGGCTAATTGTTAAATTTTTTTGGAGAGA
CAGGATCTTGCTGTTTTCCCAGGCTGATCTTGAACTCCTGGGCTCAAGCGAGACGTCTGTTTCAGCCTCCCAAAGTGCTGGGATAACAGGTGTGAGCCACTGGGCCTGCCTTGGCTTGGGTATTAAAG
GAATTGTTCTAGTTACTATATGGAGGTGACTTGGGGCCGCTGGGGAAGAAAGAGGAAGTCAGGAGCCAGTCTGAGGCAGTGGCAATGCAGCGATTATCAGAAATAATGGGCTCAATGATAGACTGGAT
AAAGAAAATGTGGCACATATACGCCATGGAGTACTATGCAGCCATAAAAAGGGATGAGTTCATGTCCTTTGCAGGGACATGGATGAAGCTGGAAACCATCATTCTCAGCAAACTAACACAAGAACAGA
AAACCAAACACCGCATGTTCTCACTCGTAAGTGGGAGTTGAACAATGAGAACACATGGACACAGGGAAGGGAACATCACACACTGGGGCCTGTCAGTGGGTGGGGGGCTGGGGGAGGGAGAGCATCAG
GAGAAATACCCAATGTAGATGATGACGGGTTCATAGGTGCAGCAAACCACCATGGCACGTGTATACCTATGTAACAAACTTGTGCGTTCTGCACGTGTACCCCATAACTGAAAGTATAATCATAATTT
TAAGAAAAGAAATGATGGCCTTTGGGGTCTAATAAGAAGGTGGGGCTGACAGGGCTTGGGGAGAGAGCGAGCTTGACAGGAGACCACGATGTCTTCCCCAGGGGTCTGAGCACCTGGGGAAATGGTGG
TGCCATTTACCATGACTGGAAAGATCATGGGAGGAGCAGGTTTGGGACACTGAAGGCCCGAGAGCCCCTGGCAAACCACCAGTGTAAGTCCAAGAGTCCAAAAGCTGAAGAACTTGGAGTCCAATGTT
TGAGGGTAAAAAACAGCCAGCATGAGAAAAAGATGAAGGCCAGAAGACTCGTCCAGTCTAGCCCTTCCACATTCCTCTGCCCGCTTTTATCCTAGCCTCGCTGGCAGGTGATTAGATGGTGCCCACCC
AGGTTAAGCGTGGGTCTCTGTCTCCCAGTTCACTGACTCAAATGTTAATTTCCTTTGGCGACAGCCTCACAGACACACCCAGGAACGATACTTTGCATCCTCCAATCCAATCAAGTTGGCACTCAATA
TTAAACAGTTTCGGCCGGGAGCGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCCAAAGCGGGCAGATCACTAAGTCAGGAGATCGAGACCATCCTGGCTAACACGGTGAAACCCCATCTCTA
CTAAAAATACAAAAAATTAGCCAGGCGTGGTGGTGGGCGCCTGTAGTCCCAGCTACTCGGGAGGCTGAGGCAAGAGAGTGGCGTGAACCCGGGAGGCAGAACTTGCAGCAAGCAGAGATCGCACCACT
GCACTCCAGCCTCCAGCCTGGGCGACAGAGCAAGACACCGTCTCAAAAAAAAAAAAAAAACAACTAACAGTTTCGTTCATTAAGGCAATGTCCATGGGGCAGCTCCTGCATGCCACGCCACCCCTGCC
CTGACATACTCCCAGGCTGACCAGCCAGAACTGGGGAGAGGGCATCTTGAAGAAACAGTCCACCCTCCGCCCTCGCATACCTGTGTCTCCCAGCAGACAAGACACACAAGGGCAGGGACTGCACTTTC
CTGTGTGCAAATCTCAGGTATGGTCCAGAAATCACATCTCTTTGGTCTGATTGGCCTTACTTACCAAACCCTTGAAACAATGGAAAGAAGCTTGCTGCAATGGGAAGACCCCTGCCCCCCAAACCCTC
TAACCAGGAGTCTACAGACCTCATTCCGTGGAAGTTCCCATTGTCCCCTGGGAAACCACCACCTTCTGAATCGGCACAGCCAAGGCCCCCAACCCTGCTATCAACAGCTTTCCTTAGCCACCTTCCCC
ATCCTGCAGGGCTTTTCAACATTTCGACTTTTTAATCCTTCCCTCCCTAAGATATAGACATGGTGTTAGTAGCAGAACCCTGAAGGCAAAGGAACAGAAACTAACACTCTCAGAAAGTCCTAGCAGGA
TGGTCTGAATTAATAGACAGCTGCAGGCAGCCAGTGTGCAAGGCACGCTCGTAATGTCAGTGGCGTTCCGGAATGAGGGCTGTGATCCCAGGCAGCCCAGATCCCAAGGCGAAAACATTCATGTCGCC
CAGCATCACCCTGTCCTTGCCCAGGGTGACCCTGAGACGGCACTTGGATTCTTCCACATCTGAACTCAAACCTGCTCCCTCAGCTCTCCCCAGCAGGAATTGGAGCCCTCTCCAGGCCGTTCAGCCAA
AGCAGAATGTGTCTGGCCAAGCAGATCTGCCCAGAGAAGAACAAAGACGTGTTCAGACACTGTCTGGGGAATTGGTTTTGAGCTCACTCTGAGCTCCATCTGTGCAACAAGGCCAGCGTCAGCTGTTA
CAGAGAAGGGGCTTGTGGCAGTTTATTACCCTGGTGAGCTGGCTCGGGGCCATGCTGACCGCAGGACTGTAAAGGACATAAGGCAGTTGGCAATATGGGAAGCAGCAGTCCCCAAAGCACCCCGTCAA
GGAAACGATGCAAGAGCTCTGTCCACTGGACCAGCCCCACCCTACCCCGCCACGCCCTGGCCTAGGGGGAGGGACCTTGTGTTTCACGGGCCTGGATGGCCAGGGATGGACAGTGGCATGGGCACAGA
CACACCCAGACCGAAGGAAGGGCCCGGGCTCCAGAACCAGACCCGATCCAGGCTCCCAGCTCTGTCACCTACTGGCTGCATGAAAAGGGTGGGTTTTCCTTGTTTTGCAGCCTCAGCTATCTCAGCTG
TGAGGGAACAATGACGCCACCTCCCTCACGTGGCGGTCCTGAAGATGAAATGTAATGCATGCAGCGCGGCGGCCGGCCCACCGTGTGCTCTTAGTAACTGGCCGCTGTTCTCTTCAGCCCTCCCGTTA
CTGACCACCTCGAGGGCACCGTTCCTCCAAGCTGACCATTTCCTGCCAGTCACCCACTGCCCAGCTCGCCCAGCCATGGAGTGGGCTCTGGTCCACGTGCATGGTGAGCTGCCATCTTTGTCGTCCTC
TGGACACCACGTCTACCTCCTTGGGAAATAGAAACGAGTCCTGCATTGCTTTGTCAAATTTCACAAAAACCCTAGAAAGCAGATATTGCCCTGGTTTACAGACGGACAGACAGAAGCAAAGAGAAGCC
AACTGACCCACTCCAGGTTACAAGCAGGGTCTGGTAGGAGAGCACGCGTCCACCCCACCGCTCACTGCGCCCACCTACTCCTCGCTTGAGGGCAGAGAACGAGCTGGGGCGGGGCGCTCCAGGGGGCA
CAGGCAGCCTGTGTTCAAGGCATGCTCGTGAGCCCCACAGCAGGGGCGGAGTCAAACCAGGGCTCTGGTTCTGGGGTGAGCAGAGGGTGGGGCCAGGCCCCCACTGGGAGGCTGACTGAGGAGGGGCT
CAAAGGGCAGGCAGGCTCCATCAGAGCGGTTTGATGAGCAGGGCCGCTGAGTGGCCCTCAGGTCAAGGCTGGGGCCGGGACCACCAGGGACCAGGTCTGCGGGGCCAGGGGTCCCTCCCCAGGGTGGA
GCAGGAAAACTCCGGCAACCGCCTTCTTGAGTGGACTTGACCTTCCCTTTCTCTGCTAATGATCTCAGATTAATCCCTTAAGGCAAGTGCCCCAGGGTGGGTGTTGGTTGCATAAAACAAGAGGAGTC
CTTCTTCCCTTCCTTCCTGGCACAAACATTTGTAGGCCACCCCCGATGTGGCTGGTCGTAGTCTGGATTTGGGGGCACATTCAGGCATTCAACAAATACGTCATGAGGCCCCGTGATGAGCTGGGGGG
CTATGCTTGATGTCGGCAGTACAGCTGTGGTCGCTCGAATGAATGTGCCCGCCCTCACGGGACTGACCTCTAGTGGTGAGAGACAGACACTAACCGAGTCACATGTGTGATTACACGTGTAATCATAC
TTACATATGTAACAACACGAGTTACACGTGCAGTGTGGGGAGGGGGCCCTTCACGGTGACCAGCCCATCAGGGAAGGGGATGCGGGTGGCAGAAGGAAGCGGCACACCCTTGTCCTCACGGAGCTCAC
AGGAGGTTCTCTGACCCTCATCTTAAGCCACAGGCTGTGTCTGAGCCTCACTGCCCTAGCTATCAACTGGGTGCAGGACTAGGCCTTAATCACTGGGCAGCGGGAAGAACTACATAAGCTCATACTGG
CGCAAAGCCCCTTGGGAGACCGCAGGGAAAGCCATTGCATGAGGTGGTGACAGGCTCGGCCTTCAGAGTCGGGCTAGAATCTGAGTTCTGACAATGATCCCCGCCTTGACCCATCTCTCCTCAGGCCG
CCCTGAGCCTTCCAGTTAGGCCTGGGCTTTGGGCTTCCGTGTTTGTCTCTGGATTGTTCGGTTTTAGCAAGAGTCCTGCTAAATTGGTCTTGCTGGAATCCTCCGCCCTCCACATCTGATTGCCCTTC
CTGTCTGATCGTGGTCTTCATGCCCCACGGCCTCCAGGGGACGTCTGATCACCTGGCCTGCCTTCAGCAAGAATCCCCCCAGGTGTTTCCTCTTAAGAGGTTTTCCATCCACTGAGCCCACCCTGCTC
CTTGGCCATCAATTCCCACTTGCCTGTACTGTATTCAGAGGGGACCCCAATCTCTCTTCCCAGCTGCAGCGGTCCCTGTCCAACACTGCCCCCCACCTCAAATAAAGTCTTTCTTACTGTCTTTAACA
TATGCCGTCAATAAAGTTTTAGCAGATCCAA

hide sequence


Protein RefSeqs	NP_001159755	(Get FASTA)	NCBI Sequence Viewer
	NP_001159758	(Get FASTA)	NCBI Sequence Viewer
	NP_001159759	(Get FASTA)	NCBI Sequence Viewer
	NP_001159760	(Get FASTA)	NCBI Sequence Viewer
	NP_001159761	(Get FASTA)	NCBI Sequence Viewer
	NP_064596	(Get FASTA)	NCBI Sequence Viewer
GenBank Protein	AAH15886	(Get FASTA)	NCBI Sequence Viewer
	AAI27827	(Get FASTA)	NCBI Sequence Viewer
	AAI40839	(Get FASTA)	NCBI Sequence Viewer
	AAI51133	(Get FASTA)	NCBI Sequence Viewer
	ACS13733	(Get FASTA)	NCBI Sequence Viewer
	BAC11285	(Get FASTA)	NCBI Sequence Viewer
	BAC11321	(Get FASTA)	NCBI Sequence Viewer
	BAC11330	(Get FASTA)	NCBI Sequence Viewer
	BAF84054	(Get FASTA)	NCBI Sequence Viewer
	BAG54165	(Get FASTA)	NCBI Sequence Viewer
	BAH13014	(Get FASTA)	NCBI Sequence Viewer
	CAB66760	(Get FASTA)	NCBI Sequence Viewer
	CAB98207	(Get FASTA)	NCBI Sequence Viewer
	CAF86163	(Get FASTA)	NCBI Sequence Viewer
	CAF86186	(Get FASTA)	NCBI Sequence Viewer
	CAF86838	(Get FASTA)	NCBI Sequence Viewer
	EAX02166	(Get FASTA)	NCBI Sequence Viewer
	EAX02167	(Get FASTA)	NCBI Sequence Viewer
Ensembl Protein	ENSP00000330005
	ENSP00000330005.7
	ENSP00000404442
	ENSP00000404442.2
	ENSP00000440025
	ENSP00000440025.2
	ENSP00000442498
	ENSP00000442498.1
	ENSP00000452126
	ENSP00000452126.1
GenBank Protein	Q96B86	(Get FASTA)	NCBI Sequence Viewer

RefSeq Acc Id:	NP_001159759 ⟸ NM_001166287
- Peptide Label:	isoform 2 precursor
- UniProtKB:	C6G485 (UniProtKB/TrEMBL)
- Sequence:	show sequence MGMGRGAGRSALGFWPTLAFLLCSFPAATSPCKILKCNSEFWSATSGSHAPASDDTPEFCAALRSYALCTRRTARTCRGDLAYHSAVHGIEDLMSQHNCSKDGPTSQPRLRTLPPAGDSQERSDSPEI CHYEKSFHKHSATPNYTHCGLFGDPHLRTFTDRFQTCKVQGAWPLIDNNYLNVQVTNTPVLPGSAATATSKLTIIFKNFQECVDQKVYQAEMDELPAAFVDGSKNGGDKHGANSLKITEKVSGQHVEI QAKYIGTTIVVRQVGRYLTFAVRMPEEVVNAVEDWDSQGLYLCLRGCPLNQQIDFQAFHTNAEGTGARRLAAASPAPTAPETFPYETAVAKCKEKLPVEDLYYQACVFDLLTTGDVNFTLAAYYALED VKMLHSNKDKLHLYERTRDLPGRAAAGLPLAPRPLLGALVPLLALLPVFC hide sequence

RefSeq Acc Id:	NP_001159755 ⟸ NM_001166283
- Peptide Label:	isoform 1
- UniProtKB:	A0A0A0MTQ4 (UniProtKB/TrEMBL), C6G485 (UniProtKB/TrEMBL)
- Sequence:	show sequence MGGLGPRRAGTSRERLVVTGRAGWMGMGRGAGRSALGFWPTLAFLLCSFPAATSPCKILKCNSE FWSATSGSHAPASDDTPEFCAALRSYALCTRRTARTCRGDLAYHSAVHGIEDLMSQHNCSKDGPTSQPRLRTLPPAGDSQERSDSPEICHYEKSFHKHSATPNYTHCGLFGDPHLRTFTDRFQTCKVQ GAWPLIDNNYLNVQVTNTPVLPGSAATATSKLTIIFKNFQECVDQKVYQAEMDELPAAFVDGSKNGGDKHGANSLKITEKVSGQHVEIQAKYIGTTIVVRQVGRYLTFAVRMPEEVVNAVEDWDSQGL YLCLRGCPLNQQIDFQAFHTNAEGTGARRLAAASPAPTAPETFPYETAVAKCKEKLPVEDLYYQACVFDLLTTGDVNFTLAAYYALEDVKMLHSNKDKLHLYERTRDLPGRAAAGLPLAPRPLLGALV PLLALLPVFC hide sequence

RefSeq Acc Id:	NP_001159760 ⟸ NM_001166288
- Peptide Label:	isoform 2 precursor
- UniProtKB:	C6G485 (UniProtKB/TrEMBL)
- Sequence:	show sequence MGMGRGAGRSALGFWPTLAFLLCSFPAATSPCKILKCNSEFWSATSGSHAPASDDTPEFCAALR SYALCTRRTARTCRGDLAYHSAVHGIEDLMSQHNCSKDGPTSQPRLRTLPPAGDSQERSDSPEICHYEKSFHKHSATPNYTHCGLFGDPHLRTFTDRFQTCKVQGAWPLIDNNYLNVQVTNTPVLPGS AATATSKLTIIFKNFQECVDQKVYQAEMDELPAAFVDGSKNGGDKHGANSLKITEKVSGQHVEIQAKYIGTTIVVRQVGRYLTFAVRMPEEVVNAVEDWDSQGLYLCLRGCPLNQQIDFQAFHTNAEG TGARRLAAASPAPTAPETFPYETAVAKCKEKLPVEDLYYQACVFDLLTTGDVNFTLAAYYALEDVKMLHSNKDKLHLYERTRDLPGRAAAGLPLAPRPLLGALVPLLALLPVFC hide sequence

RefSeq Acc Id:	NP_001159761 ⟸ NM_001166289
- Peptide Label:	isoform 2 precursor
- UniProtKB:	C6G485 (UniProtKB/TrEMBL)
- Sequence:	show sequence MGMGRGAGRSALGFWPTLAFLLCSFPAATSPCKILKCNSEFWSATSGSHAPASDDTPEFCAALRSYALCTRRTARTCRGDLAYHSAVHGIEDLMSQHNCSKDGPTSQPRLRTLPPAGDSQERSDSPEI CHYEKSFHKHSATPNYTHCGLFGDPHLRTFTDRFQTCKVQGAWPLIDNNYLNVQVTNTPVLPGSAATATSKLTIIFKNFQECVDQKVYQAEMDELPAAFVDGSKNGGDKHGANSLKITEKVSGQHVEI QAKYIGTTIVVRQVGRYLTFAVRMPEEVVNAVEDWDSQGLYLCLRGCPLNQQIDFQAFHTNAEGTGARRLAAASPAPTAPETFPYETAVAKCKEKLPVEDLYYQACVFDLLTTGDVNFTLAAYYALED VKMLHSNKDKLHLYERTRDLPGRAAAGLPLAPRPLLGALVPLLALLPVFC hide sequence

RefSeq Acc Id:	NP_001159758 ⟸ NM_001166286
- Peptide Label:	isoform 2 precursor
- UniProtKB:	C6G485 (UniProtKB/TrEMBL)
- Sequence:	show sequence MGMGRGAGRSALGFWPTLAFLLCSFPAATSPCKILKCNSEFWSATSGSHAPASDDTPEFCAALR SYALCTRRTARTCRGDLAYHSAVHGIEDLMSQHNCSKDGPTSQPRLRTLPPAGDSQERSDSPEICHYEKSFHKHSATPNYTHCGLFGDPHLRTFTDRFQTCKVQGAWPLIDNNYLNVQVTNTPVLPGS AATATSKLTIIFKNFQECVDQKVYQAEMDELPAAFVDGSKNGGDKHGANSLKITEKVSGQHVEIQAKYIGTTIVVRQVGRYLTFAVRMPEEVVNAVEDWDSQGLYLCLRGCPLNQQIDFQAFHTNAEG TGARRLAAASPAPTAPETFPYETAVAKCKEKLPVEDLYYQACVFDLLTTGDVNFTLAAYYALEDVKMLHSNKDKLHLYERTRDLPGRAAAGLPLAPRPLLGALVPLLALLPVFC hide sequence

Protein Domains

Repulsive guidance molecule C-terminal Repulsive guidance molecule N-terminal

Name	Modeler	Protein Id	AA Range	Protein Structure
AF-Q96B86-F1-model_v2	AlphaFold	Q96B86	1-450	view protein structure

RGD ID:

6810809

Promoter ID:

HG_ACW:28186

Type:

CpG-Island

SO ACC ID:

SO:0000170

Source:

MPROMDB

Tissues & Cell Lines:

K562

Transcripts:

RGMA.EAPR07-UNSPLICED

Position:

Human Assembly	Chr	Position (strand)	Source
Build 36	15	91,387,966 - 91,388,466 (-)	MPROMDB

RGD ID:

7230621

Promoter ID:

EPDNEW_H21056

Type:

initiation region

Name:

RGMA_1

Description:

repulsive guidance molecule family member a

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H21057

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	15	93,073,156 - 93,073,216	EPDNEW

RGD ID:

7230623

Promoter ID:

EPDNEW_H21057

Type:

initiation region

Name:

RGMA_2

Description:

repulsive guidance molecule family member a

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H21056

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	15	93,089,200 - 93,089,260	EPDNEW

Database	Acc Id	Source(s)
COSMIC	RGMA	COSMIC
Ensembl Genes	ENSG00000182175	Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript	ENST00000329082	ENTREZGENE
	ENST00000329082.12	UniProtKB/Swiss-Prot
	ENST00000425933	ENTREZGENE
	ENST00000425933.6	UniProtKB/Swiss-Prot
	ENST00000542321	ENTREZGENE
	ENST00000542321.6	UniProtKB/Swiss-Prot
	ENST00000543599	ENTREZGENE
	ENST00000543599.5	UniProtKB/Swiss-Prot
	ENST00000557301	ENTREZGENE
	ENST00000557301.2	UniProtKB/Swiss-Prot
Gene3D-CATH	Mog1/PsbP, alpha/beta/alpha sandwich	UniProtKB/Swiss-Prot
GTEx	ENSG00000182175	GTEx
HGNC ID	HGNC:30308	ENTREZGENE
Human Proteome Map	RGMA	Human Proteome Map
InterPro	RGM	UniProtKB/Swiss-Prot
	RGM_C	UniProtKB/Swiss-Prot
	RGM_N	UniProtKB/Swiss-Prot
KEGG Report	hsa:56963	UniProtKB/Swiss-Prot
NCBI Gene	56963	ENTREZGENE
OMIM	607362	OMIM
PANTHER	PTHR31428	UniProtKB/Swiss-Prot
	PTHR31428:SF4	UniProtKB/Swiss-Prot
Pfam	RGM_C	UniProtKB/Swiss-Prot
	RGM_N	UniProtKB/Swiss-Prot
PharmGKB	PA128394693	PharmGKB
UniProt	A0A0A0MTQ4	ENTREZGENE, UniProtKB/TrEMBL
	A0A0G2JL92_HUMAN	UniProtKB/TrEMBL
	A1L187_HUMAN	UniProtKB/TrEMBL
	B2RTW1	ENTREZGENE
	B7Z5S8	ENTREZGENE
	C6G485	ENTREZGENE, UniProtKB/TrEMBL
	F5GXQ7	ENTREZGENE
	F5GZU6	ENTREZGENE
	F5H7G2_HUMAN	UniProtKB/TrEMBL
	G3V3Z3_HUMAN	UniProtKB/TrEMBL
	G3V4C2_HUMAN	UniProtKB/TrEMBL
	G3V518	ENTREZGENE
	G3V545_HUMAN	UniProtKB/TrEMBL
	Q0JV97	ENTREZGENE
	Q8NC80	ENTREZGENE
	Q96B86	ENTREZGENE
	Q9H0E6	ENTREZGENE
	Q9NPM3	ENTREZGENE
	RGMA_HUMAN	UniProtKB/Swiss-Prot
UniProt Secondary	B2RTW1	UniProtKB/Swiss-Prot
	B7Z5S8	UniProtKB/Swiss-Prot
	F5GXQ7	UniProtKB/Swiss-Prot
	F5GZU6	UniProtKB/Swiss-Prot
	G3V518	UniProtKB/Swiss-Prot
	Q0JV97	UniProtKB/Swiss-Prot
	Q8NC80	UniProtKB/Swiss-Prot
	Q9H0E6	UniProtKB/Swiss-Prot
	Q9NPM3	UniProtKB/Swiss-Prot

Nomenclature History

Date	Current Symbol	Current Name	Previous Symbol	Previous Name	Description	Reference	Status
2018-01-16	RGMA	repulsive guidance molecule BMP co-receptor a		repulsive guidance molecule family member a	Symbol and/or name change	5135510	APPROVED
2013-11-12	RGMA	repulsive guidance molecule family member a		RGM domain family, member A	Symbol and/or name change	5135510	APPROVED

Gene Annotator (Functional Annotation) unavailable	Gene Annotator (Annotation Distribution) unavailable	Variant Visualizer (Genomic Variants) unavailable


InterViewer (Protein-Protein Interactions) unavailable	Gviewer (Genome Viewer) unavailable	Variant Visualizer (Damaging Variants) unavailable


Gene Annotator (Annotation Comparison) unavailable	OLGA (Gene List Generator) unavailable
		Excel (Download)

MOET (Multi-Ontology Enrichement) unavailable	GOLF (Gene-Ortholog Location Finder) unavailable

Send us a Message

Imported Annotations - PID (archival)

Manual Human Phenotype Annotations - RGD